Translational neuroblastoma and medulloblastoma research – John Inge Johnsen research group

Publications

All publications from group members

• Journal article: PLOS MEDICINE. 2026;23(3):e1004934

  Childhood cancer in Sweden during the COVID-19 pandemic: Temporal patterns in incidence and survival in a nationwide register-based cohort study.

  Kampitsi C-E; Louro J; Mogensen H; Erdmann F; Georgantzi K; Heyman M; Lähteenmäki P; Nilsson A; Feychting M; Tettamanti G
• Article: PLOS MEDICINE. 2026;23(3):e1004934

  Childhood cancer in Sweden during the COVID-19 pandemic: Temporal patterns in incidence and survival in a nationwide register-based cohort study

  Kampitsi C-E; Louro J; Mogensen H; Erdmann F; Georgantzi K; Heyman M; Lahteenmaki P; Nilsson A; Feychting M; Tettamanti G
• Article: NPJ PRECISION ONCOLOGY. 2026;10(1):113

  Novel activating SNRNP70-ALK fusion in congenital infant-type hemispheric glioma displays clinical response to lorlatinib: a case-report

  Arthur C; Georgantzi K; de Stahl TD; Guan J; Oder B; Jylha C; Illies C; Sandgren J; Svoboda J; Eisfeldt J; Barbany G; Rosenquist R; Sandvik U; Hagerstrand D; Hallberg B; Palmer R; Tham E
• Article: EMBO MOLECULAR MEDICINE. 2026;18(2):433-461

  Repurposing statins and phenothiazines to treat chemoresistant neuroblastoma

  Radke K; Aaltonen K; Mucino-Olmos EA; Esfandyari J; Adamska A; Siaw JT; Adamic D; Lago C; Manas A; Seger A; Hansson K; Rogova O; Lehn S; Mason DJ; O'donovan DJ; Roberts I; Lock A; Brennan J; Pietras K; Davies EJ; Spegel P; Bedoya-Reina OC; Brown D; Thompson NT; Spadoni C; Bexell D
• Article: EJHAEM. 2026;7(1):e70228

  Systemic Immune Alterations in Paediatric Classical Hodgkin Lymphoma With CCL17 and MCP-4 as Diagnostic and Predictive Biomarkers.

  Hedberg G; Chen Q; Lakshmikanth T; Herold N; Kogner P; Brodin P; Ljungblad L
• Article: ONCOIMMUNOLOGY. 2025;14(1):2485535

  EphA2 and phosphoantigen-mediated selective killing of medulloblastoma by γδT cells preserves neuronal and stem cell integrity

  Boutin L; Liu M; Merville JD; Bedoya-Reina O; Wilhelm MT
• Journal article: NEURO-ONCOLOGY PEDIATRICS. 2025;1(2)

  Forty years of follow-up: Incidence, diagnoses and long-term survival in children diagnosed with central nervous system tumors in Sweden 1984-2021

  Schepke E; Lähteenmäki P; Georgantzi K; Sandström P-E; Nyman P; Mörse H; Öberg A; Carén H; Sabel M
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2025;122(43):e2516922122

  HIF2α negatively regulates MYCN protein levels and promotes a low- risk noradrenergic phenotype in neuroblastoma

  Yuan J; Maitra S; Antoniou E; Zhu J; Li W; Demirel IS; Toskas K; Martinez IL; Ozcimen L; Lindehell H; Muhr J; Stenman J; Kogner P; Bedoya-Reina OC; Schlisio S; Holmberg J
• Journal article: ACTA NEUROPATHOLOGICA. 2025;150(1):42

  Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORM

  Pfaff E; Schramm K; Blattner-Johnson M; Jones BC; Stark S; Balasubramanian GP; Previti C; Autry RJ; Fiesel P; Sahm F; Reuss D; von Deimling A; van Tilburg CM; Pajtler KW; Milde T; Dirksen U; Kramm CM; von Bueren AO; Hutter C; de Wilde B; Molenaar J; Gerber NU; Lohi O; Munthe-Kaas MC; Georgantzi K; Kazanowska B; Zapotocky M; Kattamis A; Filippidou M; Fried I; Pfister SM; Witt O; Jones DTW
• Article: NPJ PRECISION ONCOLOGY. 2025;9(1):311

  Targeted ferroptosis induction enhances chemotherapy efficacy in chemoresistant neuroblastoma

  Manas A; Seger A; Adamska A; Smyrilli K; Siaw JT; Radke K; Mucino-Olmos EA; Bedoya-Reina OC; Esfandyari J; Aaltonen K; Bexell D
• Article: CANCER LETTERS. 2025;625:217769

  Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression

  Milosevic J; Fransson S; Svensson J; Otte J; Olsen TK; Sveinbjornsson B; Hertwig F; Bartenhagen C; Abel F; Reinsbach SE; Djos A; Javanmardi N; Shi Y; Hehir-Kwa JY; Mensenkamp A; Tytgat GAM; Holmberg J; Molenaar JJ; Jongmans M; Fischer M; Baryawno N; Gisselsson D; Martinsson T; Kogner P; Johnsen JI
• Article: CLINICAL EPIGENETICS. 2025;17(1):131

  DNA methylation profiling for molecular classification of neuroblastoma

  Lofgren M; Djos A; Rezaei S; Suman M; Kogner P; Martinsson T; Fransson S; Caren H
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2025;122(25):e2427211122

  Combined targeting of PRDX6 and GSTP1 as a potential differentiation strategy for neuroblastoma treatment

  Liano-Pons J; Garde-Lapido E; Fahrig FL; Jackering M; Yuan Y; Andersson S; Schort L; Esteve M; Mohlin S; Bedoya-Reina OC; Arsenian-Henriksson M
• Journal article: EJC PAEDIATRIC ONCOLOGY. 2025;5:100211

  Local application of sodium thiosulfate as an otoprotectant for cisplatin-exposed patients-A narrative literature review to explore the potential benefit for children with cancer

  Streefkerk N; Masroor A; Geller JI; van Grotel M; Ansari M; Bouffet E; Bleyer A; Fresnau B; Sullivan M; Huitema ADR; Hoetink AE; Kogner P; Maibach R; O'Neill AF; Papadakis V; Rajput KM; Veal GJ; Brock PR; Meijer AJM; van den Heuvel-Eibrink MM
• Doctoral thesis: 2025

  Unveiling the cellular heterogeneity of cancer metastasis

  Tsea I
• Article: FRONTIERS IN ONCOLOGY. 2025;15:1569520

  Comparative analysis of whole-genome sequencing of tumor and cfDNA in a neuroblastoma patient: a case report

  Fransson S; Georgantzi K; Djos A; Gaarder J; Svensson J; Anthonydhason V; Kogner P; Martinsson T; Umapathy G
• Article: CELL DEATH & DISEASE. 2025;16(1):318

  Targeted inhibition of WIP1 and histone H3K27 demethylase activity synergistically suppresses neuroblastoma growth

  Treis D; Lundberg KI; Bell N; Polychronopoulos PA; Tuemmler C; Akerlund E; Aliverti S; Lilienthal I; Pepich A; Seashore-Ludlow B; Sakaguchi K; Kogner P; Johnsen JI; Wickstroem M
• Dataset: KI DATA REPOSITORY. 2025

  RNA sequencing of drug combinations for SL-176 and GSK-J4 in neuroblastoma cell lines

  Treis D; Wickström Näsman M
• Article: CANCER RESEARCH. 2025;85(6):1015-1034

  Comparative Single-Cell Transcriptomics of Human Neuroblastoma and Preclinical Models Reveals Conservation of an Adrenergic Cell State

  Embaie BT; Sarkar H; Alchahin AM; Otte J; Olsen TK; Tummler C; Kameneva P; Artemov AV; Akkuratova N; Adameyko I; Stukenborg J-B; Wickstrom M; Kogner P; Johnsen JI; Mei S; Kharchenko PV; Baryawno N
• Article: NEURO-ONCOLOGY. 2025;27(3):779-794

  Development of an orthotopic medulloblastoma zebrafish model for rapid drug testing

  van Bree N; Oppelt A-S; Lindstroem S; Zhou L; Boutin L; Coyle B; Swartling FJ; Johnsen JI; Braeutigam L; Wilhelm M
• Article: CELL. 2025;188(5):1425-1440.e11

  Systems-level immunomonitoring in children with solid tumors to enable precision medicine

  Chen Q; Zhao B; Tan Z; Hedberg G; Wang J; Gonzalez L; Mugabo CH; Johnsson A; Negrini E; Paez LP; Rodriguez L; James A; Chen Y; Mikes J; Bernhardsson AK; Reitzner SM; von Walden F; O'Neill O; Barcenilla H; Wang C; Davis MM; Carlson L-M; Pal N; Blomgren K; Repsilber D; Herold N; Lakshmikanth T; Kogner P; Ljungblad L; Brodin P
• Preprint: RESEARCH SQUARE. 2025

  Gain of chromosome 17 is an early genetic abnormality in neuroblastoma with PPM1D emerging as a strong candidate oncogene driving tumor progression

  Milosevic J; Fransson S; Svensson J; Otte J; Olsen T; Sveinbjornsson B; Hertwig F; Bartenhagen C; Abel F; Reinsbach S; Djos A; Javanmardi N; Shi Y; Hehir-Kwa J; Mensenkamp A; Tytgat GAM; Holmberg J; Molenaar J; Jongmans M; Fischer M; Baryawno N; Gisselsson D; Martinsson T; Kogner P; Johnsen JI
• Article: EMBO JOURNAL. 2024;43(24):6310-6335

  METTL3/MYCN cooperation drives neural crest differentiation and provides therapeutic vulnerability in neuroblastoma

  Thombare K; Vaid R; Pucci P; Lundberg KI; Ayyalusamy R; Baig MH; Mendez A; Burgos-Panadero R; Hoeppner S; Bartenhagen C; Sjovall D; Rehan AA; Nale SD; Djos A; Martinsson T; Jaako P; Dong J-J; Kogner P; Johnsen JI; Fischer M; Turner SD; Mondal T
• Article: CANCERS. 2024;16(24):4162

  DHODH Inhibition Suppresses MYC and Inhibits the Growth of Medulloblastoma in a Novel In Vivo Zebrafish Model

  Tsea I; Olsen TK; Polychronopoulos PA; Tummler C; Sykes DB; Baryawno N; Dyberg C
• Journal article: NEURO-ONCOLOGY ADVANCES. 2024;6(1):vdae172

  Genomic tumor evolution dictates human medulloblastoma progression

  Ruchiy Y; Tsea I; Preka E; Verhoeven BM; Olsen TK; Mei S; Sinha I; Blomgren K; Carlson L-M; Dyberg C; Johnsen JI; Baryawno N
• Article: AMERICAN JOURNAL OF MEDICAL GENETICS PART A. 2024;194(12):e63812

  Occurrence of cancer in Marfan syndrome: Report of two patients with neuroblastoma and review of the literature

  Maya-Gonzalez C; Delgado-Vega AM; Taylan F; Robinson KL; Hansson L; Pal N; Fagman H; Puls F; Wessman S; Stenman J; Georgantzi K; Fransson S; De Stahl TD; Ek T; Palmer R; Tesi B; Kogner P; Martinsson T; Nordgren A
• Article: CANCER LETTERS. 2024;605:217261

  The ROCK-1/2 inhibitor RKI-1447 blocks N-MYC, promotes cell death, and emerges as a synergistic partner for BET inhibitors in neuroblastoma

  Pepich A; Tummler C; Abu Ajamieh S; Treis D; Boje AS; Vellema Q; Tsea I; Akerlund E; Seashore-Ludlow B; Fard SS; Kogner P; Johnsen JI; Wickstrom M
• Preprint: BIORXIV. 2024

  HIF2α negatively regulates MYCN protein levels and promotes a low-risk noradrenergic phenotype in neuroblastoma

  Yuan J; Maitra S; Antoniou E; Zhu J; Li W; Demirel IS; Toskas K; Martinez IL; Ozcimen L; Lindehell H; Kogner P; Bedoya-Reina O; Schlisio S; Holmberg J
• Conference publication: 2024;:a217

  189 Genomic landscape and systemic immune states across pediatric solid tumors

  Zhao B; Chen Q; Tan Z; Hedberg G; Wang J; Gonzalez L; Mugabo C; Johansson A; Rodriguez L; Paez LP; James A; Chen Y; Mikes J; Barcenilla H; Wang C; Davis M; Carlson LM; Pal N; Blomgren K; Repsilber D; Lakshmikanth T; Kogner P; Ljungblad L; Brodin P
• Conference publication: 2024;:a41

  37 Systems-level immunity in children with solid tumors

  Chen Q; Zhao B; Tan Z; Hedberg G; Wang J; Gonzalez L; Mugabo C; Johnsson A; Paez LP; Rodriguez L; James A; Chen Y; Mikes J; Barcenilla H; Wang C; Davis M; Carlson LM; Pal N; Blomgren K; Repsilber D; Lakshmikanth T; Kogner P; Ljungblad L; Brodin P
• Article: FRONTIERS IN ONCOLOGY. 2024;14:1408729

  Heterogeneous SSTR2 target expression and a novel KIAA1549::BRAF fusion clone in a progressive metastatic lesion following ¹⁷⁷Lutetium-DOTATATE molecular radiotherapy in neuroblastoma: a case report

  Park SWS; Fransson S; Sundquist F; Nilsson JN; Gryback P; Wessman S; Stromgren J; Djos A; Fagman H; Sjoegren H; Georgantzi K; Herold N; Kogner P; Granberg D; Gaze MN; Martinsson T; Karlsson K; Stenman JJE
• Article: JOURNAL OF CLINICAL INVESTIGATION. 2024;134(21):e175310

  Epigenetic regulation of cell state by H2AFY governs immunogenicity in high-risk neuroblastoma

  Nagarajan D; Parracho RT; Corujo D; Xie M; Kutkaite G; Olsen TK; Bedos MR; Salehi M; Baryawno N; Menden MP; Chen X; Buschbeck M; Mao Y
• Journal article: CANCER RESEARCH. 2024;84(17):b060

  Clonal composition of αβ and γδ T cells in primary human neuroblastoma tumors - Is every child unique?

  Verhoeven BM; Ye K; Stenman J; Kogner P; Johnsen JI; Reina OB; Kreslavskiy T; Baryawno N
• Article: CANCER RESEARCH COMMUNICATIONS. 2024;4(9):2553-2564

  Long-Lasting Response to Lorlatinib in Patients with ALK-Driven Relapsed or Refractory Neuroblastoma Monitored with Circulating Tumor DNA Analysis

  Ek T; Ibrahim RR; Vogt H; Georgantzi K; Trager C; Gaarder J; Djos A; Rahmqvist I; Mellstroem E; Pujol-Calderon F; Vannas C; Hansson L; Fagman H; Treis D; Fransson S; Osterlund T; Chuang T-P; Verhoeven BM; Stahlberg A; Palmer RH; Hallberg B; Martinsson T; Kogner P; Dalin M
• Article: MOLECULAR CANCER. 2024;23(1):180

  Joint single-cell genetic and transcriptomic analysis reveal pre-malignant SCP-like subclones in human neuroblastoma

  Olsen TK; Otte J; Mei S; Embaie BT; Kameneva P; Cheng H; Gao T; Zachariadis V; Tsea I; Bjorklund A; Kryukov E; Hou Z; Johansson A; Sundstrom E; Martinsson T; Fransson S; Stenman J; Fard SS; Johnsen JI; Kogner P; Adameyko I; Enge M; Kharchenko PV; Baryawno N
• Article: JOURNAL OF TRANSLATIONAL MEDICINE. 2024;22(1):808

  Altered methylation of imprinted genes in neuroblastoma: implications for prognostic refinement

  Suman M; Lofgren M; Fransson S; Yousuf JI; Svensson J; Djos A; Martinsson T; Kogner P; Kling T; Caren H
• Review: PEDIATRICS. 2024;154(2):e2024066081

  Bone Mineral Density in Survivors of Childhood Cancer: A Meta-Analysis

  Velentza L; Filis P; Wilhelmsson M; Kogner P; Herold N; Savendahl L
• Article: GENES CHROMOSOMES & CANCER. 2024;63(7):e23260

  Loss of Chromosome Y in Neuroblastoma Is Associated With High-Risk Disease, 11q-Deletion, and Telomere Maintenance

  Djos A; Svensson J; Gaarder J; Umapathy G; Nilsson S; Ek T; Vogt H; Georgantzi K; Ora I; Trager C; Kogner P; Martinsson T; Fransson S
• Review: JOURNAL OF CLINICAL ONCOLOGY. 2024;42(18):2219-2232

  Use of Sodium Thiosulfate as an Otoprotectant in Patients With Cancer Treated With Platinum Compounds: A Review of the Literature

  Meijer AJM; Diepstraten FA; Ansari M; Bouffet E; Bleyer A; Fresneau B; Geller JI; Huitema ADR; Kogner P; Maibach R; O'Neill AF; Papadakis V; Rajput KM; Veal GJ; Sullivan M; van den Heuvel-eibrink MM; Brock PR
• Journal article: NEURO-ONCOLOGY. 2024;26:0

  IN VITRO MODELLING OF PEDIATRIC SUPRATENTORIAL EPENDYMOMAS USING CEREBRAL ORGANOIDS

  Roosen M; Morscio J; Stathi P; Mack N; Schwalm B; Polychronopoulos PA; Kranendonk MEG; Hoving E; Bunt J; Kool M
• Review: CANCERS. 2024;16(10):1863

  The Neuroblastoma Microenvironment, Heterogeneity and Immunotherapeutic Approaches

  Polychronopoulos PA; Bedoya-Reina OC; Johnsen JI
• Review: GYNECOLOGIC ONCOLOGY. 2024;184:206-213

  A comprehensive population-based study of malignant ovarian tumors, including histologic and immunohistochemical review, in children and adolescents 0-19 years old in Sweden between 1970 and 2014

  Wessman S; Nister M; Kokaraki G; Pal N; Tettamanti G; Petta TB; Carlson JW
• Article: LANCET REGIONAL HEALTH-EUROPE. 2024;39:100881

  Diagnostic yield and clinical impact of germline sequencing in children with CNS and extracranial solid tumors - a nationwide, prospective Swedish study

  Tesi B; Robinson KL; Abel F; Stahl TDD; Orrsjoe S; Poluha A; Hellberg M; Wessman S; Samuelsson S; Frisk T; Vogt H; Henning K; Sabel M; Ek T; Pal N; Nyman P; Giraud G; Wille J; Pronk CJ; Noren-Nystroem U; Borssen M; Fili M; Stalhammar G; Herold N; Tettamanti G; Maya-Gonzalez C; Arvidsson L; Rosen A; Ekholm K; Kuchinskaya E; Hallbeck A-L; Nordling M; Palmebaeck P; Kogner P; Smoler GK; Laehteenmaeki P; Fransso S; Martinsson T; Shamik A; Mertens F; Rosenquist R; Wirta V; Tham E; Grillner P; Sandgren J; Ljungman G; Gisselsson D; Taylan F; Nordgren A
• Article: NUCLEIC ACIDS RESEARCH. 2024;52(5):2648-2671

  METTL3 drives telomere targeting of TERRA lncRNA through m⁶A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma

  Vaid R; Thombare K; Mendez A; Burgos-Panadero R; Djos A; Jachimowicz D; Lundberg KI; Bartenhagen C; Kumar N; Tummler C; Sihlbom C; Fransson S; Johnsen JI; Kogner P; Martinsson T; Fischer M; Mondal T
• Journal article: CANCER RESEARCH. 2024;84(6):6378

  Systems-level immunomonitoring in children with solid tumors

  Chen Q; Zhao B; Tan Z; Hedberg G; Wang J; Gonzalez L; Mugabo C; Johnsson A; Paez L; Rodriguez L; James A; Chen Y; Mikes J; Barcenilla H; Wang C; Davis MM; Carlson L-M; Pal N; Herold N; Blomgren K; Repsilber D; Lakshmikanth T; Kogner P; Ljungblad L; Brodin P
• Preprint: BIORXIV. 2024

  Development of an orthotopic medulloblastoma zebrafish model for rapid drug testing

  van Bree N; Oppelt A-S; Lindström S; Zhou L; Boutin L; Johnsen JI; Bräutigam L; Wilhelm M
• Article: CANCERS. 2024;16(4):812

  Recent Advances in Neuroblastoma Research

  Johnsen JI; Kogner P
• Article: JCI INSIGHT. 2024;9(6):e173337

  Single-cell analyses of metastatic bone marrow in human neuroblastoma reveals microenvironmental remodeling and metastatic

  Mei S; Alchahin AM; Embaie BT; Gavriliuc IM; Verhoeven BM; Zhao T; Li X; Jeffries NE; Pepich A; Sarkar H; Olsen TK; Wickstrom M; Stenman J; Reina-Bedoya O; Kharchenko PV; Saylor PJ; Johnsen JI; Sykes DB; Kogner P; Baryawno N
• Article: MOLECULAR ONCOLOGY. 2024;18(2):317-335

  High-content screening of drug combinations of an mPGES-1 inhibitor in multicellular tumor spheroids leads to mechanistic insights into neuroblastoma chemoresistance

  Zaghmi A; Aybay E; Jiang L; Shang M; Steinmetz-Spah J; Wermeling F; Kogner P; Korotkova M; Ostling P; Jakobsson P-J; Seashore-Ludlow B; Larsson K
• Article: GENOME MEDICINE. 2024;16(1):1

  Single-cell analysis of immune and stroma cell remodeling in clear cell renal cell carcinoma primary tumors and bone metastatic lesions

  Mei S; Alchahin AM; Tsea I; Kfoury Y; Hirz T; Jeffries NE; Zhao T; Xu Y; Zhang H; Sarkar H; Wu S; Subtelny AO; Johnsen JI; Zhang Y; Salari K; Wu C-L; Randolph MA; Scadden DT; Dahl DM; Shin J; Kharchenko PV; Saylor PJ; Sykes DB; Baryawno N
• Article: JOURNAL OF THE ENDOCRINE SOCIETY. 2024;8(3):bvae009

  Humanin Treatment Protects Against Venetoclax-Induced Bone Growth Retardation in Ex Vivo Cultured Rat Bones.

  Velentza L; Wickström M; Kogner P; Ohlsson C; Zaman F; Sävendahl L
• Journal article: JOURNAL OF THE ENDOCRINE SOCIETY. 2024;8(3):bvae009

  Humanin Treatment Protects Against Venetoclax-Induced Bone Growth Retardation in Ex Vivo Cultured Rat Bones

  Velentza L; Wickstrom M; Kogner P; Ohlsson C; Zaman F; Saevendahl L
• Article: NEURO-ONCOLOGY ADVANCES. 2024;6(1):vdae172

  Genomic tumor evolution dictates human medulloblastoma progression.

  Ruchiy Y; Tsea I; Preka E; Verhoeven BM; Olsen TK; Mei S; Sinha I; Blomgren K; Carlson L-M; Dyberg C; Johnsen JI; Baryawno N
• Conference publication: EUROPEAN JOURNAL OF HUMAN GENETICS. 2024;32:545-546

  Occurrence of cancer in Marfan syndrome: report of two females with neuroblastoma and review of the literature

  Gonzalez CM; Taylan F; Tesi B; Lagerstedt-Robinson K; Wessman S; Stenman J; Fagman H; Olsen TK; Georgantzi K; de Stahl TD; Ek T; Palmer R; Forsberg S; Martinsson T; Kogner P; Nordgren A
• Article: CANCERS. 2023;15(24):5732

  Telomere Maintenance Mechanisms in a Cohort of High-Risk Neuroblastoma Tumors and Its Relation to Genomic Variants in the TERT and ATRX Genes

  Djos A; Thombare K; Vaid R; Gaarder J; Umapathy G; Reinsbach SE; Georgantzi K; Stenman J; Caren H; Ek T; Mondal T; Kogner P; Martinsson T; Fransson S
• Conference publication: PEDIATRIC BLOOD & CANCER. 2023;70:S107

  EXPANSION OF VD1+GAMMA DELTA T CELLS IN HUMAN NEUROBLASTOMA TUMORS REVEALS NOVEL POSSIBILITIES FOR IMMUNOTHERAPY

  Verhoeven BM; Ye K; Stenman J; Kogner P; Johnsen JI; Baryawno N; Kreslavskiy T
• Conference publication: PEDIATRIC BLOOD & CANCER. 2023;70:S89

  HIGH RISK NEUROBLASTOMA (HR-NB) WITH MNA AND AGE

  Ladenstein R; Poetschger U; Valteau-Couanet D; Ash S; Beck-Popovic M; Balwierz W; Boterberg T; Chan GCF; Elliott M; Kogner P; Lode H; Laureys G; Luksch R; Malis J; Owens C; Papadakis V; Sarnacki S; Taschner-Mandl S; Schleiermacher G; Canete A
• Conference publication: PEDIATRIC BLOOD & CANCER. 2023;70

  RISK FACTORS IN HIGH RISK NEUROBLASTOMA PATIENTS OVER 5 YEARS: RESULTS FROM THE HR-NBL1/SIOPEN TRIAL

  Ladenstein R; Valteau-Couanet D; Elliott M; Luksch R; Castel V; Ash S; Balwierz W; Laureys G; Beiske K; Kogner P; Papadakis V; Beck-Popovic M; Malis J; Brok JS; Vettenranta K; Bician P; Trahair T; Chan GCF; Owens C; Lacerda A; Sarnacki S; Boterberg T; Taschner-Mandl S; Schleiermacher G; Lode H; Poetschger U
• Review: CANCERS. 2023;15(19):4734

  Recent Advances in Single-Cell RNA-Sequencing of Primary and Metastatic Clear Cell Renal Cell Carcinoma

  Alchahin AM; Tsea I; Baryawno N
• Article: CANCERS. 2023;15(18):4599

  Target Genes of c-MYC and MYCN with Prognostic Power in Neuroblastoma Exhibit Different Expressions during Sympathoadrenal Development

  Yuan Y; Alzrigat M; Rodriguez-Garcia A; Wang X; Bexelius TS; Johnsen JI; Arsenian-Henriksson M; Liano-Pons J; Bedoya-Reina OC
• Article: FRONTIERS IN PHARMACOLOGY. 2023;14:1183720

  The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironment

  Proestler E; Donzelli J; Nevermann S; Breitwieser K; Koch LF; Best T; Fauth M; Wickstrom M; Harter PN; Kogner P; Lavieu G; Larsson K; Saul MJ
• Conference publication: NEURO-ONCOLOGY. 2023;25:i62

  SINGLE-CELL TRANSCRIPTOMIC ANALYSIS REVEALS DISTINCT GENOMIC LANDSCAPES, CELL TRAJECTORIES, AND TUMOUR-MICROENVIRONMENT INTERACTIONS IN FOUR SUBTYPES OF MEDULLOBLASTOMA

  Ruchiy Y; Tsea I; Verhoeven BM; Sinha I; Preka E; Olsen TK; Mei S; Blomgren K; Johnsen JI; Carlson L-M; Dyberg C; Baryawno N
• Journal article: NEURO-ONCOLOGY. 2023;25(Suppl 1):i62

  MDB-04. SINGLE-CELL TRANSCRIPTOMIC ANALYSIS REVEALS DISTINCT GENOMIC LANDSCAPES, CELL TRAJECTORIES, AND TUMOUR-MICROENVIRONMENT INTERACTIONS IN FOUR SUBTYPES OF MEDULLOBLASTOMA
• Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16)

  High risk neuroblastoma (HR-NB) with MNA and age <18 months: Results from the HR-NBL1/SIOPEN trial

  Ladenstein RL; Poetschger U; Couanet DV; Ash S; Popovic MB; Balwierz W; Boterberg T; Chan GC-F; Elliott M; Kogner P; Lode HN; Laureys G; Luksch R; Malis J; Owens C; Papadakis V; Sarnacki S; Taschner-Mandl S; Schleiermacher G; Canete A
• Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2023;41(16_SUPPL):10000

  High risk neuroblastoma (HR-NB) with MNA and age <18 months: Results from the HR-NBL1/SIOPEN trial.

  Ladenstein RL; Poetschger U; Couanet DV; Ash S; Popovic MB; Balwierz W; Boterberg T; Chan GC-F; Elliott M; Kogner P; Lode HN; Laureys G; Luksch R; Malis J; Owens C; Papadakis V; Sarnacki S; Taschner-Mandl S; Schleiermacher G; Canete A
• Article: JCO PRECISION ONCOLOGY. 2023;7:e2300039

  Diagnostic Yield From a Nationwide Implementation of Precision Medicine for all Children With Cancer

  Wadensten E; Wessman S; Abel F; De Stahl TD; Tesi B; Pietras CO; Arvidsson L; Taylan F; Fransson S; Vogt H; Poluha A; Pradhananga S; Hellberg M; Lagerstedt-Robinson K; Raj Somarajan P; Samuelsson S; Orrsjo S; Maqbool K; Henning K; Strid T; Ek T; Fagman H; Bontell TO; Martinsson T; Puls F; Kogner P; Wirta V; Pronk CJ; Wille J; Rosenquist R; Nister M; Mertens F; Sabel M; Noren-Nystrom U; Grillner P; Nordgren A; Ljungman G; Sandgren J; Gisselsson D
• Article: JOURNAL OF TRANSLATIONAL MEDICINE. 2023;21(1):342

  The Swedish childhood tumor biobank: systematic collection and molecular characterization of all pediatric CNS and other solid tumors in Sweden

  de Stahl TD; Shamikh A; Mayrhofer M; Juhos S; Basmaci E; Prochazka G; Garcia M; Somarajan PR; Zielinska-Chomej K; Illies C; Ora I; Siesjo P; Sandstrom P-E; Stenman J; Sabel M; Gustavsson B; Kogner P; Pfeifer S; Ljungman G; Sandgren J; Nister M
• Article: SCIENTIFIC REPORTS. 2023;13(1):8054

  Pharmacological inhibition of BCL-2 with the FDA-approved drug venetoclax impairs longitudinal bone growth

  Velentza L; Wickstrom M; Kogner P; Ohlsson C; Zaman F; Savendahl L
• Editorial: PEDIATRIC BLOOD & CANCER. 2023;70(5):e30248

  Sodium thiosulfate as cisplatin otoprotectant in children: The challenge of when to use it

  Brock P; Meijer A; Kogner P; Ansari M; Capra M; Geller J; van den Heuvel-Eibrink M; Knight K; Kruger M; Lindemulder S; Maibach R; O'Neill A; Papadakis V; Rajput K; Bleyer A; Bouffet E; Sullivan M
• Article: ECLINICALMEDICINE. 2023;59:101963

  Pregnancy and neonatal outcomes among women with early-onset colorectal cancer: a nationwide case-control study

  Cao Y; Zhao S; Bexelius TS; Soederling J; Shi M; Roelstraete B; Warner BB; Stephansson O; Ludvigsson JF
• Preprint: RESEARCH SQUARE. 2023

  The Swedish Childhood Tumor Biobank: Systematic collection and molecular characterization of all pediatric CNS and other solid tumors in Sweden

  de Ståhl TD; Shamikh A; Mayrhofer M; Juhos S; Basmaci E; Prochazka G; Garcia M; Somarajan PR; Illies C; Øra I; Siesjö P; Sandström P-E; Stenman J; Sabel M; Gustavsson B; Kogner P; Pfeifer S; Zielinska-Chomej K; Ljungman G; Sandgren J; Nistér M
• Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023

  Supplementary Materials and Methods, Figures 1-6 from MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner

  Castell A; Yan Q; Fawkner K; Bazzar W; Zhang F; Wickström M; Alzrigat M; Franco M; Krona C; Cameron DP; Dyberg C; Olsen TK; Verschut V; Schmidt L; Lim SY; Mahmoud L; Hydbring P; Lehmann S; Baranello L; Nelander S; Johnsen JI; Larsson L-G
• Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023

  Supplementary Materials and Methods, Figures 1-6 from MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner

  Castell A; Yan Q; Fawkner K; Bazzar W; Zhang F; Wickström M; Alzrigat M; Franco M; Krona C; Cameron DP; Dyberg C; Olsen TK; Verschut V; Schmidt L; Lim SY; Mahmoud L; Hydbring P; Lehmann S; Baranello L; Nelander S; Johnsen JI; Larsson L-G
• Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023

  Data from MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner

  Castell A; Yan Q; Fawkner K; Bazzar W; Zhang F; Wickström M; Alzrigat M; Franco M; Krona C; Cameron DP; Dyberg C; Olsen TK; Verschut V; Schmidt L; Lim SY; Mahmoud L; Hydbring P; Lehmann S; Baranello L; Nelander S; Johnsen JI; Larsson L-G
• Other: AMERICAN ASSOCIATION FOR CANCER RESEARCH (AACR). 2023

  Data from MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner

  Castell A; Yan Q; Fawkner K; Bazzar W; Zhang F; Wickström M; Alzrigat M; Franco M; Krona C; Cameron DP; Dyberg C; Olsen TK; Verschut V; Schmidt L; Lim SY; Mahmoud L; Hydbring P; Lehmann S; Baranello L; Nelander S; Johnsen JI; Larsson L-G
• Doctoral thesis: 2023

  Identifying and targeting vulnerabilities in cancers that metastasize to the bone and bone marrow

  Alchahin A
• Conference publication: CANCER SCIENCE. 2023;114:249

  Pharmacological activation of p53 triggers viral mimicry response thereby promoting anti-tumor immunity

  Selivanova G; Zhou X; Singh M; Sanz G; Guerlavais V; Carvajal LA; Aivado M; Annis A; Zhan Y; Oliveira M; Westerberg L; Johnsen JI
• Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2023;62(2):27

  Identification of recurrent 3q13.31 chromosomal rearrangement indicates LSAMP as a tumor suppressor gene in neuroblastoma

  Martinez-Monleon A; Gaarder J; Djos A; Kogner P; Fransson S
• Journal article: FRONTIERS IN PHARMACOLOGY. 2023;14:1183720

  The multiple functions of miR-574-5p in the neuroblastoma tumor microenvironment.

  Proestler E; Donzelli J; Nevermann S; Breitwieser K; Koch LF; Best T; Fauth M; Wickström M; Harter PN; Kogner P; Lavieu G; Larsson K; Saul MJ
• Article: CANCER RESEARCH. 2022;82(24):4586-4603

  Dormant SOX9-Positive Cells Facilitate MYC-Driven Recurrence of Medulloblastoma

  Borgenvik A; Holmberg KO; Bolin S; Zhao M; Savov V; Rosen G; Hutter S; Garancher A; Rahmanto AS; Bergstrom T; Olsen TK; Mainwaring OJ; Sattanino D; Verbaan AD; Rusert JM; Sundstrom A; Bravo MB; Dang Y; Wenz AS; Richardson S; Fotaki G; Hill RM; Dubuc AM; Kalushkova A; Remke M; Cancer M; Jernberg-Wiklund H; Giraud G; Chen X; Taylor MD; Sangfelt O; Clifford SC; Schueller U; Wechsler-Reya RJ; Weishaupt H; Swartling FJ
• Preprint: BIORXIV. 2022

  METTL3 drives telomere targeting of TERRA lncRNA through m⁶A-dependent R-loop formation: a therapeutic target for ALT-positive neuroblastoma

  Vaid R; Thombare K; Mendez A; Burgos-Panadero R; Djos A; Jachimowicz D; Lundberg KI; Bartenhagen C; Kumar N; Tümmler C; Sihlbom C; Fransson S; Johnsen JI; Kogner P; Martinsson T; Fischer M; Mondal T
• Corrigendum: CELL DEATH DISCOVERY. 2022;8(1):472

  Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells (vol 15, pg 548, 2022)

  Alkasalias T; Zhang J; Madapura H; Dalarun B; Reina OB; Lewensohn R; Viktorsson K; Salihi A; Darekar S; Lain S
• Article: CELL DEATH DISCOVERY. 2022;8(1):464

  Proof-of-principle studies on a strategy to enhance nucleotide imbalance specifically in cancer cells

  Alkasalias T; Zhang J; Madapura H; Dalarun B; Reina OB; Lewensohn R; Viktorsson K; Salihi A; Darekar S; Lain S
• Article: BRITISH JOURNAL OF CANCER. 2022;127(11):2060-2071

  Mutant p53 gain of function mediates cancer immune escape that is counteracted by APR-246

  Zhou X; Santos GS; Zhan Y; Oliveira MMS; Rezaei S; Singh M; Peuget S; Westerberg LS; Johnsen JI; Selivanova G
• Conference publication: PEDIATRIC BLOOD & CANCER. 2022;69:S211-S212

  SINGLE CELL ANALYSIS OF HUMAN BONE METASTATIC NEUROBLASTOMA UNRAVELS EMERGING IMMUNE CELL POPULATIONS IN THE BONE MARROW

  Alchahin A; Embaie BT; Mei S; Verhoeven BM; Olsen T; Kharchenko P; Johnsen JI; Kogner P; Baryawno N
• Conference publication: PEDIATRIC BLOOD & CANCER. 2022;69:S230

  NOVEL DRUG COMBINATIONS FOR NEUROBLASTOMA THERAPY - EXPLORING THE FULL POTENTIAL OF THE ROCK2-SPECIFIC INHIBITOR KD025

  Tummler C; Pepich A; Vellema Q; Abu Ajamieh S; Park SW; Ljungblad L; Seashore-Ludlow B; Karlsson K; Kogner P; Johnsen JI; Nasman MW
• Conference publication: PEDIATRIC BLOOD & CANCER. 2022;69

  THE IMMUNE CELL ATLAS OF HUMAN NEUROBLASTOMA

  Verhoeven BM; Mei S; Olsen T; Gustafsson K; Valind A; Nord DG; Fard S; Hagerling C; Kharchenko P; Kogner P; Johnsen JI; Baryawno N
• Conference publication: PEDIATRIC BLOOD & CANCER. 2022;69:S211

  CHARACTERIZATION OF TENEURIN-4 AND ITS ROLE IN NEUROBLASTOMA TUMORIGENESIS

  Abu Ajamieh S; Andonova T; Pepich A; Olsen T; Tummler C; Thankaswamy-Kosalai S; Kanduri C; Fransson S; Martinsson T; Baryawno N; Nasman A; Kogner P; Johnsen JI; Wickstrom M
• Conference publication: PEDIATRIC BLOOD & CANCER. 2022;69:S227

  COMBINATIONAL TREATMENT WITH ROCK INHIBITOR RKI-1447 AND BET INHIBITORS SYNERGISTICALLY IMPAIRS NEUROBLASTOMA GROWTH COMBINATIONAL TREATMENT WITH ROCK INHIBITOR RKI-1447 AND BET INHIBITORS SYNERGISTICALLY IMPAIRS NEUROBLASTOMA GROWTH

  Pepich A; Tummler C; Abu Ajamieh S; Vellema Q; Akerlund E; Treis D; Seashore-Ludlow B; Kogner P; Johnsen JI; Wickstrom M
• Conference publication: PEDIATRIC BLOOD & CANCER. 2022;69:S229-S230

  INVESTIGATING THE INTERACTIONS OF DISTINCT TUMOR SUBPOPULATIONS IN HUMAN NEUROBLASTOMA USING SINGLE-CELL RNASEQ AND NOVEL SPATIAL MULTI-OMICS

  Tsea I; Olsen T; Otte J; Mei S; Embaie BT; Kogner P; Johnsen JI; Baryawno N; Fard S
• Conference publication: PEDIATRIC BLOOD & CANCER. 2022;69:S229

  SYNERGISTIC EFFECT OF WIP1 INHIBITOR SL-176 AND H3K27 DEMETHYLASE INHIBITOR GSK-J4 ON NEUROBLASTOMA CELLS AND SPHEROIDS

  Treis D; Tummler C; Kogner P; Johnsen JI; Nasman MW
• Conference publication: PEDIATRIC BLOOD & CANCER. 2022;69:S226

  SCHWANN CELL PRECURSORS IS THE CELL-OF-ORIGIN IN HUMAN NEUROBLASTOMA

  Otte J; Olsen T; Mei S; Kameneva P; Embaie BT; Bjorklund A; Johansson A; Sundstrom E; Martinsson T; Fransson S; Stenman J; Cheng H; Zachariadis V; Enge M; Johnsen JI; Kogner P; Adameyko I; Kharchenko P; Baryawno N
• Doctoral thesis: 2022

  Targeting ALK and WIP1 : neuroblastoma precision medicine under development

  Treis D
• Corrigendum: NATURE METABOLISM. 2022;4(10):1421

  Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel-Lindau syndrome (June, 10.1038/s42255-022-00593-x, 2022)

  Li S; Li W; Yuan J; Bullova P; Wu J; Zhang X; Liu Y; Plescher M; Rodriguez J; Bedoya-Reina OC; Jannig PR; Valente-Silva P; Yu M; Henriksson MA; Zubarev RA; Smed-Sorensen A; Suzuki CK; Ruas JL; Holmberg J; Larsson C; Christofer Juhlin C; von Kriegsheim A; Cao Y; Schlisio S
• Article: PEDIATRIC BLOOD & CANCER. 2022;69(10):e29750

  Low numbers of COVID-19 in Swedish pediatric oncology patients during the first pandemic year despite an open society

  Sundberg E; Georgantzi K; Langenskiold C; Krol L; Nilsson F; Vogt H; Palle J; Ek T; Nilsson A
• Article: NATURE COMMUNICATIONS. 2022;13(1):5747

  A transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma

  Alchahin AM; Mei S; Tsea I; Hirz T; Kfoury Y; Dahl D; Wu C-L; Subtelny AO; Wu S; Scadden DT; Shin JH; Saylor PJ; Sykes DB; Kharchenko PV; Baryawno N
• Article: DIAGNOSTICS. 2022;12(9):2260

  Multifocal Neuroblastoma and Central Hypoventilation in An Infant with Germline ALK F1174I Mutation

  Djos A; Treis D; Fransson S; Murkes LG; Wessman S; Asmundsson J; Markstrom A; Kogner P; Martinsson T
• Conference publication: HORMONE RESEARCH IN PAEDIATRICS. 2022;95(SUPPL 2):145

  Effects of pharmacological inhibition of BCL-2 on linear bone growth

  Velentza L; Wickstrom M; Kogner P; Zaman F; Savendahl L
• Article: JCI INSIGHT. 2022;7(17):e153836

  DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma

  Olsen TK; Dyberg C; Embaie BT; Alchahin A; Milosevic J; Ding J; Otte J; Tummler C; Myrberg IH; Westerhout EM; Koster J; Versteeg R; Ding H-F; Kogner P; Johnsen JI; Sykes DB; Baryawno N
• Review: CURRENT ONCOLOGY REPORTS. 2022;24(8):1053-1062

  Neuroblastoma Heterogeneity, Plasticity, and Emerging Therapies

  Lundberg KI; Treis D; Johnsen JI
• Article: SCIENTIFIC REPORTS. 2022;12(1):12420

  Amplification of CDK4 and MDM2: a detailed study of a high-risk neuroblastoma subgroup

  Martinez-Monleon A; Oberg HK; Gaarder J; Berbegall AP; Javanmardi N; Djos A; Ussowicz M; Taschner-Mandl S; Ambros IM; Ora I; Sandstedt B; Beiske K; Ladenstein R; Noguera R; Ambros PF; Murkes LG; Ljungman G; Kogner P; Fransson S; Martinsson T
• Article: JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH. 2022;41(1):226

  Expression and activation of nuclear hormone receptors result in neuronal differentiation and favorable prognosis in neuroblastoma

  Sainero-Alcolado L; Mushtaq M; Liano-Pons J; Rodriguez-Garcia A; Yuan Y; Liu T; Ruiz-Perez MV; Schlisio S; Bedoya-Reina O; Arsenian-Henriksson M
• Preprint: BIORXIV. 2022

  A new transcriptional metastatic signature predicts survival in clear cell renal cell carcinoma

  Alchahin AM; Mei S; Tsea I; Hirz T; Kfoury Y; Dahl D; Wu C-L; Subtelny AO; Wu S; Scadden DT; Shin JH; Saylor PJ; Sykes DB; Kharchenko PV; Baryawno N
• Article: CELL REPORTS MEDICINE. 2022;3(6):100657

  The immune cell atlas of human neuroblastoma

  Verhoeven BM; Mei S; Olsen TK; Gustafsson K; Valind A; Lindstrom A; Gisselsson D; Fard SS; Hagerling C; Kharchenko PV; Kogner P; Johnsen JI; Baryawno N
• Conference publication: CANCER RESEARCH. 2022;82(12)

  Single-cell landscape of the TH-MYCN neuroblastoma mouse model

  Embaie BT; Alchahin A; Olsen TK; Sarkar H; Mei S; Baryawno N
• Conference publication: CANCER RESEARCH. 2022;82(12)

  Transcriptomic landscape of medulloblastoma reveals pathways of tumor-stroma remodelling

  Tsea I; Ruchiy Y; Verhoeven M; Sinha I; Blomgren K; Carlson LM; Johnsen JI; Dyberg C; Baryawno N
• Journal article: CANCER RESEARCH. 2022;82(12_Supplement):1677

  Abstract 1677: Transcriptomic landscape of medulloblastoma reveals pathways of tumor-stroma remodelling

  Tsea I; Ruchiy Y; Verhoeven M; Sinha I; Blomgren K; Carlson LM; Johnsen JI; Dyberg C; Baryawno N
• Conference publication: CANCER RESEARCH. 2022;82(12)

  The immune cell atlas of human neuroblastoma

  Verhoeven BM; Mei S; Olsen TK; Gustafsson KK; Valind A; Lindstrom A; Nord DG; Fard SS; Hagerling C; Kharchenko PV; Kogner P; Johnsen JI; Baryawno N
• Conference publication: CANCER RESEARCH. 2022;82(12)

  The immune cell atlas of human neuroblastoma.

  Verhoeven BM; Mei S; Olsen TK; Gustafsson KK; Valind A; Lindstrom A; Nord DG; Fard SS; Hagerling C; Kharchenko PV; Kogner P; Johnsen JI; Baryawno N
• Journal article: CANCER RESEARCH. 2022;82(12_Supplement):6215

  Abstract 6215: The immune cell atlas of human neuroblastoma

  Verhoeven BM; Mei S; Olsen TK; Gustafsson KK; Valind A; Lindström A; Nord DG; Fard SS; Hagerling C; Kharchenko PV; Kogner P; Johnsen JI; Baryawno N
• Journal article: NEURO-ONCOLOGY. 2022;24(Supplement_1):i51

  ETMR-09.In vitro modelling of embryonal tumors with multilayered rosettes (ETMR) and other novel brain tumor types.

  Bunt J; Roosen M; Stathi P; Polychronopoulos P; Odé Z; Maas J; Kool M
• Article: NATURE METABOLISM. 2022;4(6):739-758

  Impaired oxygen-sensitive regulation of mitochondrial biogenesis within the von Hippel-Lindau syndrome

  Li S; Li W; Yuan J; Bullova P; Wu J; Zhang X; Liu Y; Plescher M; Rodriguez J; Bedoya-Reina OC; Jannig PR; Valente-Silva P; Yu M; Henriksson MA; Zubarev RA; Smed-Sorensen A; Suzuki CK; Ruas JL; Holmberg J; Larsson C; Christofer Juhlin C; von Kriegsheim A; Cao Y; Schlisio S
• Article: INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS. 2022;113(2):355-359

  Five-Year Follow-up After Multimodal Treatment Incorporating HDR Brachytherapy for Bladder Prostate Rhabdomyosarcoma in Children

  Stenman J; Wickart-Johansson G; Sundquist F; Nilsson J; Ljungman G; Osterlundh G; Jalnas M; Pal N; Mercke C
• Article: LIFE SCIENCES. 2022;295:120394

  Omega-3 fatty acids decrease CRYAB, production of oncogenic prostaglandin E₂ and suppress tumor growth in medulloblastoma

  Ljungblad L; Bergqvist F; Tummler C; Madawala S; Olsen TK; Andonova T; Jakobsson P-J; Johnsen JI; Pickova J; Strandvik B; Kogner P; Gleissman H; Wickstrom M
• Article: CANCER RESEARCH COMMUNICATIONS. 2022;2(3):182-201

  MYCMI-7: A Small MYC-Binding Compound that Inhibits MYC: MAX Interaction and Tumor Growth in a MYC-Dependent Manner

  Castell A; Yan Q; Fawkner K; Bazzar W; Zhang F; Wickstrom M; Alzrigat M; Franco M; Krona C; Cameron DP; Dyberg C; Olsen TK; Verschut V; Schmidt L; Lim SY; Mahmoud L; Hydbring P; Lehmann S; Baranello L; Nelander S; Johnsen JI; Larsson L-G
• Article: INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 2022;23(7):3702

  The Merkel Cell Polyomavirus T-Antigens and IL-33/ST2-IL1RAcP Axis: Possible Role in Merkel Cell Carcinoma

  Rasheed K; Moens U; Policastro B; Johnsen JI; Koljonen V; Sihto H; Lui W-O; Sveinbjornsson B
• Article: NATURE COMMUNICATIONS. 2022;13(1):1537

  GIT1 protects against breast cancer growth through negative regulation of Notch

  Zhang S; Miyakawa A; Wickstrom M; Dyberg C; Louhivuori L; Varas-Godoy M; Kemppainen K; Kanatani S; Kaczynska D; Ellstrom ID; Elfman L; Kronqvist P; Repo H; Mikoshiba K; Sahlgren C; Johnsen JI; Uhlen P
• Article: FRONTIERS IN PEDIATRICS. 2022;10:836230

  A Phase II Trial of a Personalized, Dose-Intense Administration Schedule of ¹⁷⁷Lutetium-DOTATATE in Children With Primary Refractory or Relapsed High-Risk Neuroblastoma-LuDO-N

  Sundquist F; Georgantzi K; Jarvis KB; Brok J; Koskenvuo M; Rascon J; van Noesel M; Grybaeck P; Nilsson J; Braat A; Sundin M; Wessman S; Herold N; Hjorth L; Kogner P; Granberg D; Gaze M; Stenman J
• Article: BMC GENOMICS. 2022;23(1):149

  TC-hunter: identification of the insertion site of a transgenic gene within the host genome

  Borjesson V; Martinez-Monleon A; Fransson S; Kogner P; Johnsen JI; Milosevic J; Lopez MD
• Article: JOURNAL OF MEDICAL GENETICS. 2022;59(2):141-146

  A complex DICER1 syndrome phenotype associated with a germline pathogenic variant affecting the RNase IIIa domain of DICER1

  Ponten E; Frisk S; Taylan F; Vaz R; Wessman S; de Kock L; Pal N; Foulkes WD; Lagerstedt-Robinson K; Nordgren A
• Article: CANCERS. 2022;14(2):380

  Whole-Body MRI Surveillance-Baseline Findings in the Swedish Multicentre Hereditary TP53-Related Cancer Syndrome Study (SWEP53)

  Omran M; Tham E; Brandberg Y; Ahlstrom H; Lundgren C; Paulsson-Karlsson Y; Kuchinskaya E; Silander G; Rosen A; Persson F; Leonhardt H; Stenmark-Askmalm M; Berg J; van Westen D; Bajalica-Lagercrantz S; Blomqvist L
• Article: NEURO-ONCOLOGY ADVANCES. 2022;4(1):vdac028

  Filamin A increases aggressiveness of human neuroblastoma

  Bandaru S; Prajapati B; Juvvuna PK; Dosa S; Kogner P; Johnsen JI; Kanduri C; Akyurek LM
• Article: JCO PRECISION ONCOLOGY. 2022;6:e2100271

  Sustained Response to Entrectinib in an Infant With a Germline ALKAL2 Variant and Refractory Metastatic Neuroblastoma With Chromosomal 2p Gain and Anaplastic Lymphoma Kinase and Tropomyosin Receptor Kinase Activation

  Treis D; Umapathy G; Fransson S; Guan J; Mendoza-Garcia P; Siaw JT; Wessman S; Murkes LG; Stenman JJE; Djos A; Elfman LHM; Johnsen JI; Hallberg B; Palmer RH; Martinsson T; Kogner P
• Article: CANCER DISCOVERY. 2021;11(12):3090-3105

  Pharmacologic Activation of p53 Triggers Viral Mimicry Response Thereby Abolishing Tumor Immune Evasion and Promoting Antitumor Immunity

  Zhou X; Singh M; Santos GS; Guerlavais V; Carvajal LA; Aivado M; Zhan Y; Oliveira MMS; Westerberg LS; Annis DA; Johnsen JI; Selivanova G
• Article: CANCERS. 2021;13(23):6042

  PPM1D Is a Therapeutic Target in Childhood Neural Tumors

  Milosevic J; Treis D; Fransson S; Gallo-Oller G; Sveinbjoernsson B; Eissler N; Tanino K; Sakaguchi K; Martinsson T; Wickstroem M; Kogner P; Johnsen JI
• Editorial: ANNALS OF ONCOLOGY. 2021;32(11):1327-1331

  Fifty years of clinical and research studies for childhood renal tumors within the International Society of Pediatric Oncology (SIOP)

  Graf N; Bergeron C; Brok J; de Camargo B; Chowdhury T; Furtwangler R; Gessler M; Godzinski J; Pritchard-Jones K; Ramirez-Villar GL; Rube C; Sandstedt B; Schenk J-P; Spreafico F; Sudour-Bonnange H; van Tinteren H; Verschuur A; Vujanic G; van den Heuvel-Eibrink MM
• Review: ACTA PAEDIATRICA. 2021;110(11):2912-2920

  Kostmann disease and other forms of severe congenital neutropenia

  Fadeel B; Garwicz D; Carlsson G; Sandstedt B; Nordenskjold M
• Article: CANCERS. 2021;13(21):5493

  High Expression of PPM1D Induces Tumors Phenotypically Similar to TP53 Loss-of-Function Mutations in Mice

  Milosevic J; Fransson S; Gulyas M; Olsen TK; Gallo-Oller G; Treis D; Elfman LHM; Wilhelm M; Martinsson T; Baryawno N; Kogner P; Johnsen JI
• Article: JOURNAL OF CLINICAL ONCOLOGY. 2021;39(30):3377-3390

  Frequency and Prognostic Impact of ALK Amplifications and Mutations in the European Neuroblastoma Study Group (SIOPEN) High-Risk Neuroblastoma Trial (HR-NBL1)

  Bellini A; Poetschger U; Bernard V; Lapouble E; Baulande S; Ambros PF; Auger N; Beiske K; Bernkopf M; Betts DR; Bhalshankar J; Bown N; de Preter K; Clement N; Combaret V; de Mora JF; George SL; Jimenez I; Jeison M; Marques B; Martinsson T; Mazzocco K; Morini M; Muehlethaler-Mottet A; Noguera R; Pierron G; Rossing M; Taschner-Mandl S; Van Roy N; Vicha A; Chesler L; Balwierz W; Castel V; Elliott M; Kogner P; Laureys G; Luksch R; Malis J; Popovic-Beck M; Ash S; Delattre O; Valteau-Couanet D; Tweddle DA; Ladenstein R; Schleiermacher G
• Article: CELL DEATH & DISEASE. 2021;12(10):914

  Inhibition of the ubiquitin-proteasome system by an NQO1-activatable compound

  Giovannucci TA; Salomons FA; Haraldsson M; Elfman LHM; Wickstroem M; Young P; Lundbaeck T; Eirich J; Altun M; Jafari R; Gustavsson A-L; Johnsen JI; Dantuma NP
• Article: LANCET ONCOLOGY. 2021;22(10):1416-1426

  Global characteristics and outcomes of SARS-CoV-2 infection in children and adolescents with cancer (GRCCC): a cohort study.

  Mukkada S; Bhakta N; Chantada GL; Chen Y; Vedaraju Y; Faughnan L; Homsi MR; Muniz-Talavera H; Ranadive R; Metzger M; Friedrich P; Agulnik A; Jeha S; Lam C; Dalvi R; Hessissen L; Moreira DC; Santana VM; Sullivan M; Bouffet E; Caniza MA; Devidas M; Pritchard-Jones K; Rodriguez-Galindo C; Global Registry of COVID-19 in Childhood Cancer
• Preprint: BIORXIV. 2021

  DHODH is an independent prognostic marker and potent therapeutic target in neuroblastoma

  Olsen TK; Dyberg C; Embaie B; Alchahin A; Milosevic J; Otte J; Tümmler C; Myrberg IH; Westerhout E; Koster J; Versteeg R; Kogner P; Johnsen JI; Sykes D; Baryawno N
• Article: NATURE COMMUNICATIONS. 2021;12(1):5309

  Single-nuclei transcriptomes from human adrenal gland reveal distinct cellular identities of low and high-risk neuroblastoma tumors

  Bedoya-Reina OC; Li W; Arceo M; Plescher M; Bullova P; Pui H; Kaucka M; Kharchenko P; Martinsson T; Holmberg J; Adameyko I; Deng Q; Larsson C; Juhlin CC; Kogner P; Schlisio S
• Journal article: CLINICAL CANCER RESEARCH. 2021;27(17):4943

  Editor's Note: Dual Targeting of Wild-Type and Mutant p53 by Small-molecule RITA Results in the Inhibition of N-Myc and Key Survival Oncogenes and Kills Neuroblastoma Cells In Vivo and In Vitro

  Burmakin M; Shi Y; Hedstrom E; Kogner P; Selivanova G
• Article: PLOS NEGLECTED TROPICAL DISEASES. 2021;15(9):e0009764

  Role of T cells during the cerebral infection with Trypanosoma brucei

  Olivera GC; Vetter L; Tesoriero C; Del Gallo F; Hedberg G; Basile J; Rottenberg ME
• Article: VIROLOGY JOURNAL. 2021;18(1):139

  Reciprocal transactivation of Merkel cell polyomavirus and high-risk human papillomavirus promoter activities and increased expression of their oncoproteins

  Rasheed K; Sveinbjornsson B; Moens U
• Article: INTERNATIONAL JOURNAL OF CANCER. 2021;148(11):2724-2735

  Characteristics and outcome of pediatric renal cell carcinoma patients registered in the International Society of Pediatric Oncology (SIOP) 93-01, 2001 and UK-IMPORT database: A report of the SIOP-Renal Tumor Study Group

  van der Beek JN; Hol JA; Coulomb-l'Hermine A; Graf N; van Tinteren H; Pritchard-Jones K; Houwing ME; de Krijger RR; Vujanic GM; Dzhuma K; Schenk J-P; Littooij AS; Ramirez-Villar GL; Murphy D; Ray S; Al-Saadi R; Gessler M; Godzinski J; Ruebe C; Collini P; Verschuur AC; Frisk T; Vokuhl C; Hulsbergen-van de Kaa CA; de Camargo B; Sandstedt B; Selle B; Tytgat GAM; van den Heuvel-Eibrink MM
• Review: TRENDS IN CANCER. 2021;7(6):557-572

  Targeting Cancer Heterogeneity with Immune Responses Driven by Oncolytic Peptides

  Vitale I; Yamazaki T; Wennerberg E; Sveinbjornsson B; Rekdal O; Demaria S; Galluzzi L
• Article: PROSTAGLANDINS LEUKOTRIENES AND ESSENTIAL FATTY ACIDS. 2021;169:102285

  Body surface area-based omega-3 fatty acids supplementation strongly correlates to blood concentrations in children.

  Ljungblad L; Gleissman H; Hedberg G; Wickstrom M; Eissler N; Pickova J; Johnsen JI; Tedroff K; Strandvik B; Kogner P
• Article: NATURE GENETICS. 2021;53(5):694-706

  Single-cell transcriptomics of human embryos identifies multiple sympathoblast lineages with potential implications for neuroblastoma origin

  Kameneva P; Artemov AV; Kastriti ME; Faure L; Olsen TK; Otte J; Erickson A; Semsch B; Andersson ER; Ratz M; Frisen J; Tischler AS; de Krijger RR; Bouderlique T; Akkuratova N; Vorontsova M; Gusev O; Fried K; Sundstrom E; Mei S; Kogner P; Baryawno N; Kharchenko PV; Adameyko I
• Preprint: BIORXIV. 2021

  Single-nuclei transcriptomes from human adrenal gland reveals distinct cellular identities of low and high-risk neuroblastoma tumors

  Bedoya-Reina OC; Li W; Arceo M; Plescher M; Bullova P; Pui H; Kaucka M; Kharchenko P; Martinsson T; Holmberg J; Adameyko I; Deng Q; Larsson C; Juhlin CC; Kogner P; Schlisio S
• Article: NUCLEIC ACIDS RESEARCH. 2021;49(5):2509-2521

  Aberrant splicing in neuroblastoma generates RNA-fusion transcripts and provides vulnerability to spliceosome inhibitors

  Shi Y; Yuan J; Rraklli V; Maxymovitz E; Cipullo M; Liu M; Li S; Westerlund I; Bedoya-Reina OC; Bullova P; Rorbach J; Juhlin CC; Stenman A; Larsson C; Kogner P; O'Sullivan MJ; Schlisio S; Holmberg J
• Article: CANCER CELL INTERNATIONAL. 2021;21(1):170

  The loss of DLG2 isoform 7/8, but not isoform 2, is critical in advanced staged neuroblastoma

  Keane S; Martinsson T; Kogner P; Ejeskar K
• Preprint: BIORXIV. 2021

  Inhibition of the ubiquitin-proteasome system by a bioactivatable compound

  Giovannucci T; Salomons F; Haraldsson M; Elfman L; Wickström M; Young P; Lundbäck T; Eirich J; Altun M; Jafari R; Gustavsson A-L; Johnsen JI; Dantuma N
• Article: CANCER RESEARCH. 2021;81(6):1457-1471

  Subcellular Distribution of p53 by the p53-Responsive lncRNA NBAT1 Determines Chemotherapeutic Response in Neuroblastoma

  Mitra S; Muralidharan SV; Di Marco M; Juvvuna PK; Kosalai ST; Reischl S; Jachimowicz D; Subhash S; Raimondi I; Kurian L; Huarte M; Kogner P; Fischer M; Johnsen JI; Mondal T; Kanduri C
• Article: CANCER. 2021;127(4):628-638

  Clinical characteristics and outcomes of children with WAGR syndrome and Wilms tumor and/or nephroblastomatosis: The 30-year SIOP-RTSG experience

  Hol JA; Jongmans MCJ; Sudour-Bonnange H; Ramirez-Villar GL; Chowdhury T; Rechnitzer C; Pal N; Schleiermacher G; Karow A; Kuiper RP; de Camargo B; Avcin S; Redzic D; Wachtel A; Segers H; Vujanic GM; van Tinteren H; Bergeron C; Pritchard-Jones K; Graf N; van den Heuvel-Eibrink MM
• Letter: CANCER CELL. 2021;39(2):134-135

  Chromaffin Cells with Sympathoblast Signature: Too Similar to Keep Apart?

  Bedoya-Reina OC; Schlisio S
• Preprint: RESEARCH SQUARE. 2021

  The loss of DLG2 isoform 7/8, but not isoform 2, is critical in advanced staged neuroblastoma

  Keane S; Martinsson T; Kogner P; Ejeskar K
• Article: EUROPEAN JOURNAL OF CANCER. 2021;144:1-8

  Central nervous system relapse in high-risk stage 4 neuroblastoma: The HR-NBL1/SIOPEN trial experience

  Berlanga P; Pasqualini C; Poetschger U; Sanguesa C; Castellani MR; Canete A; Luksch R; Elliot M; Schreier G; Kropf M; Morgenstern D; Papadakis V; Ash S; Ruud E; Brock P; Wieczorek A; Kogner P; Trahair T; Ambros P; Boterberg T; Castel V; Valteau-Couanet D; Ladenstein R
• Article: BMJ CASE REPORTS. 2021;14(1):e234876

  Hyperthermic intraperitoneal chemotherapy (HIPEC) as another treatment modality for desmoplastic round cell tumour patients: first paediatric experience from UK.

  Sjoberg Bexelius T; Chisholm JC; Okoye B; Cecil T; Angelini P; Dayal S
• Review: FRONTIERS IN ONCOLOGY. 2021;10:624079

  MYCN Function in Neuroblastoma Development

  Otte J; Dyberg C; Pepich A; Johnsen JI
• Article: ONCOIMMUNOLOGY. 2021;10(1):1962592

  LTX-315-enabled, radiotherapy-boosted immunotherapeutic control of breast cancer by NK cells

  Yamazaki T; Wennerberg E; Hensler M; Buque A; Kraynak J; Fucikova J; Zhou XK; Sveinbjornsson B; Rekdal O; Demaria S; Galluzzi L
• Article: SCIENTIFIC REPORTS. 2020;10(1):22432

  Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenance

  Fransson S; Martinez-Monleon A; Johansson M; Sjoberg R-M; Bjorklund C; Ljungman G; Torben E; Kogner P; Martinsson T
• Article: FRONTIERS IN ONCOLOGY. 2020;10:598872

  Hodgkin Lymphoma Monozygotic Triplets Reveal Divergences in DNA Methylation Signatures

  Xia C; Olsen TK; Zirakzadeh AA; Almamoun R; Sjoholm LK; Dahlstrom J; Sjoberg J; Claesson H-E; Johnsen JI; Winqvist O; Xu D; Ekstrom TJ; Bjorkholm M; Straat K
• Conference publication: BONE MARROW TRANSPLANTATION. 2020;55(SUPPL 1):151-152

  EBMT Lessons from 40 Years of High Dose Chemotherapy (HDT) and Stem Cell Transplantation (SCT) In Neuroblastoma. A Report From the Paediatric Working Party

  Ladenstein R; Poetschger U; Brock P; Luksch R; Castel V; Ash S; Papadakis V; Laureys G; Malis J; Balwierz W; Ruud E; Kogner P; Schroeder H; de lacerda AF; Beck-Popovic M; Bician P; Garami M; Glogova E; Valteau-Couanet D; Corbacioglu S
• Conference publication: PEDIATRIC BLOOD & CANCER. 2020;67:S3

  Malignant Schwann Cell Precursors Mediate Intratumoral Plasticity in Human Neuroblastoma

  Olsen TK; Otte J; Mei S; Kameneva P; Bjorklund A; Kryukov E; Hou Z; Johansson A; Sundstrom E; Martinsson T; Fransson S; Johnsen JI; Kogner P; Adameyko I; Kharchenko P; Baryawno N
• Article: JOURNAL OF CLINICAL ONCOLOGY. 2020;38(31):3685-3697

  Age Dependency of the Prognostic Impact of Tumor Genomics in Localized Resectable MYCN-Nonamplified Neuroblastomas. Report From the SIOPEN Biology Group on the LNESG Trials and a COG Validation Group

  Ambros IM; Tonini G-P; Poetschger U; Gross N; Mosseri V; Beiske K; Berbegall AP; Benard J; Bown N; Caron H; Combaret V; Couturier J; Defferrari R; Delattre O; Jeison M; Kogner P; Lunec J; Marques B; Martinsson T; Mazzocco K; Noguera R; Schleiermacher G; Valent A; Van Roy N; Villamon E; Janousek D; Pribill I; Glogova E; Attiyeh EF; Hogarty MD; Monclair TF; Holmes K; Valteau-Couanet D; Castel V; Tweddle DA; Park JR; Cohn S; Ladenstein R; Beck-Popovic M; De Bernardi B; Michon J; Pearson ADJ; Ambros PF
• Preprint: RESEARCH SQUARE. 2020

  The Loss of DLG2 Isoform 7/8, But Not Isoform 2, is Critical in Advanced Staged Neuroblastoma

  Keane S; Martinsson T; Kogner P; Ejeskar K
• Preprint: RESEARCH SQUARE. 2020

  The loss of DLG2 isoform 7/8, but not isoform 2, is critical in advanced staged neuroblastoma

  Keane S; Martinsson T; Kogner P; Ejeskar K
• Article: CELL REPORTS. 2020;32(12):108171

  11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma

  Siaw JT; Javanmardi N; Van den Eynden J; Lind DE; Fransson S; Martinez-Monleon A; Djos A; Sjoberg R-M; Ostensson M; Caren H; Troen G; Beiske K; Berbegall AP; Noguera R; Lai W-Y; Kogner P; Palmer RH; Hallberg B; Martinsson T
• Preprint: BIORXIV. 2020

  PPM1D is a neuroblastoma oncogene and therapeutic target in childhood neural tumors

  Milosevic J; Fransson S; Gulyas M; Gallo-Oller G; Olsen T; Treis D; Wickström M; Elfman LHM; Sveinbjornsson B; Hertwig F; Bartenhagen C; Reinsbach S; Wilhelm M; Abel F; Javanmardi N; Thankaswamy-Kosalai S; Eissler N; Kock A; Shi Y; Tanino K; Hehir-Kwa J; Mensenkamp A; Tytgat GAM; Kanduri C; Holmberg J; Gisselsson D; Molenaar J; Jongmans M; Fischer M; Kool M; Sakaguchi K; Baryawno N; Martinsson T; Johnsen JI; Kogner P
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2020;117(33):20127-20138

  Modeling SHH-driven medulloblastoma with patient iPS cell-derived neural stem cells

  Susanto E; Navarro AM; Zhou L; Sundstrom A; van Bree N; Stantic M; Moslem M; Tailor J; Rietdijk J; Zubillaga V; Huebner J-M; Weishaupt H; Wolfsberger J; Alafuzoff I; Nordgren A; Magnaldo T; Siesjo P; Johnsen JI; Kool M; Tammimies K; Darabi A; Swartling FJ; Falk A; Wilhelm M
• Article: FASEB JOURNAL. 2020;34(8):11101-11114

  Establishment of an in vitro 3D model for neuroblastoma enables preclinical investigation of combined tumor-stroma drug targeting

  Kock A; Bergqvist F; Steinmetz J; Elfman LHM; Korotkova M; Johnsen JI; Jakobsson P-J; Kogner P; Larsson K
• Article: CANCER DISCOVERY. 2020;10(7):942-963

  Infant High-Grade Gliomas Comprise Multiple Subgroups Characterized by Novel Targetable Gene Fusions and Favorable Outcomes

  Clarke M; Mackay A; Ismer B; Pickles JC; Tatevossian RG; Newman S; Bale TA; Stoler I; Izquierdo E; Temelso S; Carvalho DM; Molinari V; Burford A; Howell L; Virasami A; Fairchild AR; Avery A; Chalker J; Kristiansen M; Haupfear K; Dalton JD; Orisme W; Wen J; Hubank M; Kurian KM; Rowe C; Maybury M; Crosier S; Knipstein J; Schueller U; Kordes U; Kram DE; Snuderl M; Bridges L; Martin AJ; Doey LJ; Al-Sarraj S; Chandler C; Zebian B; Cairns C; Natrajan R; Boult JKR; Robinson SP; Sill M; Dunkel IJ; Gilheeney SW; Rosenblum MK; Hughes D; Proszek PZ; Macdonald TJ; Preusser M; Haberler C; Slavc I; Packer R; Ng H-K; Caspi S; Popovi M; Kotnik BF; Wood MD; Baird L; Davare MA; Solomon DA; Olsen TK; Brandal P; Farrell M; Cryan JB; Capra M; Karremann M; Schittenhelm J; Schuhmann MU; Ebinger M; Dinjens WNM; Kerl K; Hettmer S; Pietsch T; Andreiuolo F; Driever PH; Korshunov A; Hiddingh L; Worst BC; Sturm D; Zuckermann M; Witt O; Bloom T; Mitchell C; Miele E; Colafati GS; Diomedi-Camassei F; Bailey S; Moore AS; Hassall TEG; Lowis SP; Tsoli M; Cowley MJ; Ziegler DS; Karajannis MA; Aquilina K; Hargrave DR; Carceller F; Marshall LV; von Deimling A; Kramm CM; Pfister SM; Sahm F; Baker SJ; Mastronuzzi A; Carai A; Vinci M; Capper D; Popov S; Ellison DW; Jacques TS; Jones DTW; Jones C
• Preprint: BIORXIV. 2020

  Malignant Schwann cell precursors mediate intratumoral plasticity in human neuroblastoma

  Olsen T; Otte J; Mei S; Kameneva P; Björklund Å; Kryukov E; Hou Z; Johansson A; Sundström E; Martinsson T; Fransson S; Johnsen JI; Kogner P; Adameyko I; Kharchenko P; Baryawno N
• Review: FRONTIERS IN ONCOLOGY. 2020;10:518

  Mini-Review on Targeted Treatment of Desmoplastic Small Round Cell Tumor

  Bexelius TS; Wasti A; Chisholm JC
• Article: HEREDITARY CANCER IN CLINICAL PRACTICE. 2020;18(1):1

  Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants-the Swedish constitutional TP53 study SWEP53

  Omran M; Blomqvist L; Brandberg Y; Pal N; Kogner P; Stahlbom AK; Tham E; Bajalica-Lagercrantz S
• Article: NATURE COMMUNICATIONS. 2020;11(1):71

  Integrative discovery of treatments for high-risk neuroblastoma

  Almstedt E; Elgendy R; Hekmati N; Rosen E; Warn C; Olsen TK; Dyberg C; Doroszko M; Larsson I; Sundstrom A; Henriksson MA; Pahlman S; Bexell D; Vanlandewijck M; Kogner P; Jornsten R; Krona C; Nelander S
• Article: GENES CHROMOSOMES & CANCER. 2020;59(1):50-57

  Analysis of ALK, MYCN, and the ALK ligand ALKAL2 (FAM150B/AUGα) in neuroblastoma patient samples with chromosome arm 2p rearrangements

  Javanmardi N; Fransson S; Djos A; Umapathy G; Ostensson M; Milosevic J; Borenaes M; Hallberg B; Kogner P; Martinsson T; Palmer RH
• Preprint: SSRN ELECTRONIC JOURNAL. 2020

  Inhibition of the Ubiquitin-Proteasome System by a Bioactivatable Prodrug

  Giovannucci TA; Salomons FA; Martin Haraldsson M; Elfman LMH; Wickström M; Young P; Lundbäck T; Eirich J; Altun M; Jafari R; Gustavsson A-L; Johnsen JI; Dantuma N
• Preprint: SSRN ELECTRONIC JOURNAL. 2020

  11q Deletion or ALK Activity Curbs DLG2 Expression to Maintain an Undifferentiated State in Neuroblastoma

  Siaw J; Javanmardi N; Van den Eynden J; Lind DE; Fransson S; Marinez-Monleon A; Djos A; Sjöberg R-M; Östensson M; Carén H; Trøen G; Beiske K; Bergegall A; Noguera R; Lai W-Y; Kogner P; Palmer RH; Hallberg B; Martinsson T
• Article: CANCERS. 2019;12(1):E73-73

  Inhibition of Rho-Associated Kinase Suppresses Medulloblastoma Growth

  Dyberg C; Andonova T; Olsen TK; Brodin B; Kool M; Kogner P; Johnsen JI; Wickstrom M
• Preprint: BIORXIV. 2019

  Alternative splicing in neuroblastoma generates RNA-fusion transcripts and is associated with vulnerability to spliceosome inhibitors

  Shi Y; Rraklli V; Maxymovitz E; Li S; Westerlund I; Bedoya-Reina O; Yuan J; Bullova P; Juhlin C; Stenman A; Larsson C; Kogner P; O’Sullivan M; Schlisio S; Holmberg J
• Article: EUROPEAN JOURNAL OF CANCER. 2019;121:224-235

  A tailored molecular profiling programme for children with cancer to identify clinically actionable genetic alterations.

  George SL; Izquierdo E; Campbell J; Koutroumanidou E; Proszek P; Jamal S; Hughes D; Yuan L; Marshall LV; Carceller F; Chisholm JC; Vaidya S; Mandeville H; Angelini P; Wasti A; Bexelius T; Thway K; Gatz SA; Clarke M; Al-Lazikani B; Barone G; Anderson J; Tweddle DA; Gonzalez D; Walker BA; Barton J; Depani S; Eze J; Ahmed SW; Moreno L; Pearson A; Shipley J; Jones C; Hargrave D; Jacques TS; Hubank M; Chesler L
• Conference publication: EUROPEAN JOURNAL OF HUMAN GENETICS. 2019;27:1576

  Whole-body MRI for cancer screening in patients with germline TP53 pathogenic variants - a presentation of the Swedish surveillance program including two case reports

  Omran M; Blomqvist L; Brandberg Y; Pal N; Kogner P; Stahlbom AK; Tham E; Lagercrantz SB
• Article: ENDOCRINE PATHOLOGY. 2019;30(3):173-179

  Synaptic Vesicle Protein 2 and Vesicular Monoamine Transporter 1 and 2 Are Expressed in Neuroblastoma

  Georgantzi K; Tsolakis AV; Jakobson A; Christofferson R; Janson ET; Grimelius L
• Article: CELL DEATH AND DIFFERENTIATION. 2019;26(8):1467-1484

  Recruitment of LC3 to damaged Golgi apparatus

  Gomes-da-Silva LC; Jimenez AJ; Sauvat A; Xie W; Souquere S; Divoux S; Storch M; Sveinbjornsson B; Rekdal O; Arnaut LG; Kepp O; Kroemer G; Perez F
• Article: BMC MEDICAL EDUCATION. 2019;19(1):244

  Swedish doctors choice of medical speciality and associations with cultural capital and perceived status: a cross-sectional study

  Olsson C; Jarnbert-Pettersson H; Ponzer S; Dahlin M; Bexelius T
• Article: ONCOIMMUNOLOGY. 2019;8(7):1594555-e1594555

  Tumor lysis with LTX-401 creates anticancer immunity

  Xie W; Mondragon L; Mauseth B; Wang Y; Pol J; Levesque S; Zhou H; Yamazaki T; Eksteen JJ; Zitvogel L; Sveinbjornsson B; Rekdal O; Kepp O; Kroemer G
• Conference publication: CANCER RESEARCH. 2019;79(13):1692

  Genomic changes in relapsed neuroblastoma

  Fransson S; Monleon AM; Djos A; Reinsbach S; Sjoberg R-M; Sikora P; Kogner P; Martinsson T
• Conference publication: 2019;:1692

  Abstract 1692: Genomic changes in relapsed neuroblastoma

  Fransson S; Monleon AM; Djos A; Reinsbach S; Sjoberg R-M; Sikora P; Kogner P; Martinsson T
• Published conference paper: JOURNAL OF PEDIATRIC SURGERY. 2019;54(6):1253-1256

  Diagnostic ultrasound-guided cutting needle biopsies in neuroblastoma: A safe and efficient procedure.

  Georgantzi K; Sköldenberg E; Janson ET; Jakobson Å; Christofferson R
• Article: G3-GENES GENOMES GENETICS. 2019;9(5):1633-1646

  Genomic Variants Among Threatened Acropora Corals.

  Kitchen SA; Ratan A; Bedoya-Reina OC; Burhans R; Fogarty ND; Miller W; Baums IB
• Article: ELIFE. 2019;8:e45051

  The long non-coding RNA Cerox1 is a post transcriptional regulator of mitochondrial complex I catalytic activity

  Sirey TM; Roberts K; Haerty W; Bedoya-Reina O; Rogatti-Granados S; Tan JY; Li N; Heather LC; Carter RN; Cooper S; Finch AJ; Wills J; Morton NM; Marques AC; Ponting CP
• Article: ONCOGENE. 2019;38(15):2800-2813

  Inhibitors of ribosome biogenesis repress the growth of MYCN-amplified neuroblastoma

  Hald OH; Olsen L; Gallo-Oller G; Elfman LHM; Lokke C; Kogner P; Sveinbjornsson B; Flaegstad T; Johnsen JI; Einvik C
• Article: INTERNATIONAL JOURNAL OF MEDICAL EDUCATION. 2019;10:68-74

  Stress among medical students during clinical courses: a longitudinal study using contextual activity sampling system

  Bexelius TS; Lachmann H; Jarnbert-Pettersson H; Kalen S; Moller R; Ponzer S
• Article: SCIENTIFIC REPORTS. 2019;9(1):2199

  Low Frequency ALK Hotspots Mutations In Neuroblastoma Tumours Detected By Ultra-deep Sequencing: Implications For ALK Inhibitor Treatment

  Javanmardi N; Fransson S; Djos A; Sjoberg R-M; Nilsson S; Truve K; Kogner P; Martinsson T
• Article: CANCERS. 2019;11(2):E202-202

  SYK Inhibition Potentiates the Effect of Chemotherapeutic Drugs on Neuroblastoma Cells In Vitro

  Tummler C; Dumitriu G; Wickstrom M; Coopman P; Valkov A; Kogner P; Johnsen JI; Moens U; Sveinbjornsson B
• Article: CANCER LETTERS. 2019;442:341-350

  RITA downregulates Hedgehog-GLI in medulloblastoma and rhabdomyosarcoma via JNK-dependent but p53-independent mechanism

  Azatyan A; Gallo-Oller G; Diao Y; Selivanova G; Johnsen JI; Zaphiropoulos PG
• Review: FRONTIERS IN MOLECULAR NEUROSCIENCE. 2019;12:9

  Neuroblastoma - A Neural Crest Derived Embryonal Malignancy

  Johnsen JI; Dyberg C; Wickstrom M
• Article: STEM CELL RESEARCH. 2019;34:101356

  Generation of induced pluripotent stem cell lines from two Neuroblastoma patients carrying a germline ALK R1275Q mutation

  Navarro AM; Day K; Kogner P; Wilhelm M; Falk A
• Published conference paper: CELL BIOLOGY AND TRANSLATIONAL MEDICINE, VOL 14: STEM CELLS IN LINEAGE SPECIFIC DIFFERENTIATION AND DISEASE. 2019;1161:89-100

  Targeting the COX/mPGES-1/PGE2 Pathway in Neuroblastoma

  Larsson K; Kock A; Kogner P; Jakobsson P-J
• Letter: ACTA OPHTHALMOLOGICA. 2018;96(8):E1040-E1041

  Intra-arterial chemotherapy for retinoblastoma in Sweden - evaluation of treatment efficacy and complications

  Radros J; All-Eriksson C; Pal N; Holm S; Seregard S; Soderman M; Arnberg F; Holmin S
• Article: PEDIATRIC BLOOD & CANCER. 2018;65(11):e27363

  Risk stratification of high-risk metastatic neuroblastoma: A report from the HR-NBL-1/SIOPEN study

  Morgenstern DA; Poetschger U; Moreno L; Papadakis V; Owens C; Ash S; Pasqualini C; Luksch R; Garaventa A; Canete A; Elliot M; Wieczorek A; Laureys G; Kogner P; Malis J; Ruud E; Beck-Popovic M; Schleiermacher G; Valteau-Couanet D; Ladenstein R
• Article: PEDIATRIC BLOOD & CANCER. 2018;65(11):e27301

  Convergent evolution of 11p allelic loss in multifocal Wilms tumors arising in WT1 mutation carriers

  Valind A; Wessman S; Pal N; Karlsson J; Jonson T; Sandstedt B; Gisselsson D
• Article: CELL DEATH & DISEASE. 2018;9(11):1086

  Oncolysis with DTT-205 and DTT-304 generates immunological memory in cured animals

  Zhou H; Mondragon L; Xie W; Mauseth B; Leduc M; Sauvat A; Gomes-da-Silva LC; Forveille S; Iribarren K; Souquere S; Bezu L; Liu P; Zhao L; Zitvogel L; Sveinbjornsson B; Eksteen JJ; Rekdal O; Kepp O; Kroemer G
• Conference publication: BONE MARROW TRANSPLANTATION. 2018;53:128-129

  Success of the HR-NBL/SIOPEN local control trial strategy in high risk neuroblastoma patients undergoing high dose therapy with peripheral stem cell transplantation

  Ladenstein R; Poetscher U; Luksch R; Castel V; Yaniv I; Papadakis V; Laureys G; Malis J; Balwierz W; Ruud E; Kogner P; Schroeder H; de Lacerda AF; Beck-Popovic M; Bician P; Garami M; Trahair T; Canete A; Ambros P; Holmes K; Garaventa A; Michon J; Pearson A; Valteau-Couanet D; Gaze M; Botterberg T
• Article: JOURNAL OF PEDIATRIC SURGERY. 2018;53(9):1660-1664

  The effect of gestational age on clinical and radiological presentation of necrotizing enterocolitis

  Palleri E; Aghamn I; Bexelius TS; Bartocci M; Wester T
• Article: COLD SPRING HARBOR MOLECULAR CASE STUDIES. 2018;4(4):a002550

  Clinical response of the novel activating ALK-I1171T mutation in neuroblastoma o the ALK inhibitor ceritinib

  Guan J; Fransson S; Siaw JT; Treis D; Van den Eynden J; Chand D; Umapathy G; Ruuth K; Svenberg P; Wessman S; Shamikh A; Jacobsson H; Gordon L; Stenman J; Svensson P-J; Hansson M; Larsson E; Martinsson T; Palmer RH; Kogner P; Hallberg B
• Article: EMBO JOURNAL. 2018;37(13):e98354

  Photodynamic therapy with redaporfin targets the endoplasmic reticulum and Golgi apparatus

  Gomes-da-Silva LC; Zhao L; Bezu L; Zhou H; Sauvat A; Liu P; Durand S; Leduc M; Souquere S; Loos F; Mondragon L; Sveinbjornsson B; Rekdal O; Boncompain G; Perez F; Arnaut LG; Kepp O; Kroemer G
• Conference publication: CANCER RESEARCH. 2018;78(13):2246

  Identification of mutational signatures in high-risk neuroblastoma patients

  Reinsbach SE; Larsson M; Martinez-Monleon A; Sjoberg R-M; Javanmardi N; Djos A; Kogner P; Fransson S; Lekholm EL; Martinsson T
• Conference publication: CANCER RESEARCH. 2018;78(13):4145

  Characterization of the ODZ receptor family in neuroblastoma

  Andonova T; Kogner P; Johnsen JI; Wickstrom M
• Conference publication: CANCER RESEARCH. 2018;78(13):3185

  Whole genome sequencing for precision medicine in high-risk neuroblastoma patients: Translation from research to clinical practice in Sweden

  Fransson SM; Martinez-Monleon A; Reinsbach S; Sikora P; Sjoberg R-M; Kogner P; Martinsson T
• Conference publication: CANCER RESEARCH. 2018;78(13):5092

  Establishment of an induction protocol for medulloblastoma during prenatal stages of a floxed-cre inducible model

  Gallo-Oller G; Azatyan A; Baryawno N; Kogner P; Johnsen JI
• Article: NATURE GENETICS. 2018;50(7):944-950

  Four evolutionary trajectories underlie genetic intratumoral variation in childhood cancer

  Karlsson J; Valind A; Mengelbier LH; Bredin S; Cornmark L; Jansson C; Wali A; Staaf J; Viklund B; Ora I; Borjesson A; Backman T; Braekeveldt N; Sandstedt B; Pal N; Isaksson A; Lackner BG; Jonson T; Bexell D; Gisselsson D
• Article: PEDIATRIC BLOOD & CANCER. 2018;65(7):e27052

  Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis

  Corrias MV; Parodi S; Tchirkov A; Lammens T; Vicha A; Pasqualini C; Trager C; Yanez Y; Dallorso S; Varesio L; Luksch R; Laureys G; Valteau-Couanet D; Canete A; Poeetschger U; Ladenstein R; Burchill SA
• Article: EBIOMEDICINE. 2018;32:84-92

  Inhibition of Microsomal Prostaglandin E Synthase-1 in Cancer-Associated Fibroblasts Suppresses Neuroblastoma Tumor Growth

  Kock A; Larsson K; Bergqvist F; Eissler N; Elfman LHM; Raouf J; Korotkova M; Johnsen JI; Jakobsson P-J; Kogner P
• Article: PHARMACOLOGICAL RESEARCH. 2018;131:164-176

  Molecular mechanisms and therapeutic targets in neuroblastoma

  Johnsen JI; Dyberg C; Fransson S; Wickstrom M
• Article: CURRENT PROTOCOLS IN MOLECULAR BIOLOGY. 2018;122(1):e57

  Introduction to Single-Cell RNA Sequencing.

  Olsen TK; Baryawno N
• Article: CANCER CELL. 2018;33(3):417-434.e7

  Sense-Antisense lncRNA Pair Encoded by Locus 6p22.3 Determines Neuroblastoma Susceptibility via the USP36-CHD7-SOX9 Regulatory Axis

  Mondal T; Juvvuna PK; Kirkeby A; Mitra S; Kosalai ST; Traxler L; Hertwig F; Wernig-Zorc S; Miranda C; Deland L; Volland R; Bartenhagen C; Bartsch D; Bandaru S; Engesser A; Subhash S; Martinsson T; Caren H; Akyurek LM; Kurian L; Kanduri M; Huarte M; Kogner P; Fischer M; Kanduri C
• Article: PEDIATRIC HEMATOLOGY AND ONCOLOGY. 2018;35(2):156-165

  Chromogranin A and neuron-specific enolase in neuroblastoma: Correlation to stage and prognostic factors

  Georgantzi K; Skoldenberg EG; Stridsberg M; Kogner P; Jakobson A; Janson ET; Christofferson RHB
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2018;115(6):E1229-E1238

  MYCN-amplified neuroblastoma maintains an aggressive and undifferentiated phenotype by deregulation of estrogen and NGF signaling

  Dzieran J; Garcia AR; Westermark UK; Henley AB; Sanchez EE; Trager C; Johansson HJ; Lehtio J; Arsenian-Henriksson M
• Article: PLOS ONE. 2018;13(1):e0190970

  Doxorubicin-provoked increase of mitotic activity and concomitant drain of G0-pool in therapy-resistant BE(2)-C neuroblastoma

  Hultman I; Haeggblom L; Rognmo I; Edqvist JJ; Blomberg E; Ali R; Phillips L; Sandstedt B; Kogner P; Fard SS; Ahrlund-Richter L
• Article: BMJ PAEDIATRICS OPEN. 2018;2(1):e000316

  Intestinal failure after necrotising enterocolitis: incidence and risk factors in a Swedish population-based longitudinal study

  Sjoberg Bexelius T; Ahle M; Elfvin A; Bjoerling O; Ludvigsson JF; Andersson RE
• Conference publication: BLOOD. 2017;130

  MAPKAP1 (Sin1), a Key Component of the MTORC2 Complex, Confers Resistance to Sorafenib and Correlates with Adverse Clinical Outcomes in Acute Myeloid Leukemia

  Khoury JD; Xagoraris I; Tsesmetzis N; Myrberg IHH; Olsen TK; Ng SB; Chng W-J; Yan B; Ng CH; Andreeff M; Medeiros LJ; Kantarjian HM; Herold N; Grander D; Rassidakis G
• Article: JOURNAL OF NEUROCHEMISTRY. 2017;143(6):708-721

  16p11.2 deletion syndrome mice perseverate with active coping response to acute stress - rescue by blocking 5-HT2A receptors.

  Panzini CM; Ehlinger DG; Alchahin AM; Guo Y; Commons KG
• Conference publication: CANCER RESEARCH. 2017;77(22):b40

  A novel activating I1171T ALK mutation in neuroblastoma responds better to ceritinib compare to the first generation inhibitor crizotinib

  Siaw JT; Guan J; Martinsson T; Hansson M; Kogner P; Palmer R
• Article: ONCOTARGET. 2017;8(56):95135-95151

  Inhibition of chemerin/CMKLR1 axis in neuroblastoma cells reduces clonogenicity and cell viability in vitro and impairs tumor growth in vivo

  Tummler C; Snapkov I; Wickstrom M; Moens U; Ljungblad L; Elfman LHM; Winberg J-O; Kogner P; Johnsen JI; Sveinbjornsson B
• Conference publication: PEDIATRIC BLOOD & CANCER. 2017;64:S135

  Development of a Small Molecule Inhibitor for SAMHD1 to Improve Outcome for Patients with Acute Myelogenous Leukaemia and Relapsed T-Lymphoblastic Malignancies Treated with Nucleoside Analogues

  Herold N; Rudd S; Myrberg IH; Sanjiv K; Ljungblad L; Kutzner J; Grander D; Kogner P; Rassidakis G; Helleday T; Henter JI; Schaller T
• Conference publication: PEDIATRIC BLOOD & CANCER. 2017;64:S343

  Omegachild - An Early Clinical Study Aiming at a Novel Approach to Treat Neural Tumors and Prevent Long-Term Side Effects

  Ljungblad L; Wickstrom M; Eissler N; Pickova J; Johnsen JI; Tedroff K; Strandvik B; Gleissman H; Kogner P
• Conference publication: PEDIATRIC BLOOD & CANCER. 2017;64:S232

  Complete Clinical Response in High-Risk Neuroblastoma After ALK-Inhibitor Mono-Therapy Specifically Targeting the Novel Activating I1171T ALK Mutation

  Kogner P; Treis D; Siaw J; Fransson S; Guan J; Svenberg P; Hansson M; Wessman S; Gordon L; Stenman J; Svensson PJ; Johnsen JI; Martinsson T; Palmer RH; Hallberg B
• Conference publication: PEDIATRIC BLOOD & CANCER. 2017;64:S471

  Early Evaluation of Precision Medicine Efficiency for Swedish Children and Adolescents with Cancer

  Rinaldo C; Vigholm J; Hybinette HH; Wahlo YC; Kogner P; Heyman M; Petersen C; Saari AH; Ora I
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2017;114(32):E6603-E6612

  Rho-associated kinase is a therapeutic target in neuroblastoma

  Dyberg C; Fransson S; Andonova T; Sveinbjornsson B; Lannerholm-Palm J; Olsen TK; Forsberg D; Herlenius E; Martinsson T; Brodin B; Kogner P; Johnsen JI; Wickstrom M
• Review: EXPERT OPINION ON DRUG DISCOVERY. 2017;12(8):801-811

  Accelerating drug development for neuroblastoma - New Drug Development Strategy: an Innovative Therapies for Children with Cancer, European Network for Cancer Research in Children and Adolescents and International Society of Paediatric Oncology Europe Neuroblastoma project

  Moreno L; Caron H; Geoerger B; Eggert A; Schleiermacher G; Brock P; Valteau-Couanet D; Chesler L; Schulte JH; De Preter K; Molenaar J; Schramm A; Eilers M; Van Maerken T; Johnsen JI; Garrett M; George SL; Tweddle DA; Kogner P; Berthold F; Koster J; Barone G; Tucker ER; Marshall L; Herold R; Sterba J; Norga K; Vassal G; Pearson ADJ
• Article: EXPERIMENTAL HEMATOLOGY. 2017;52:32-39

  With me or against me: Tumor suppressor and drug resistance activities of SAMHD 1

  Herold N; Rudd SG; Sanjiv K; Kutzner J; Myrberg IH; Paulin CBJ; Olsen TK; Helleday T; Henter J-I; Schaller T
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2017;114(30):E6137-E6146

  Combined epigenetic and differentiation-based treatment inhibits neuroblastoma tumor growth and links HIF2α to tumor suppression

  Westerlund I; Shi Y; Toskas K; Fell SM; Li S; Surova O; Sodersten E; Kogner P; Nyman U; Schlisio S; Holmberg J
• Conference publication: CANCER RESEARCH. 2017;77:5832

  Rho-associated kinase is a therapeutic target in neuroblastoma

  Dyberg CH; Fransson S; Andonova T; Sveinbjornsson B; Lannerholm-Palm J; Forsberg D; Herlenius E; Martinsson T; Kogner P; Johnsen JI; Wickstrom M
• Journal article: CANCER RESEARCH. 2017;77:687

  Targeting tumor-promoting neuroblastoma microenvironment: inhibiton of tumor development and progression by targeting mPGES-1 expressed by cancer associated fibroblasts

  Kock A; Larsson K; Eissler N; Bergqvist F; Rauf J; Korotkova M; Johnsen J-I; Jakobsson P-J; Kogner P
• Journal article: CANCER RESEARCH. 2017;77:1945

  PPM1D/Wip1, promising new target in childhood cancers neuroblastoma and medulloblastoma

  Milosevic J; Eissler N; Treis D; Wicktrom M; Fransson S; Sveinbjornsson B; Baryawno N; Kosalai S; Kanduri C; Sakaguchi K; Martinsson T; Johnsen JI; Kogner P
• Journal article: CANCER RESEARCH. 2017;77:4876

  Low frequent ALK hotspot mutations in neuroblastoma tumors detected by ultra deep sequencing: Implications for ALK inhibitor treatment

  Fransson SM; Javanmardi N; Sjoberg R-M; Kogner P; Martinsson T
• Journal article: CANCER RESEARCH. 2017;77:4867

  Exome- and whole genome sequencing for clinical evaluation and precision medicine in neuroblastoma

  Monleon AM; Reinsbach S; Javanmardi N; Djos A; Sjoberg R-M; Kogner P; Martinsson T; Fransson S
• Letter: JOURNAL OF CLINICAL ONCOLOGY. 2017;35(17):1965-1966

  Improved Local Control by Extensive Surgery in High-Risk Neuroblastoma May Be Dependent on Adjuvant Radiotherapy

  Stenman J; Herold N; Svensson P-J; Kogner P
• Article: ONCOTARGET. 2017;8(21):34111-34127

  Lithium protects hippocampal progenitors, cognitive performance and hypothalamus-pituitary function after irradiation to the juvenile rat brain

  Zhou K; Xie C; Wickstrom M; Dolga AM; Zhang Y; Li T; Xu Y; Culmsee C; Kogner P; Zhu C; Blomgren K
• Article: GENES & DEVELOPMENT. 2017;31(10):1036-1053

  Neuroblast differentiation during development and in neuroblastoma requires KIF1Bβ-mediated transport of TRKA

  Fell SM; Li S; Wallis K; Kock A; Surova O; Rraklli V; Hoefig CS; Li W; Mittag J; Henriksson MA; Kenchappa RS; Holmberg J; Kogner P; Schlisio S
• Article: SCIENTIFIC REPORTS. 2017;7:46366

  Establishment and characterization of an orthotopic patient-derived Group 3 medulloblastoma model for preclinical drug evaluation

  Sanden E; Dyberg C; Krona C; Gallo-Oller G; Olsen TK; Perez JE; Wickstrom M; Estekizadeh A; Kool M; Visse E; Ekstrom TJ; Siesjo P; Johnsen JI; Darabi A
• Article: LANCET ONCOLOGY. 2017;18(4):500-514

  Busulfan and melphalan versus carboplatin, etoposide, and melphalan as high-dose chemotherapy for high-risk neuroblastoma (HR-NBL1/SIOPEN): an international, randomised, multi-arm, open-label, phase 3 trial

  Ladenstein R; Poetschger U; Pearson ADJ; Brock P; Luksch R; Castel V; Yaniv I; Papadakis V; Laureys G; Malis J; Balwierz W; Ruud E; Kogner P; Schroeder H; de Lacerda AF; Beck-Popovic M; Bician P; Garami M; Trahair T; Canete A; Ambros PF; Holmes K; Gaze M; Schreier G; Garaventa A; Vassal G; Michon J; Valteau-Couanet D
• Corrigendum: BMC GENOMICS. 2017;18(1):256

  Erratum to: Unity in defence: honeybee workers exhibit conserved molecular responses to diverse pathogens.

  Doublet V; Poeschl Y; Gogol-Döring A; Alaux C; Annoscia D; Aurori C; Barribeau SM; Bedoya-Reina OC; Brown MJF; Bull JC; Flenniken ML; Galbraith DA; Genersch E; Gisder S; Grosse I; Holt HL; Hultmark D; Lattorff HMG; Le Conte Y; Manfredini F; McMahon DP; Moritz RFA; Nazzi F; Niño EL; Nowick K; van Rij RP; Paxton RJ; Grozinger CM
• Article: BMC GASTROENTEROLOGY. 2017;17(1):36

  Angiotensin II receptor blockers and risk of acute pancreatitis - a population based case-control study in Sweden

  Bexelius TS; Ljung R; Mattsson F; Lu Y; Lindblad M
• Article: BMC GENOMICS. 2017;18(1):207

  Unity in defence: honeybee workers exhibit conserved molecular responses to diverse pathogens.

  Doublet V; Poeschl Y; Gogol-Döring A; Alaux C; Annoscia D; Aurori C; Barribeau SM; Bedoya-Reina OC; Brown MJF; Bull JC; Flenniken ML; Galbraith DA; Genersch E; Gisder S; Grosse I; Holt HL; Hultmark D; Lattorff HMG; Le Conte Y; Manfredini F; McMahon DP; Moritz RFA; Nazzi F; Niño EL; Nowick K; van Rij RP; Paxton RJ; Grozinger CM
• Article: BMC MEDICAL EDUCATION. 2017;17(1):47

  Medical students' experiences of their own professional development during three clinical terms: a prospective follow-up study

  Kalen S; Lachmann H; Varttinen M; Moeller R; Bexelius TS; Ponzer S
• Article: NATURE MEDICINE. 2017;23(2):256-263

  Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies

  Herold N; Rudd SG; Ljungblad L; Sanjiv K; Myrberg IH; Paulin CBJ; Heshmati Y; Hagenkort A; Kutzner J; Paget BDG; Calderon-Montano JM; Loseva O; Jemth A-S; Bulli L; Axelsson H; Tesi B; Valerie NCK; Hoglund A; Bladh J; Wiita E; Sundin M; Uhlin M; Rassidakis G; Heyman M; Tamm KP; Warpman-Berglund U; Walfridsson J; Lehmann S; Grander D; Lundback T; Kogner P; Henter J-I; Helleday T; Schaller T
• Article: ONCOGENE. 2017;36(4):570-584

  Differential propagation of stroma and cancer stem cells dictates tumorigenesis and multipotency

  Behnan J; Stangeland B; Hosainey SAM; Joel M; Olsen TK; Micci F; Glover JC; Isakson P; Brinchmann JE
• Editorial: NATURE STRUCTURAL & MOLECULAR BIOLOGY. 2017;24(1):7-8

  Functional RNA classes: a matter of time?

  Bedoya-Reina OC; Ponting CP
• Article: GENES CHROMOSOMES & CANCER. 2016;55(12):944-953

  Novel fusion genes and chimeric transcripts in ependymal tumors.

  Olsen TK; Panagopoulos I; Gorunova L; Micci F; Andersen K; Kilen Andersen H; Meling TR; Due-Tønnessen B; Scheie D; Heim S; Brandal P
• Conference publication: PEDIATRIC BLOOD & CANCER. 2016;63:S28

  Combination Therapy of Anti-PD-1 Antibody and CSF-1R Inhibitor Reverses Induction of Suppressive Myeloid Cells and Controls Spontaneous Neuroblastoma Progression

  Eissler N; Mao Y; Brodin D; Reutersward P; Svahn HA; Johnsen JI; Kiessling R; Kogner P
• Conference publication: PEDIATRIC BLOOD & CANCER. 2016;63:S82

  The PPM1D-Encoded Wip1-Phosphatase is a Candidate Oncogene on 17q Contributing to Neuroblastoma Development and Providing a Novel Therapeutic Target

  Milosevic J; Fransson S; Treis D; Tanino K; Wickstrom M; Sveinbjornsson B; Kosalai ST; Baryawno N; Johnsen JI; Sakaguchi K; Kanduri C; Martinsson T; Kogner P
• Conference publication: PEDIATRIC BLOOD & CANCER. 2016;63:S32

  Long-Term Results for Children with High-Risk Neuroblastoma Treated on the Randomized High-Dose Therapy Trial of Busulphan-Melphalan Versus Carboplatin-Etoposide-Melphalan: A Siopen Study

  Ladenstein R; Poetschger U; Brock P; Luksch R; Castel V; Yaniv I; Papadakis V; Laureys G; Malis J; Balwierz W; Kogner P; Ambros P; Holmes K; Gaze M; Schreier G; Garaventa A; Vassal G; Michon J; Pearson A; Valteau-Couanet D
• Conference publication: PEDIATRIC BLOOD & CANCER. 2016;63:S82-S83

  Targeting the Benign to Kill the Malignant : Inhibition of Inflammatory Progression of Neuroblastoma by Targeting mPGES-1 in Cancer Associated Fibroblasts in the Tumour Microenvironment

  Kock A; Larsson K; Eissler N; Bergqvist F; Elfman L; Raouf J; Korotkova M; Johnsen JI; Jakobsson PJ; Kogner P
• Article: PHARMACOEPIDEMIOLOGY AND DRUG SAFETY. 2016;25(11):1337-1341

  Polypharmacy and risk of acute pancreatitis

  Razavi D; Lindblad M; Bexelius T; Oskarsson V; Sadr-Azodi O; Ljung R
• Doctoral thesis: 2016

  Targeting dysfunctional developmental signaling cascades as a tool for tailored therapy in embryonal tumors

  Dyberg C
• Letter: HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL. 2016;15(4):443-445

  Type 2 diabetes, high blood pressure and acute pancreatitis

  Bexelius TS; Ljung R; Garcia Rodriguez LA
• Article: PLOS ONE. 2016;11(8):e0160602

  FITC Conjugation Markedly Enhances Hepatic Clearance of N-Formyl Peptides

  Oie CI; Snapkov I; Elvevold K; Sveinbjornsson B; Smedsrod B
• Letter: LANCET ONCOLOGY. 2016;17(8):e319-e320

  Venetoclax in cancer therapy and potential effects on bone

  Zaman F; Kogner P; Savendahl L
• Article: CLINICAL CANCER RESEARCH. 2016;22(15):3849-3859

  Targeting Suppressive Myeloid Cells Potentiates Checkpoint Inhibitors to Control Spontaneous Neuroblastoma

  Mao Y; Eissler N; Le Blanc K; Johnsen JI; Kogner P; Kiessling R
• Article: POSTGRADUATE MEDICAL JOURNAL. 2016;92(1090):441-446

  Association between personality traits and future choice of specialisation among Swedish doctors: a cross-sectional study

  Bexelius TS; Olsson C; Jarnbert-Pettersson H; Parmskog M; Ponzer S; Dahlin M
• Article: CELL REPORTS. 2016;16(4):979-993

  Regulation of Nuclear Hormone Receptors by MYCN-Driven miRNAs Impacts Neural Differentiation and Survival in Neuroblastoma Patients

  Ribeiro D; Klarqvist MDR; Westermark UK; Oliynyk G; Dzieran J; Kock A; Banares CS; Hertwig F; Johnsen JI; Fischer M; Kogner P; Loven J; Henriksson MA
• Article: BMC CANCER. 2016;16:490

  The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis

  Snapkov I; Oqvist CO; Figenschau Y; Kogner P; Johnsen JI; Sveinbjornsson B
• Journal article: CANCER RESEARCH. 2016;76:2465

  Spleen tyrosine kinase (SYK) in neuroblastoma tumorigenesis

  Tuemmler C; Dumitriu G; Cserna J; Moens UL; Kogner P; Johnsen JI; Sveinbjornsson B
• Journal article: CANCER RESEARCH. 2016;76:761

  Specific inhibition of prostaglandin E2 production in medulloblastoma

  Bergqvist F; Ljungblad L; Wickstrom M; Larsson K; Kock A; Korotkova M; Johnsen JI; Kogner P; Jakobsson P-J
• Journal article: CANCER RESEARCH. 2016;76:2454

  Omega-3 fatty acids DHA and EPA decrease oncogenic PGE2 in medulloblastoma in vitro and in vivo

  Ljungblad L; Bergqvist F; Andonova T; Jakobsson P-J; Johnsen JI; Kogner P; Wickstrom M
• Journal article: CANCER RESEARCH. 2016;76:2435

  Amplification of CDK4 and MDM2 is associated with atypical clinical features in high risk neuroblastoma patients

  Fransson SM; Kryh H; Javanmardi N; Ambros IM; Berbegall AP; Ora I; Noguera R; Asmundsson J; Sandstedt B; Ambros PF; Kogner P; Martinsson T
• Journal article: CANCER RESEARCH. 2016;76:2430

  Neuroblastoma: Telomere elongation is responsible for aggressive behavior

  Javanmardi N; Fransson S; Sjoberg R-M; Djos A; Kogner P; Martinsson T
• Conference publication: NEURO-ONCOLOGY. 2016;18:116

  OMEGA-3 FATTY ACIDS DHA AND EPA SUPPRESS ONCOGENIC PGE2 IN MEDULLOBLASTOMA

  Ljungblad L; Bergqvist F; Andonova T; Jakobsson P-J; Johnsen JI; Gleissman H; Kogner P; Wickstrom M
• Journal article: NEURO-ONCOLOGY. 2016;18(suppl_3):iii116

  MB-83OMEGA-3 FATTY ACIDS DHA AND EPA SUPPRESS ONCOGENIC PGE2 IN MEDULLOBLASTOMA

  Ljungblad L; Bergqvist F; Andonova T; Jakobsson P-J; Johnsen JI; Gleissman H; Kogner P; Wickström M
• Letter: BRITISH JOURNAL OF CANCER. 2016;114(11):e12

  Reply to 'Comment on 'New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer''

  Lu Y; Garcia Rodriguez LA; Malgerud L; Gonzalez-Perez A; Martin-Perez M; Lagergren J; Bexelius TS
• Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2016;34(15):10527

  Prognostic factors in stage 4 neuroblastoma treated with busulphan-melphalan: Report from the European HR-NBIA/Siopen trial.

  Ladenstein R; Poetschger U; Elliott M; Luksch R; Castel V; Yaniv I; Papadakis V; Laureys G; Malis J; Balwierz W; Ruud E; Kogner P; Schroeder H; De Lacerda AF; Popovic MB; Bician P; Garami M; Trahair T; Pearson ADJ; Couanet DV
• Article: NATURE COMMUNICATIONS. 2016;7:11519

  Giraffe genome sequence reveals clues to its unique morphology and physiology.

  Agaba M; Ishengoma E; Miller WC; McGrath BC; Hudson CN; Bedoya Reina OC; Ratan A; Burhans R; Chikhi R; Medvedev P; Praul CA; Wu-Cavener L; Wood B; Robertson H; Penfold L; Cavener DR
• Journal article: NEURO-ONCOLOGY. 2016;18(Suppl 3):iii116

  MB-83OMEGA-3 FATTY ACIDS DHA AND EPA SUPPRESS ONCOGENIC PGE2 IN MEDULLOBLASTOMA
• Article: BMC CANCER. 2016;16:259

  Planar cell polarity gene expression correlates with tumor cell viability and prognostic outcome in neuroblastoma

  Dyberg C; Papachristou P; Haug BH; Lagercrantz H; Kogner P; Ringstedt T; Wickstrom M; Johnsen JI
• Article: MOLECULAR & CELLULAR ONCOLOGY. 2016;3(2):e1131356

  Wingless/β-catenin signaling as a modulator of chemoresistance in cancer

  Johnsen JI; Wickstrom M; Baryawno N
• Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2016;48(3):1103-1116

  Estimation of copy number aberrations: Comparison of exome sequencing data with SNP microarrays identifies homozygous deletions of 19q13.2 and iin neuroblastoma

  Fransson S; Ostensson M; Djos A; Javanmardi N; Kogner P; Martinsson T
• Article: PLOS ONE. 2016;11(2):e0148980

  The Cytolytic Amphipathic β(2,2)-Amino Acid LTX-401 Induces DAMP Release in Melanoma Cells and Causes Complete Regression of B16 Melanoma

  Eike L-M; Mauseth B; Camilio KA; Rekdal O; Sveinbjornsson B
• Article: DEVELOPMENTAL CELL. 2016;36(2):164-178

  The 1p36 Tumor Suppressor KIF 1Bβ Is Required for Calcineurin Activation, Controlling Mitochondrial Fission and Apoptosis

  Li S; Fell SM; Surova O; Smedler E; Wallis K; Chen ZX; Hellman U; Johnsen JI; Martinsson T; Kenchappa RS; Uhlen P; Kogner P; Schlisio S
• Article: EPIGENETICS. 2016;11(1):74-84

  Genome-wide methylation profiling identifies novel methylated genes in neuroblastoma tumors

  Olsson M; Beck S; Kogner P; Martinsson T; Caren H
• Article: ONCOIMMUNOLOGY. 2016;5(12):e1232222

  Regulation of myeloid cells by activated T cells determines the efficacy of PD-1 blockade

  Eissler N; Mao Y; Brodin D; Reutersward P; Svahn HA; Johnsen JI; Kiessling R; Kogner P
• Article: BRITISH JOURNAL OF CANCER. 2015;113(11):1607-1614

  New-onset type 2 diabetes, elevated HbA1c, anti-diabetic medications, and risk of pancreatic cancer

  Lu Y; Garcia Rodriguez LA; Malgerud L; Gonzalez-Perez A; Martin-Perez M; Lagergren J; Bexelius TS
• Article: NATURE COMMUNICATIONS. 2015;6:8904

  Wnt/β-catenin pathway regulates MGMT gene expression in cancer and inhibition of Wnt signalling prevents chemoresistance

  Wickstrom M; Dyberg C; Milosevic J; Einvik C; Calero R; Sveinbjornsson B; Sanden E; Darabi A; Siesjo P; Kool M; Kogner P; Baryawno N; Johnsen JI
• Conference publication: PEDIATRIC BLOOD & CANCER. 2015;62:S332

  THE PPM1D ENCODED PHOSPHATASE WIP1 IS A NOVEL ONCOGENE AND POTENTIAL THERAPEUTIC TARGET IN NEUROBLASTOMA AND MEDULLOBLASTOMA

  Milosevic J; Treis D; Malin M; Fransson S; Sveinbjornsson B; Eissler N; Baryawno N; Tanino K; Selivanova G; Sakaguchi K; Martinsson T; Johnsen JI; Kogner P
• Conference publication: PEDIATRIC BLOOD & CANCER. 2015;62:S276

  THE WNT/β-CATENIN SIGNALING PATHWAY REGULATES MGMT GENE EXPRESSION IN CHILDHOOD NEURAL TUMORS AND INHIBITION OF WNT SIGNALING PREVENTS CHEMORESISTANCE

  Johnsen J; Wickstrom M; Dyberg C; Milosevic J; Einvik C; Calero R; Sveinbjornson B; Sanden E; Darabi A; Siesjo P; Kool M; Kogner P; Baryawno N
• Conference publication: PEDIATRIC BLOOD & CANCER. 2015;62:S328-S329

  INHIBITION OF RHO-ASSOCIATED KINASE 2 INHIBITS MALIGNANT PROGRESSION IN NEUROBLASTOMA BY INDUCING DIFFERENTIATION AND MYCN DEGRADATION

  Dyberg C; Forsberg D; Fransson S; Lannerholm-Palm J; Sveinbjornsson B; Martinsson T; Kogner P; Johnsen JI; Wickstrom M
• Conference publication: PEDIATRIC BLOOD & CANCER. 2015;62:S149

  NEUROBLASTOMA IMMUNOTHERAPY TARGETING CSF-1R REVERSES INDUCTION OF SUPPRESSIVE MYELOID CELLS AND CONTROLS AGGRESSIVE TUMOR PROGRESSION

  Eissler N; Mao Y; Johnsen JI; Kiessling R; Kogner P
• Conference publication: PEDIATRIC BLOOD & CANCER. 2015;62:S331

  ARSENIC TRIOXIDE POTENTIATES THE CYTOTOXICITY OF CHEMOTHERAPEUTIC AGENTS AGAINST HUMAN SK-N-SH NEUROBLASTOMA CELL LINE

  Kock A; Larsson K; Raouf J; Korotkova M; Johnsen I; Jakobsson PJ; Kogner P
• Article: NEURO-ONCOLOGY. 2015;17(10):1365-1373

  Fusion genes with ALK as recurrent partner in ependymoma-like gliomas: a new brain tumor entity?

  Olsen TK; Panagopoulos I; Meling TR; Micci F; Gorunova L; Thorsen J; Due-Tønnessen B; Scheie D; Lund-Iversen M; Krossnes B; Saxhaug C; Heim S; Brandal P
• Article: LANCET. 2015;386(9999):1156-1164

  Omission of doxorubicin from the treatment of stage II-III, intermediate-risk Wilms' tumour (SIOP WT 2001): an open-label, non-inferiority, randomised controlled trial

  Pritchard-Jones K; Bergeron C; de Camargo B; van den Heuvel-Eibrink MM; Acha T; Godzinski J; Oldenburger F; Boccon-Gibod L; Leuschner I; Vujanic G; Sandstedt B; de Kraker J; van Tinteren H; Graf N
• Conference publication: CANCER RESEARCH. 2015;75:495

  Amplification of chromosomal regions 12q13-14 and 12q15 defines a distinct subgroup of high-risk neuroblastoma patients and is associated with atypical clinical features

  Fransson SM; Kryh H; Javanmardi N; Ambros I; Berbegall A; Ora I; Noguera R; Asmundsson J; Sandstedt B; Ladenstein R; Ambros PF; Kogner P; Martinsson T
• Conference publication: CANCER RESEARCH. 2015;75:3275

  A novel approach to treat medulloblastoma: The omega-3 fatty acids DHA and EPA reduce medulloblastoma tumor growth in vitro and in vivo

  Ljungblad LM; Johnsen J-I; Wickstrom M; Kogner P; Gleissman H
• Conference publication: CANCER RESEARCH. 2015;75:503

  The PPM1D encoded phosphatase Wip1 is a novel oncogene and potential therapeutic target in neuroblastoma and medulloblastoma

  Miloseyic J; Treis D; Wickstrom M; Fransson S; Eissler N; Syeinbjornsson B; Baryawno N; Tanino K; Selivanova G; Sakaguchi K; Martinsson T; Johnsen JI; Kogner P
• Conference publication: CANCER RESEARCH. 2015;75:3266

  Inhibition of Rho-associated kinase 2 suppresses MYCN expression and induces differentiation of neuroblastoma

  Dyberg C; Forsberg D; Fransson S; Palm JL; Haug BH; Sveinbjornsson B; Martinsson T; Kogner P; Johnsen JI; Wickstrom M
• Conference publication: CANCER RESEARCH. 2015;75:4831

  Analysis of genetic variations in neuroblastoma using deep targeted sequencing

  Javanmardi N; Fransson S; Ostensson M; Sjoberg R-M; Kogner P; Martinsson T
• Conference publication: CANCER RESEARCH. 2015;75:3279

  Expression of chemerin and chemerin receptors in neuroblastoma: implications in tumorigenesis

  Tuemmler C; Snapkov I; Moens UL; Kogner P; Johnsen JI; Sveinbjornsson B
• Conference publication: CANCER RESEARCH. 2015;75:3283

  The role of formyl peptide receptor 1 (FPR1) in neuroblastoma tumorigenesis

  Snapkov I; Oqvist CO; Figenschau YA; Kogner P; Johnsen JI; Sveinbjornsson B
• Conference publication: CANCER RESEARCH. 2015;75:1632

  Microsomal prostaglandin E synthase 1: a novel therapeutic target of neuroblastoma

  Kock A; Larsson K; Joan R; Korotkova M; Johnsen J-I; Jakobsson P-J; Kogner P
• Article: CELL REPORTS. 2015;12(2):217-228

  Elephantid Genomes Reveal the Molecular Bases of Woolly Mammoth Adaptations to the Arctic.

  Lynch VJ; Bedoya-Reina OC; Ratan A; Sulak M; Drautz-Moses DI; Perry GH; Miller W; Schuster SC
• Article: BMC GENOMICS. 2015;16(1):518

  Genome-wide analysis of signatures of selection in populations of African honey bees (Apis mellifera) using new web-based tools.

  Fuller ZL; Niño EL; Patch HM; Bedoya-Reina OC; Baumgarten T; Muli E; Mumoki F; Ratan A; McGraw J; Frazier M; Masiga D; Schuster S; Grozinger CM; Miller W
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2015;112(26):8070-8075

  COX/mPGES-1/PGE₂ pathway depicts an inflammatory-dependent high-risk neuroblastoma subset

  Larsson K; Kock A; Idborg H; Henriksson MA; Martinsson T; Johnsen JI; Korotkova M; Kogner P; Jakobsson P-J
• Article: JOURNAL OF NEURO-ONCOLOGY. 2015;123(1):1-13

  Aberrant immunostaining pattern of the CD24 glycoprotein in clinical samples and experimental models of pediatric medulloblastomas

  Sanden E; Dyberg C; Krona C; Visse E; Caren H; Northcott PA; Kool M; Stahl N; Persson A; Englund E; Johnsen JI; Siesjo P; Darabi A
• Article: EUROPEAN JOURNAL OF CANCER. 2015;51(4):498-506

  Outcome of localised blastemal-type Wilms tumour patients treated according to intensified treatment in the SIOP WT 2001 protocol, a report of the SIOP Renal Tumour Study Group (SIOP-RTSG)

  van den Heuvel-Eibrink MM; van Tinteren H; Bergeron C; Coulomb-L'Hermine A; de Camargo B; Leuschner I; Sandstedt B; Acha T; Godzinski J; Oldenburger F; Gooskens SL; de Kraker J; Vujanic GM; Pritchard-Jones K; Graf N
• Review: WORLD JOURNAL OF EXPERIMENTAL MEDICINE. 2015;5(1):1-10

  Cytomegalovirus in human brain tumors: Role in pathogenesis and potential treatment options.

  Söderberg-Nauclér C; Johnsen JI
• Article: GENES CHROMOSOMES & CANCER. 2015;54(2):99-109

  Intragenic Anaplastic Lymphoma Kinase (ALK) Rearrangements: Translocations as a Novel Mechanism of ALK Activation in Neuroblastoma Tumors

  Fransson S; Hansson M; Ruuth K; Djos A; Berbegall A; Javanmardi N; Abrahamsson J; Palmer RH; Noguera R; Hallberg B; Kogner P; Martinsson T
• Article: NATURE COMMUNICATIONS. 2015;6:6125

  Intratumoral genome diversity parallels progression and predicts outcome in pediatric cancer

  Mengelbier LH; Karlsson J; Lindgren D; Valind A; Lilljebjorn H; Jansson C; Bexell D; Braekeveldt N; Ameur A; Jonson T; Kultima HG; Isaksson A; Asmundsson J; Versteeg R; Rissler M; Fioretos T; Sandstedt B; Borjesson A; Backman T; Pal N; Ora I; Mayrhofer M; Gisselsson D
• Journal article: LINDBERGIA. 2015;38(1):30-38

  Porella obtusata: distribution, ecology and threats at the west coast of Norway, the northern fringe of its European distribution

  Hassel K; Johnsen JI; Jordal JB; Knutsen A
• Conference publication: PEDIATRIC BLOOD & CANCER. 2014;61:S283

  OMEGA-3 FATTY ACIDS INHIBIT MEDULLOBLASTOMA GROWTH IN VITRO AND IN VIVO

  Ljungblad L; Wickstrom M; Johnsen J; Kogner P; Gleissman H
• Conference publication: PEDIATRIC BLOOD & CANCER. 2014;61:S119

  RISK FACTORS WITHIN THE EUROPEAN HIGH RISK NEUROBLASTOMA HR-NBL1/SIOPEN TRIAL

  Ladenstein R; Poetschger U; Luksch R; Elliot M; Castel V; Yaniv I; Papadakis V; Malis J; Kogner P; Valteau-Couanet D
• Review: SEMINARS IN CANCER BIOLOGY. 2014;29:75-79

  Experimental teratoma: At the crossroad of fetal- and onco-development

  Hultman I; Bjork L; Blomberg E; Sandstedt B; Ahrlund-Richter L
• Article: PEDIATRIC BLOOD & CANCER. 2014;61(12):2175-2179

  Nephron Sparing Surgery (NSS) for Unilateral Wilms Tumor (UWT): The SIOP 2001 Experience

  Wilde JCH; Aronson DC; Sznajder B; Van Tinteren H; Powis M; Okoye B; Cecchetto G; Audry G; Fuchs J; Von Schweinitz D; Heij H; Graf N; Bergeron C; Pritchard-Jones K; Van Den Heuvel-Eibrink M; Carli M; Oldenburger F; Sandstedt B; De Kraker J; Godzinski J
• Article: CANCER CELL. 2014;26(5):722-737

  The Risk-Associated Long Noncoding RNA NBAT-1 Controls Neuroblastoma Progression by Regulating Cell Proliferation and Neuronal Differentiation

  Pandey GK; Mitra S; Subhash S; Hertwig F; Kanduri M; Mishra K; Fransson S; Ganeshram A; Mondal T; Bandaru S; Ostensson M; Akyurek LM; Abrahamsson J; Pfeifer S; Larsson E; Shi L; Peng Z; Fischer M; Martinsson T; Hedborg F; Kogner P; Kanduri C
• Meeting abstract: EUROPEAN JOURNAL OF CANCER. 2014;50:135

  RNA helicase A is essential for 1p36 gene KIF1 Bβ tumor suppression in neuroblastomas

  Chen ZX; Wallis K; Fell SM; Sobrado VR; Hemmer MC; Ramskold D; Choo Z; Hellman U; Sandberg R; Kenchappa RS; Martinsson T; Johnsen JI; Kogner P; Schlisio S
• Article: JOURNAL OF PEDIATRIC SURGERY. 2014;49(11):1544-1548

  Minimally invasive nephrectomy for Wilms tumors in children - data from SIOP 2001

  Warmann SW; Godzinski J; van Tinteren H; Heij H; Powis M; Sandstedt B; Graf N; Fuchs J
• Conference publication: CANCER RESEARCH. 2014;74(20):a84

  Stereotactic injections of primary medulloblastomas as a representative model of the different subgroups for preclinical drug screening

  Krona C; Dyberg C; Sanden E; Darabi A; Wickstrom M; Northcott P; Johnsen JI; Siesjo P
• Meeting abstract: CANCER RESEARCH. 2014;74(19):3110

  Targeting the Wnt/PCP signaling through ROCK: A new neuroblastoma drug target

  Dyberg C; Forsberg D; Papachristou P; Lannerholm-Palm J; Haug BH; Sveinbjoernsson B; Lagercrantz H; Kogner P; Johnsen JI; Wickstrom M
• Conference publication: CANCER RESEARCH. 2014;74(19):3988

  The omega-3 fatty acids DHA and EPA inhibit medulloblastoma growth

  Ljungblad LM; Wickstrom M; Johnsen J-I; Kogner P; Gleissman H
• Conference publication: CANCER RESEARCH. 2014;74(19):3971

  PPM1D/WIP1, a potential target in neuroblastoma

  Milosevic J; Wickstrom M; Treis D; Nordegren HS; Elfman L; Baryawno N; Fransson S; Sveinbjornsson B; Martinsson T; Johnsen JI; Kogner P
• Conference publication: CANCER RESEARCH. 2014;74(19):3976

  Expression of formyl peptide receptor 1 (FPR1) in neuroblastoma: Implications in tumorigenesis

  Snapkov I; Kogner P; Johnsen J-I; Sveinbjornsson B
• Conference publication: CANCER RESEARCH. 2014;74(19):3108

  Copy number variation analysis in neuroblastoma through next generation sequencing data and SNP-microarray

  Fransson S; Ostenssson M; Djos A; Javanmardi N; Kogner P; Martinsson T
• Meeting abstract: CANCER RESEARCH. 2014;74(19):3986

  Characterization of prostaglandin signaling in primary neuroblastoma

  Kock A; Larsson K; Ljungblad L; Idborg H; Korotkova M; Elfman L; Johnsen J-I; Jakobsson P-J; Kogner P
• Article: JOURNAL OF CLINICAL ONCOLOGY. 2014;32(25):2727-2734

  Emergence of New ALK Mutations at Relapse of Neuroblastoma

  Schleiermacher G; Javanmardi N; Bernard V; Leroy Q; Cappo J; Frio TR; Pierron G; Lapouble E; Combaret V; Speleman F; de Wilde B; Djos A; Ora I; Hedborg F; Traeger C; Holmqvist B-M; Abrahamsson J; Peuchmaur M; Michon J; Janoueix-Lerosey I; Kogner P; Delattre O; Martinsson T
• Article: BMC CANCER. 2014;14:600

  The impact of S6K1 kinase on neuroblastoma cell proliferation is independent of GLI1 signaling

  Diao Y; Rahman MF-U; Villegas VE; Wickstrom M; Johnsen JI; Zaphiropoulos PG
• Article: BRAIN RESEARCH. 2014;1576:27-34

  Transgenic increase of Wnt7b in neural progenitor cells decreases expression of T-domain transcription factors and impairs neuronal differentiation

  Papachristou P; Dyberg C; Lindquist M; Horn Z; Ringstedt T
• Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2014;450(4):1600-1605

  Effects of epigenetic modificators in combination with small molecule inhibitors of receptor tyrosine kinases on medulloblastoma growth

  Marino A-M; Frijhoff J; Calero R; Baryawno N; Ostman A; Johnsen JI
• Article: CANCER MEDICINE. 2014;3(4):812-824

  U-251 revisited: genetic drift and phenotypic consequences of long-term cultures of glioblastoma cells.

  Torsvik A; Stieber D; Enger PØ; Golebiewska A; Molven A; Svendsen A; Westermark B; Niclou SP; Olsen TK; Chekenya Enger M; Bjerkvig R
• Article: ACTA OPHTHALMOLOGICA. 2014;92(5):404-411

  A 10-year experience of outcome in chemotherapy-treated hereditary retinoblastoma

  Bartuma K; Pal N; Kosek S; Holm S; All-Ericsson C
• Article: ONCOLOGY REPORTS. 2014;32(2):483-490

  Genomic characterization of ependymomas reveals 6q loss as the most common aberration.

  Olsen TK; Gorunova L; Meling TR; Micci F; Scheie D; Due-Tønnessen B; Heim S; Brandal P
• Article: GENES CHROMOSOMES & CANCER. 2014;53(7):634-638

  Confined Trisomy 8 Mosaicism of Meiotic Origin: A Rare Cause of Aneuploidy in Childhood Cancer

  Valind A; Pal N; Asmundsson J; Gisselsson D; Mengelbier LH
• Article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2014;63(6):601-613

  Complete regression and systemic protective immune responses obtained in B16 melanomas after treatment with LTX-315

  Camilio KA; Berge G; Ravuri CS; Rekdal O; Sveinbjornsson B
• Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2014;32(15):11006

  Emergence of new ALK mutations at relapse of neuroblastoma.

  Schleiermacher G; Javanmardi N; Bernard V; Leroy Q; Cappo J; Rio-Frio T; Pierron G; Combaret V; Speleman F; Djos A; Ora I; Hedborg F; Holmqvist B-M; Abrahamsson J; Peuchmaur M; Michon J; Janoueix-Lerosey I; Kogner P; Delattre O; Martinsson T
• Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2014;32(15):10026

  Immunotherapy (IT) with ch14.18/CHO for high-risk neuroblastoma: First results from the randomised HRNBLI/SIOPEN trial.

  Ladenstein RL; Poetschger U; Luksch R; Brock P; Castel V; Yaniv I; Papadakis V; Laureys G; Malis J; Balwierz W; Ruud E; Kogner P; Schroeder H; Popovic MB; Ambros PF; Schreier G; Lode HN; Loibner H; Pearson ADJ; Couanet DV
• Article: PLOS ONE. 2014;9(4):e95628

  Sunitinib Suppress Neuroblastoma Growth through Degradation of MYCN and Inhibition of Angiogenesis

  Calero R; Morchon E; Johnsen JI; Serrano R
• Article: INTERNATIONAL JOURNAL OF CANCER. 2014;134(7):1630-1637

  Tropism of the in situ growth from biopsies of childhood neuroectodermal tumors following transplantation into experimental teratoma

  Jamil S; Hultman I; Cedervall J; Ali RQ; Fuchs G; Gustavsson B; Asmundsson J; Sandstedt B; Kogner P; Ahrlund-Richter L
• Article: CANCER DISCOVERY. 2014;4(4):434-451

  RNA Helicase A Is a Downstream Mediator of KIF1Bβ Tumor-Suppressor Function in Neuroblastoma

  Chen ZX; Wallis K; Fell SM; Sobrado VR; Hemmer MC; Ramskold D; Hellman U; Sandberg R; Kenchappa RS; Martinson T; Johnsen JI; Kogner P; Schlisio S
• Article: BREAST. 2014;23(2):152-158

  Minimally-invasive treatment of early stage breast cancer: A feasibility study using radiofrequency ablation under local anesthesia

  Schassburger K-U; Lofgren L; Lagerstedt U; Leifland K; Thorneman K; Sandstedt B; Auer G; Wiksell H
• Conference publication: BONE MARROW TRANSPLANTATION. 2014;49:S65-S66

  RISK FACTORS WITHIN THE EUROPEAN HIGH RISK NEUROBLASTOMA HR-NBL1/SIOPEN TRIAL

  Ladenstein R; Poetschger U; Luksch R; Brock P; Castel V; Yaniv I; Papadakis V; Laureys G; Malis J; Balwierz W; Ruud E; Kogner P; Schroeder H; Forjaz De Lacerda A; Beck-Popovic M; Bician P; Garami M; Trahair T; Ambros P; Holmes K; Gaze M; Pearson ADJ; Valteau-Couanet D
• Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2014;106(3):djt459

  Protective Role of Humanin on Bortezomib-Induced Bone Growth Impairment in Anticancer Treatment

  Eriksson E; Wickstrom M; Perup LS; Johnsen JI; Eksborg S; Kogner P; Savendahl L
• Article: GENOME BIOLOGY AND EVOLUTION. 2014;6(2):433-450

  Polar bears exhibit genome-wide signatures of bioenergetic adaptation to life in the arctic environment.

  Welch AJ; Bedoya-Reina OC; Carretero-Paulet L; Miller W; Rode KD; Lindqvist C
• Journal article: JOURNAL FOR IMMUNOTHERAPY OF CANCER. 2014;2(Suppl 3):p203

  Immune suppression by myeloid-derived suppressor cells, MDSCs, in MYCN-driven neuroblastoma provides a potential target for cancer immunotherapy

  Eissler N; Sveinbjörnsson B; Kock A; Johnsen JI; Kogner P
• Article: GIGASCIENCE. 2013;2(1):17

  Galaxy tools to study genome diversity.

  Bedoya-Reina OC; Ratan A; Burhans R; Kim HL; Giardine B; Riemer C; Li Q; Olson TL; Loughran TP; Vonholdt BM; Perry GH; Schuster SC; Miller W
• Article: INTERNATIONAL JOURNAL OF CANCER. 2013;133(10):2351-2361

  Frequent detection of human cytomegalovirus in neuroblastoma: A novel therapeutic target?

  Wolmer-Solberg N; Baryawno N; Rahbar A; Fuchs D; Odeberg J; Taher C; Wilhelmi V; Milosevic J; Mohammad A-A; Martinsson T; Sveinbjornsson B; Johnsen JI; Kogner P; Soederberg-Naucler C
• Article: EUROPEAN JOURNAL OF CANCER. 2013;49(16):3497-3506

  Clear Cell Sarcomas of the Kidney registered on International Society of Pediatric Oncology (SIOP) 93-01 and SIOP 2001 protocols: A report of the SIOP Renal Tumour Study Group

  Furtwaengler R; Gooskens SL; van Tinteren H; de Kraker J; Schleiermacher G; Bergeron C; de Camargo B; Acha T; Godzinski J; Sandstedt B; Leuschner I; Vujanic GM; Pieters R; Graf N; van den Heuvel-Eibrink MM
• Article: BMC MEDICAL GENETICS. 2013;14:102

  Aneuploidy in neuroblastoma tumors is not associated with inactivating point mutations in the STAG2 gene

  Djos A; Fransson S; Kogner P; Martinsson T
• Article: CLINICAL CANCER RESEARCH. 2013;19(18):5092-5103

  Dual Targeting of Wild-Type and Mutant p53 by Small Molecule RITA Results in the Inhibition of N-Myc and Key Survival Oncogenes and Kills Neuroblastoma Cells In Vivo and In Vitro

  Burmakin M; Shi Y; Hedstrom E; Kogner P; Selivanova G
• Conference publication: PEDIATRIC BLOOD & CANCER. 2013;60:228

  CHROMOGRANIN A IN NEUROBLASTOMA: CORRELATION TO STAGE AND PROGNOSTIC FACTORS

  Georgantzi K; Skoldenberg E; Stridsberg M; Jakobson A; Christofferson R
• Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2013;43(3):831-838

  Neuroblastoma cells injected into experimental mature teratoma reveal a tropism for embryonic loose mesenchyme

  Jamil S; Cedervall J; Hultman I; Ali R; Margaryan NV; Rasmuson A; Johnsen JI; Sveinbjornsson B; Dalianis T; Kanter L; Orrego A; Strizzi L; Hendrix MJC; Sandstedt B; Kogner P; Ahrlund-Richter L
• Article: PANCREAS. 2013;42(6):1011-1015

  Cardiovascular Disease and Risk of Acute Pancreatitis in a Population- Based Study

  Bexelius TS; Ljung R; Mattsson F; Lagergren J
• Article: MOLECULAR CANCER. 2013;12(1):70

  ERBB3 is a marker of a ganglioneuroblastoma/ganglioneuroma-like expression profile in neuroblastic tumours

  Wilzen A; Krona C; Sveinbjornsson B; Kristiansson E; Dalevi D; Ora I; De Preter K; Stallings RL; Maris J; Versteeg R; Nilsson S; Kogner P; Abel F
• Article: ONCOIMMUNOLOGY. 2013;2(7):e24658

  Neuroblastoma-related inflammation May small doses of aspirin be suitable for small cancer patients?

  Carlson L-M; Kogner P
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2013;110(25):10258-10263

  MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells

  Zirath H; Frenzel A; Oliynyk G; Segerstrom L; Westermark UK; Larsson K; Persson MM; Hultenby K; Lehtio J; Einvik C; Pahlman S; Kogner P; Jakobsson P-J; Henriksson MA
• Letter: BRITISH JOURNAL OF CANCER. 2013;108(10):2191

  Reply: Comment on 'Quiescence and yH2AX in neuroblastoma are regulated by ouabain/Na,K-ATPase': ouabain and cancer

  Hiyoshi H; Johnsen JI; Andang M; Uhlen P
• Article: BMC CANCER. 2013;13:231

  Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation

  Cetinkaya C; Martinsson T; Sandgren J; Trager C; Kogner P; Dumanski J; de Stahl TD; Hedborg F
• Article: CARCINOGENESIS. 2013;34(5):1081-1088

  Low-dose aspirin delays an inflammatory tumor progression in vivo in a transgenic mouse model of neuroblastoma

  Carlson L-M; Rasmuson A; Idborg H; Segerstrom L; Jakobsson P-J; Sveinbjornsson B; Kogner P
• Article: JOURNAL OF MOLECULAR SIGNALING. 2013;8(1):4

  Aggressive neuroblastomas have high p110alpha but low p110delta and p55alpha/p50alpha protein levels compared to low stage neuroblastomas.

  Fransson S; Kogner P; Martinsson T; Ejeskär K
• Meeting abstract: CANCER RESEARCH. 2013;73(8):3795

  Vangl2 and Pricklel expression, interaction and regulation of Wnt/PCP signaling in medulloblastoma and neuroblastoma

  Dyberg CH; Papachristou P; Lagercrantz H; Johnsen JI; Wickstrom M
• Conference publication: CANCER RESEARCH. 2013;73(8):3817

  The potential oncogenic significance of Wip1 in neuroblastoma

  Milosevic J; Wickstrom M; Elfman L; Baryawno N; Sveinbjornsson B; Martinsson T; Johnsen JI; Kogner P
• Journal article: CANCER RESEARCH. 2013;73(8_Supplement):4107

  Abstract 4107: Targeted re-sequencing of neuroblastoma tumors reveals chromosomal rearrangements that involve the Anaplastic Lymphoma Kinase (ALK) gene.

  Fransson SM; Djos A; Javanmardi N; Noguera R; Berbegall A; Hansson M; Kogner P; Ruuth K; Palmer R; Hallberg B; Martinsson T
• Journal article: CANCER RESEARCH. 2013;73(8_Supplement):2751

  Abstract 2751: Wnt/β-catenin regulates the expression of MGMT through TCF/LEF transcription: new strategy for DNA alkylators in cancer therapy.

  Wickström M; Baryawno N; Dyberg C; Milosevic J; Sveinbjörnsson B; Northcott PA; Taylor M; Kool M; Kogner P; Johnsen JI
• Journal article: CANCER RESEARCH. 2013;73(8_Supplement):2746

  Abstract 2746: Microsomal prostaglandin E2 synthase-1 may provide a novel specific therapeutic target in neuroblastoma.

  Kock A; Rasmuson A; Korotkova M; Idborg H; Johnsen JI; Jakobsson P-J; Kogner P
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2013;110(15):5823-5828

  Aye-aye population genomic analyses highlight an important center of endemism in northern Madagascar.

  Perry GH; Louis EE; Ratan A; Bedoya-Reina OC; Burhans RC; Lei R; Johnson SE; Schuster SC; Miller W
• Conference publication: NEURO-ONCOLOGY. 2013;15:18

  EXPERIMENTAL COMBINATION THERAPY: HISTONE DEACETYLASE AND DNA METHYL TRANSFERASE INHIBITORS IN BRAIN CANCER CELL MODEL

  Marino A-M; Baryawno N; Johnsen J-I; Ostman A
• Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2013;42(4):1239-1248

  Expression of TWEAK/Fn14 in neuroblastoma: Implications in tumorigenesis

  Pettersen I; Baryawno N; Abel F; Bakkelund WH; Zykova SN; Winberg J-O; Moens U; Rasmuson A; Kogner P; Johnsen JI; Sveinbjornsson B
• Article: INTERNATIONAL JOURNAL OF CANCER. 2013;132(7):1516-1524

  Targeting the hedgehog signal transduction pathway at the level of GLI inhibits neuroblastoma cell growth in vitro and in vivo

  Wickstrom M; Dyberg C; Shimokawa T; Milosevic J; Baryawno N; Fuskevag OM; Larsson R; Kogner P; Zaphiropoulos PG; Johnsen JI
• Article: ONCOIMMUNOLOGY. 2013;2(3):e23618

  The microenvironment of human neuroblastoma supports the activation of tumor-associated T lymphocytes

  Carlson L-M; De Geer A; Sveinbjornsson B; Orrego A; Martinsson T; Kogner P; Levitskaya J
• Article: DISEASE MODELS & MECHANISMS. 2013;6(2):373-382

  Cell culture and Drosophila model systems define three classes of anaplastic lymphoma kinase mutations in neuroblastoma

  Chand D; Yamazaki Y; Ruuth K; Schonherr C; Martinsson T; Kogner P; Attiyeh EF; Maris J; Morozova O; Marra MA; Ohira M; Nakagawara A; Sandstrom P-E; Palmer RH; Hallberg B
• Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2013;42(2):609-616

  Stage-dependent expression of PI3K/Akt-pathway genes in neuroblastoma

  Fransson S; Abel F; Kogner P; Martinsson T; Ejeskar K
• Article: PEDIATRIC BLOOD & CANCER. 2013;60(2):224-229

  Malignant ectomesenchymoma in children and adolescents: Report from the Cooperative Weichteilsarkom Studiengruppe (CWS)

  Dantonello TM; Leuschner I; Vokuhl C; Gfroerer S; Schuck A; Kube S; Nathrath M; Bernbeck B; Kaatsch P; Pal N; Ljungman G; Bielack SS; Klingebiel T; Koscielniak E
• Article: PLOS ONE. 2012;7(12):e51297

  Tumor Development, Growth Characteristics and Spectrum of Genetic Aberrations in the TH-MYCN Mouse Model of Neuroblastoma

  Rasmuson A; Segerstrom L; Nethander M; Finnman J; Elfman LHM; Javanmardi N; Nilsson S; Johnsen JI; Martinsson T; Kogner P
• Conference publication: PEDIATRIC BLOOD & CANCER. 2012;59(6):1053

  ETHNIC DIFFERENCES IN NEUROBLASTOMA GENETICS INDICATED BY HIGH FREQUENCY OF ALK MUTATIONS IN VIETNAMESE TUMORS: IDENTIFICATION OF EIGHT NOVEL TYROSINE KINASE DOMAIN MISSENSE MUTATIONS

  Javanmardi N; Hoang NT; Djos A; Sjoberg R-M; Bui NL; Tuyet L; Sandstedt B; Kogner P; Martinsson T
• Conference publication: PEDIATRIC BLOOD & CANCER. 2012;59(6):1056

  LOW-DOSE ASPIRIN TREATMENT TARGETS TUMOR-PROMOTING INFLAMMATION IN NEUROBLASTOMA AND INHIBITS AGGRESSIVE TUMOR GROWTH IN VIVO

  Kogner P; Carlson L-M; Rasmuson A; Segerstrom L; Sveinbjornsson B
• Conference publication: PEDIATRIC BLOOD & CANCER. 2012;59(6):988-989

  MAJOR RESULTS FROM THE HR-NBL1/SIOPEN TRIAL FOR HIGH RISK NEUROBLASTOMA

  Ladenstein R; Poetschger U; Luksch R; Brock P; Castel V; Yaniv I; Papadakis V; Laureys G; Malis J; Balwierz W; Ruud E; Kogner P; Schroeder H; De Lacerda AF; Beck-Popovic M; Bician P; Garami M; Trahair T; Ambros P; Pearson ADJ; Valteau-Couanet D
• Article: WORLD JOURNAL OF GASTROINTESTINAL ENDOSCOPY. 2012;4(11):506-512

  Losartan to prevent hyperenzymemia after endoscopic retrograde cholangiopan-creatography: A randomized clinical trial

  Bexelius TS; Blomberg J; Lu Y-X; Hakansson H-O; Moller P; Nordgren C-E; Arnelo U; Lagergren J; Lindblad M
• Article: EUROPEAN JOURNAL OF CANCER. 2012;48(17):3240-3248

  Characteristics and outcome of stage II and III non-anaplastic Wilms' tumour treated according to the SIOP trial and study 93-01

  Graf N; van Tinteren H; Bergeron C; Pein F; van den Heuvel-Eibrink MM; Sandstedt B; Schenk J-P; Godzinski J; Oldenburger F; Furtwaengler R; de Kraker J
• Article: JOURNAL OF CLINICAL ONCOLOGY. 2012;30(28):3533-3539

  Treatment of Pulmonary Metastases in Children With Stage IV Nephroblastoma With Risk-Based Use of Pulmonary Radiotherapy

  Verschuur A; Van Tinteren H; Graf N; Bergeron C; Sandstedt B; de Kraker J
• Article: BMC MEDICAL GENETICS. 2012;13:83

  Quantitative global and gene-specific promoter methylation in relation to biological properties of neuroblastomas

  Kiss NB; Kogner P; Johnsen JI; Martinsson T; Larsson C; Geli J
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2012;109(36):E2382-E2390

  Polar and brown bear genomes reveal ancient admixture and demographic footprints of past climate change.

  Miller W; Schuster SC; Welch AJ; Ratan A; Bedoya-Reina OC; Zhao F; Kim HL; Burhans RC; Drautz DI; Wittekindt NE; Tomsho LP; Ibarra-Laclette E; Herrera-Estrella L; Peacock E; Farley S; Sage GK; Rode K; Obbard M; Montiel R; Bachmann L; Ingólfsson O; Aars J; Mailund T; Wiig O; Talbot SL; Lindqvist C
• Article: INTERNATIONAL JOURNAL OF CANCER. 2012;131(4):E555-E561

  Hepatoblastoma in the Nordic countries

  Licht SDF; Schmidt LS; Rod NH; Schmiegelow K; Lahteenmaki PM; Kogner P; Trager C; Stokland T; Schuz J
• Editorial: ONCOIMMUNOLOGY. 2012;1(5):739-740

  Cytomegalovirus infection in brain tumors A potential new target for therapy?

  Soderberg-Naucler C; Johnsen JI
• Article: PEDIATRIC BLOOD & CANCER. 2012;59(1):62-68

  SIX1 protein expression selectively identifies blastemal elements in Wilms tumor

  Sehic D; Karlsson J; Sandstedt B; Gisselsson D
• Article: MOLECULAR CANCER. 2012;11:40

  The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma

  Djos A; Martinsson T; Kogner P; Caren H
• Conference publication: NEURO-ONCOLOGY. 2012;14:99-100

  ANTINEOPLASTIC ACTION OF 5-AZA-2′DEOXYCYTIDINE AND SODIUM 4-PHENYLBUTYRATE ON MEDULLOBLASTOMA CELL MODELS

  Marino A-M; Baryawno N; Ekstrom TP; Ostman A; Johnsen J-I
• Conference publication: NEURO-ONCOLOGY. 2012;14:102

  THE POTENTIAL ONCOGENIC SIGNIFICANCE OF WIP1 IN MEDULLOBLASTOMA

  Milosevic J; Baryawno N; Sveinbjornsson B; Martinsson T; Grotzer M; Johnsen JI; Kogner P
• Conference publication: NEURO-ONCOLOGY. 2012;14:13-14

  Wnt/BETA-CATENIN SIGNALING REGULATES THE EXPRESSION OF O6-METHYLGUANINE DNA-METHYLTRANSFERASE IN MEDULLOBLASTOMA CELLS: A NEW STRATEGY TO INCREASE SENSITIVITY FOR DNA ALKYLATORS IN CANCER THERAPY

  Dyberg C; Baryawno N; Milosevic J; Wickstrom M; Northcott PA; Taylor MD; Kool M; Kogner P; Johnsen J; Johnsen I
• Journal article: NEURO-ONCOLOGY. 2012;14(suppl_1):i7-i15

  BIOLOGY

  Kim JH; Song HB; Kim DH; Park KD; Kim JH; Kim JH; Lee BJ; Kim DH; Kim JH; Khatua S; Kalkan E; Brown R; Pearlman M; Vats T; Abela L; Fiaschetti G; Shalaby T; Grunder E; Ma M; Grahlert J; Baumgartner M; Siler U; Nonoguchi N; Ohgaki H; Grotzer M; Adachi J-I; Suzuki T; Fukuoka K; Yanagisawa T; Mishima K; Koga T; Matsutani M; Nishikawa R; Sardi I; Giunti L; Bresci C; Cardellicchio S; Da Ros M; Buccoliero AM; Farina S; Arico M; Genitori L; Massimino M; Filippi L; Erdreich-Epstein A; Zhou H; Ren X; Schur M; Davidson TB; Ji L; Sposto R; Asgharzadeh S; Tong Y; White E; Murugesan M; Nimmervoll B; Wang M; Marino D; Ellison D; Finkelstein D; Pounds S; Malkin D; Gilbertson R; Eden C; Ju B; Murugesan M; Phoenix T; Poppleton H; Lessman C; Taylor M; Gilbertson R; Sardi I; la Marca G; Cardellicchio S; Da Ros M; Malvagia S; Giunti L; Fratoni V; Farina S; Arico M; Genitori L; Massimino M; Giovannini MG; Giangaspero F; Badiali M; Gleize V; Paris S; Moi L; Elhouadani S; Arcella A; Morace R; Antonelli M; Buttarelli F; Mokhtari K; Sanson M; Smith S; Ward J; Wilson M; Rahman C; Rose F; Peet A; Macarthur D; Grundy R; Rahman R; Venkatraman S; Birks D; Balakrishnan I; Alimova I; Harris P; Patel P; Foreman N; Vibhakar R; Wu H; Zhou Q; Wang D; Wang G; Dang D; Pencreach E; Nguyen A; Guerin E; Lasthaus C; Guenot D; Entz-Werle N; Unland R; Schlosser S; Farwick N; Plagemann T; Richter G; Juergens H; Fruehwald M; Chien C-L; Lee Y-H; Lin C-I; Hsieh J-Y; Lin S-C; Wong T-T; Ho DM-T; Wang H-W; Lagah S; Tan I-L; Malcolm S; Grundy R; Rahman R; Majani Y; Smith S; Grundy R; Rahman R; van Vuurden DG; Aronica E; Wedekind LE; Hulleman E; Biesmans D; Bugiani M; Vandertop WP; Kaspers GJL; Wurdinger T; Noske DP; Van der Stoop PM; van Vuurden DG; Shukla S; Wedekind LE; Kuipers GK; Hulleman E; Noske DP; Wurdinger T; Vandertop WP; Slotman BJ; Kaspers GJL; Cloos J; Sun T; Warrington N; Luo J; Ganzhorn S; Tabori U; Druley T; Gutmann D; Rubin J; Castelo-Branco P; Choufani S; Mack S; Galagher D; Zhang C; Lipman T; Zhukova N; Martin D; Merino D; Wasserman J; Samuel C; Alon N; Hitzler J; Wang JCY; Malkin D; Keller G; Dirks PB; Pfister S; Taylor MD; Weksberg R; Tabori U; Leblond P; Meignan S; Dewitte A; Le Tinier F; Wattez N; Lartigau E; Lansiaux A; Hanson R; Gordon I; Zhao S; Camphausen K; Warren K; Warrington NM; Sun T; Gutmann DH; Rubin JB; Nguyen A; Lasthaus C; Jaillet M; Pencreach E; Guerin E; Guenot D; Entz-Werle N; Kovacs Z; Martin-Fiori E; Shalaby T; Grotzer M; Bernasconi M; Werner B; Dyberg C; Baryawno N; Milosevic J; Wickstrom M; Northcott PA; Taylor MD; Kool M; Kogner P; Johnsen JI; Wilson M; Reynolds G; Davies N; Arvanitis T; Peet A; Zoghbi A; Meisterernst M; Fruehwald MC; Kerl K; Orr B; Haffner M; Nelson W; Yegnasubramanian S; Eberhart C; Fotovati A; Abu-Ali S; Wang P-S; Deleyrolle L; Lee C; Triscott J; Chen J; Franciosi S; Nakamura Y; Sugita Y; Uchiumi T; Kuwano M; Leavitt B; Singh S; Jury A; Jones C; Wakimoto H; Reynolds B; Pallen C; Dunn S; Fletcher S; Levine J; Li M; Kagawa N; Hirayama R; Chiba Y; Kijima N; Arita H; Kinoshita M; Hashimoto N; Izumoto S; Maruno M; Yoshimine T
• Journal article: NEURO-ONCOLOGY. 2012;14(suppl_1):i82-i105

  MEDULLOBLASTOMA

  Li KK-W; Pang JC-S; Ng H-K; Massimino M; Gandola L; Biassoni V; Spreafico F; Schiavello E; Poggi G; Casanova M; Pecori E; De Pava MV; Ferrari A; Meazza C; Terenziani M; Polastri D; Luksch R; Podda M; Modena P; Antonelli M; Giangaspero F; Ahmed S; Zaghloul MS; Mousa AG; Eldebawy E; Elbeltagy M; Awaad M; Massimino M; Gandola L; Biassoni V; Antonelli M; Schiavello E; Buttarelli F; Spreafico F; Collini P; Pollo B; Patriarca C; Giangaspero F; MacDonald T; Liu J; Munson J; Park J; Wang K; Fei B; Bellamkonda R; Arbiser J; Gomi A; Yamaguchi T; Mashiko T; Oguro K; Somasundaram A; Neuberg R; Grant G; Fuchs H; Driscoll T; Becher O; McLendon R; Cummings T; Gururangan S; Bourdeaut F; Grison C; Doz F; Pierron G; Delattre O; Couturier J; Cho Y-J; Pugh T; Weeraratne SD; Archer T; Krummel DP; Auclair D; Cibulkis K; Lawrence M; Greulich H; McKenna A; Ramos A; Shefler E; Sivachenko A; Amani V; Pierre-Francois J; Teider N; Northcott P; Taylor M; Meyerson M; Pomeroy S; Potts C; Cline H; Rotenberry R; Guldal C; Bhatia B; Nahle Z; Kenney A; Fan YN; Pizer B; See V; Makino K; Nakamura H; Kuratsu J-I; Grahlert J; Ma M; Fiaschetti G; Shalaby T; Grotzer M; Baumgartner M; Clifford S; Gustafsson G; Ellison D; Figarella-Branger D; Doz F; Rutkowski S; Lannering B; Pietsch T; Fiaschetti G; Shalaby T; Baumgartner M; Grotzer M; Fleischhack G; Siegler N; Zimmermann M; Rutkowski S; Warmuth-Metz M; Kortmann R-D; Pietsch T; Faldum A; Bode U; Yoon JH; Kang HJ; Park KD; Park S-H; Phi JH; Kim S-K; Wang K-C; Kim IH; Shin HY; Ahn HS; Faria C; Golbourn B; Smith C; Rutka J; Greene BD; Whitton A; Singh S; Scheinemann K; Hill R; Lindsey J; Howell C; Ryan S; Shiels K; Shrimpton E; Bailey S; Clifford S; Schwalbe E; Lindsey J; Williamson D; Hamilton D; Northcott P; O'Toole K; Nicholson SL; Lusher M; Gilbertson R; Hauser P; Taylor M; Taylor R; Ellison D; Bailey S; Clifford S; Kool M; Jones DTW; Jager N; Hovestadt V; Schuller U; Jabado N; Perry A; Cowdrey C; Croul S; Collins VP; Cho Y-J; Pomeroy S; Eils R; Korshunov A; Lichter P; Pfister S; Northcott P; Shih D; Taylor M; Darabi A; Sanden E; Visse E; Siesjo P; Harris P; Venkataraman S; Alimova I; Birks D; Cristiano B; Donson A; Foreman N; Vibhakar R; Bertin D; Vallero S; Basso ME; Romano E; Peretta P; Morra I; Mussano A; Fagioli F; Kunkele A; De Preter K; Heukamp L; Thor T; Pajtler K; Hartmann W; Mittelbronn M; Grotzer M; Deubzer H; Speleman F; Schramm A; Eggert A; Schulte J; Bandopadhayay P; Kieran M; Manley P; Robison N; Chi S; Thor T; Mestdagh P; Vandesomple J; Fuchs H; Durner VG; de Angelis MH; Heukamp L; Kunkele A; Pajtler K; Eggert A; Schramm A; Schulte JH; Ohe N; Yano H; Nakayama N; Iwama T; Lastowska M; Perek-Polnik M; Grajkowska W; Malczyk K; Cukrowska B; Dembowska-Baginska B; Perek D; Othman RT; Storer L; Grundy R; Kerr I; Coyle B; Hulleman E; Lagerweij T; Biesmans D; Crommentuijn MHW; Cloos J; Tannous BA; Vandertop WP; Noske DP; Kaspers GJL; Wurdinger T; Bergthold G; El Kababri M; Varlet P; Dhermain F; Sainte-Rose C; Raquin M-A; Valteau-Couanet D; Grill J; Dufour C; Burchill C; Hii H; Dallas P; Cole C; Endersby R; Gottardo N; Gevorgian A; Morozova E; Kazantsev I; Youhta T; Safonova S; Kozlov A; Punanov Y; Afanasyev B; Zheludkova O; Packer R; Gajjar A; Michalski J; Jakacki R; Gottardo N; Tarbell N; Vezina G; Olson J; Friedrich C; von Bueren AO; von Hoff K; Gerber NU; Benesch M; Faldum A; Pietsch T; Warmuth-Metz M; Kuehl J; Kortmann RD; Rutkowski S; Malbari F; Atlas M; Friedman G; Kelly V; Bray A; Cassady K; Markert J; Gillespie Y; Taylor R; Howman A; Brogden E; Robinson K; Jones D; Gibson M; Bujkiewicz S; Mitra D; Saran F; Michalski A; Pizer B; Jones DTW; Jager N; Kool M; Zichner T; Hutter B; Sultan M; Cho Y-J; Pugh TJ; Warnatz H-J; Reifenberger G; Northcott PA; Taylor MD; Meyerson M; Pomeroy SL; Yaspo M-L; Korbel JO; Korshunov A; Eils R; Pfister SM; Lichter P; Pajtler KW; Weingarten C; Thor T; Kuenkele A; Fleischhack G; Heukamp LC; Buettner R; Kirfel J; Eggert A; Schramm A; Schulte JH; Friedrich C; von Bueren AO; von Hoff K; Gerber NU; Benesch M; Kwiecien R; Pietsch T; Warmuth-Metz M; Faldum A; Kuehl J; Kortmann RD; Rutkowski S; Lupo P; Scheurer M; Martin A; Nirschl C; Polanczyk M; Cohen KJ; Pardoll DM; Drake CG; Lim M; Manoranjan B; Hallett R; Wang X; Venugopal C; McFarlane N; Sheinemann K; Hassell J; Singh S; Venugopal C; Manoranjan B; McFarlane N; Whitton A; Delaney K; Scheinemann K; Singh S; Manoranjan B; Hallett R; Venugopal C; McFarlane N; Hassell J; Scheinemann K; Dunn S; Singh S; Garcia I; Crowther AJ; Gama V; Miller CR; Deshmukh M; Gershon TR; Garcia I; Crowther AJ; Gershon TR; Gerber NU; von Hoff K; Friedrich C; von Bueren AO; Treulieb W; Benesch M; Faldum A; Pietsch T; Warmuth-Metz M; Rutkowski S; Kortmann RD; Zin A; De Bortoli M; Bonvini P; Viscardi E; Perilongo G; Rosolen A; Connolly E; Zhang C; Anderson R; Feldstein N; Stark E; Garvin J; Shing MMK; Lee V; Cheng FWT; Leung AWK; Zhu XL; Wong HT; Kam M; Li CK; Ward S; Sengupta R; Kroll K; Rubin J; Dallas P; Milech N; Longville B; Hopkins R; Vergiliana JVD; Endersby R; Gottardo N; von Bueren AO; Gerss J; Hagel C; Cai H; Remke M; Hasselblatt M; Feuerstein BG; Pernet S; Delattre O; Korshunov A; Rutkowski S; Pfister SM; Baudis M; Lee C; Fotovati A; Triscott J; Dunn S; Valdora F; Freier F; Seyler C; Brady N; Bender S; Northcott P; Kool M; Jones D; Coco S; Tonini GP; Scheurlen W; Boutros M; Taylor M; Katus H; Kulozik A; Zitron E; Korshunov A; Lichter P; Pfister S; Remke M; Shih DJH; Northcott PA; Van Meter T; Pollack IF; Van Meir E; Eberhart CG; Fan X; Dellatre O; Collins VP; Jones DTW; Clifford SC; Pfister SM; Taylor MD; Pompe R; von Bueren AO; von Hoff K; Friedrich C; Treulieb W; Lindow C; Deinlein F; Kuehl J; Rutkowski S; Gupta T; Krishnatry R; Shirsat N; Epari S; Kunder R; Kurkure P; Vora T; Moiyadi A; Jalali R; Cohen K; Perek D; Perek-Polnik M; Dembowska-Baginska B; Drogosiewicz M; Grajkowska W; Lastowska M; Chojnacka M; Filipek I; Tarasinska M; Roszkowski M; Hauser P; Jakab Z; Bognar L; Markia B; Gyorsok Z; Ottoffy G; Nagy K; Cservenyak J; Masat P; Turanyi E; Vizkeleti J; Krivan G; Kallay K; Schuler D; Garami M; Lacroix J; Schlund F; Adolph K; Leuchs B; Bender S; Hielscher T; Pfister S; Witt O; Schlehofer JR; Rommelaere J; Witt H; Leskov K; Ma N; Eberhart C; Stearns D; Dagri JN; Torkildson J; Evans A; Ashby LS; Zakotnik B; Brown RJ; Dhall G; Portnow J; Finlay JL; McCabe M; Pizer B; Marino A-M; Baryawno N; Ekstrom TP; Ostman A; Johnsen J-I; Robinson G; Parker M; Kranenburg T; Lu C; Pheonix T; Huether R; Easton J; Onar A; Lau C; Bouffet E; Gururangan S; Hassall T; Cohn R; Gajjar A; Ellison D; Mardis E; Wilson R; Downing J; Zhang J; Gilbertson R; Robinson G; Dalton J; O'Neill T; Yong W; Chingtagumpala M; Bouffet E; Bowers D; Kellie S; Gururangan S; Fisher P; Bendel A; Fisher M; Hassall T; Wetmore C; Broniscer A; Clifford S; Gilbertson R; Gajjar A; Ellison D; Zhukova N; Martin D; Lipman T; Castelo-Branco P; Zhang C; Fraser M; Baskin B; Ray P; Bouffet E; Alman B; Ramaswamy V; Dirks P; Clifford S; Rutkowski S; Pfister S; Bristow R; Taylor M; Malkin D; Hawkins C; Tabori U; Dhall G; Ji L; Haley K; Gardner S; Sposto R; Finlay J; Leary S; Strand A; Ditzler S; Heinicke G; Conrad L; Richards A; Pedro K; Knoblaugh S; Cole B; Olson J; Yankelevich M; Budarin M; Konski A; Mentkevich G; Stefanits H; Ebetsberger-Dachs G; Weis S; Haberler C; Milosevic J; Baryawno N; Sveinbjornsson B; Martinsson T; Grotzer M; Johnsen JI; Kogner P; Garzia L; Morrisy S; Jelveh S; Lindsay P; Hill R; Taylor M; Marks A; Zhang H; Rood B; Williamson D; Clifford S; Aurtenetxe O; Gaffar A; Lopez JI; Urberuaga A; Navajas A; O'Halloran K; Hukin J; Singhal A; Dunham C; Goddard K; Rassekh SR; Davidson TB; Fangusaro JR; Ji L; Sposto R; Gardner SL; Allen JC; Dunkel IJ; Dhall G; Finlay JL; Trivedi M; Tyagi A; Goodden J; Chumas P; O'kane R; Crimmins D; Elliott M; Picton S; Silva DS; Viana-Pereira M; Stavale JN; Malheiro S; Almeida GC; Clara C; Jones C; Reis RM; Spence T; Sin-Chan P; Picard D; Ho KC; Lu M; Huang A; Bochare S; Khatua S; Gopalakrishnan V; Chan TSY; Picard D; Pfister S; Hawkins C; Huang A; Chan TSY; Picard D; Ho KC; Huang A; Picard D; Millar S; Hawkins C; Rogers H; Kim SK; Ra YS; Fangusaro J; Toledano H; Nakamura H; Van Meter T; Pomeroy S; Ng HK; Jones C; Gajjar A; Clifford S; Pfister S; Eberhart C; Bouffet E; Grundy R; Huang A; Sengupta S; Weeraratne SD; Phallen J; Sun H; Rallapalli S; Amani V; Pierre-Francois J; Teider N; Cook J; Jensen F; Lim M; Pomeroy S; Cho Y-J
• Article: JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY. 2012;32(3):336-340

  Selective Serotonin Reuptake Inhibitors and the Risk of Acute Pancreatitis A Swedish Population-Based Case-Control Study

  Ljung R; Ruck C; Mattsson F; Bexelius TS; Lagergren J; Lindblad M
• Article: GUT. 2012;61(6):873-876

  Increased risk of acute pancreatitis among tetracycline users in a Swedish population-based case-control study

  Ljung R; Lagergren J; Bexelius TS; Mattsson F; Lindblad M
• Article: BRITISH JOURNAL OF CANCER. 2012;106(11):1807-1815

  Quiescence and γH2AX in neuroblastoma are regulated by ouabain/Na,K-ATPase

  Hiyoshi H; Abdelhady S; Segerstrom L; Sveinbjornsson B; Nuriya M; Lundgren TK; Desfrere L; Miyakawa A; Yasui M; Kogner P; Johnsen JI; Andang M; Uhlen P
• Article: CELL DEATH & DISEASE. 2012;3(4):e298

  Wig-1, a novel regulator of N-Myc mRNA and N-Myc-driven tumor growth

  Vilborg A; Bersani C; Wickstrom M; Segerstrom L; Kogner P; Wiman KG
• Conference publication: CANCER RESEARCH. 2012;72:lb-496-lb-496

  Low-dose aspirin targets tumor-associated inflammation and delays neuroblastoma tumor growth in vivo

  Carlson L-M; Rasmuson A; Segerstrom L; Sveinbjornsson B; Kogner P
• Conference publication: CANCER RESEARCH. 2012;72:2237

  Analysis of the PI3K/Akt signaling pathway in neuroblastoma shows stage dependent expression of PI3K isoforms

  Fransson SM; Abel F; Eriksson H; Kogner P; Martinsson T; Ejeskar K
• Conference publication: CANCER RESEARCH. 2012;72:4725

  Inhibition of the Hedgehog signaling pathway - a new target in treatment for children with neuroblastoma

  Wickstrom M; Dyberg C; Shimokawa T; Baryawno N; Milosevic J; Fuskevag OM; Larsson R; Zaphiropoulos PG; Kogner P; Johnsen JI
• Conference publication: CANCER RESEARCH. 2012;72:825

  Wnt/beta-catenin signaling regulates the expression of O6-methylguanine DNA-methyltransferase in cancer cells: a new strategy to overcome resistance for DNA alkylators in cancer therapy

  Dyberg CH; Baryawno N; Milosevic J; Wickstrom M; Sveinbjornsson B; Northcott PA; Taylor MD; Kool M; Kogner P; Johnsen JI
• Conference publication: CANCER RESEARCH. 2012;72:2499

  The significance of Wip1 in neuroblastoma and medulloblastoma

  Milosevic J; Baryawno N; Syeinbjornsson B; Martinsson T; Johnsen JI; Kogner P
• Meeting abstract: CANCER RESEARCH. 2012;72:1420

  Microsomal prostaglandin E2 synthase 1 (mPGES-1) is expressed in neuroblastoma and may represent a novel target for therapy

  Kock A; Rasmuson A; Idborg H; Johnsen JI; Kogner P
• Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2012;47(2):162-169

  Clinical application of the multigene analysis test in discriminating between ulcerative colitis and Crohn's disease: a retrospective study

  Janczewska I; Kapraali M; Saboonchi F; Nekzada Q; Wessulv A; Khoshkar J; Marouf F; Gorsetman J; Risberg D; Lissing M; Wirstrom G; Sandstedt B
• Article: PLOS ONE. 2012;7(1):e29331

  Autocrine Prostaglandin E₂ Signaling Promotes Tumor Cell Survival and Proliferation in Childhood Neuroblastoma

  Rasmuson A; Kock A; Fuskevag OM; Kruspig B; Simon-Santamaria J; Gogvadze V; Johnsen JI; Kogner P; Sveinbjornsson B
• Article: CYTOJOURNAL. 2012;9:8

  Establishing a protocol for immunocytochemical staining and chromogenic in situ hybridization of Giemsa and Diff-Quick prestained cytological smears.

  Beraki E; Olsen TK; Sauer T
• Article: BMJ OPEN. 2012;2(3):e000914

  Antidopaminergic drugs and acute pancreatitis: a population-based study

  Boden R; Bexelius TS; Mattsson F; Lagergren J; Lindblad M; Ljung R
• Article: ONCOTARGET. 2011;2(12):1329-1338

  Is human cytomegalovirus a target in cancer therapy?

  Johnsen JI; Baryawno N; Soderberg-Naucler C
• Article: PEDIATRIC BLOOD & CANCER. 2011;57(7):1266-1269

  Nephroblastoma: Does the Decrease in Tumor Volume Under Preoperative Chemotherapy Predict the Lymph Nodes Status at Surgery?

  Godzinski J; van Tinteren H; de Kraker J; Graf N; Bergeron C; Heij H; von Schweinitz D; Fuchs J; Cecchetto G; Audry G; Gauthier F; Sandstedt B
• Article: INTERNATIONAL JOURNAL OF CANCER. 2011;129(12):2958-2965

  Effects of small molecule inhibitors of PI3K/Akt/mTOR signaling on neuroblastoma growth in vitro and in vivo

  Segerstrom L; Baryawno N; Sveinbjornsson B; Wickstrom M; Elfman L; Kogner P; Johnsen JI
• Review: INTERNATIONAL JOURNAL OF COLORECTAL DISEASE. 2011;26(12):1501-1509

  Risk of anastomotic leakage with use of NSAIDs after gastrointestinal surgery

  Rushfeldt CF; Sveinbjornsson B; Soreide K; Vonen B
• Article: PLOS ONE. 2011;6(11):e27741

  Early Events in Xenograft Development from the Human Embryonic Stem Cell Line HS181-Resemblance with an Initial Multiple Epiblast Formation

  Gertow K; Cedervall J; Jamil S; Ali R; Imreh MP; Gulyas M; Sandstedt B; Ahrlund-Richter L
• Article: CANCER LETTERS. 2011;310(2):222-231

  Inhibition of the sonic hedgehog pathway by cyplopamine reduces the CD133+/CD15+cell compartment and the in vitro tumorigenic capability of neuroblastoma cells

  Schiapparelli P; Shahi MH; Enguita-German M; Johnsen JI; Kogner P; Lazcoz P; Castresana JS
• Conference publication: PEDIATRIC BLOOD & CANCER. 2011;57(5):733

  BUSULPHAN-MELPHALAN IS THE SUPERIOR MYELOABLATIVE THERAPY (MAT) FOR HIGH RISK NEUROBLASTOMA: RESULTS FROM THE HR-NBL1/SIOPEN TRIAL

  Ladenstein R; Poetschger U; Luksch R; Brock P; Castel V; Yaniv I; Papadakis V; Laureys G; Malis J; Balwierz W; Ruud E; Kogner P; Schroeder H; De Lacerda AF; Beck-Popovic M; Bician P; Garami M; Trahair T; Pearson ADJ; Valteau-Couanet D
• Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2011;39(5):1063-1071

  MYCN amplicon junctions as tumor-specific targets for minimal residual disease detection in neuroblastoma

  Kryh H; Abrahamsson J; Jegeras E; Sjoberg R-M; Devenney I; Kogner P; Martinsson T
• Article: JOURNAL OF CLINICAL INVESTIGATION. 2011;121(10):4043-4055

  Detection of human cytomegalovirus in medulloblastomas reveals a potential therapeutic target

  Baryawno N; Rahbar A; Wolmer-Solberg N; Taher C; Odeberg J; Darabi A; Khan Z; Sveinbjornsson B; Fuskevag O-M; Segerstrom L; Nordenskjold M; Siesjo P; Kogner P; Johnsen JI; Soderberg-Naucler C
• Article: BMC GENOMICS. 2011;12:443

  Comprehensive SNP array study of frequently used neuroblastoma cell lines; copy neutral loss of heterozygosity is common in the cell lines but uncommon in primary tumors

  Kryh H; Caren H; Erichsen J; Sjoberg R-M; Abrahamsson J; Kogner P; Martinsson T
• Letter: EPIDEMIOLOGY. 2011;22(5):749-750

  Oral Disease and Risk of Pancreatic Cancer

  Ljung R; Bexelius TS; Martin L; Lagergren J
• Article: BMJ CASE REPORTS. 2011;2011:bcr0320114007

  Ten-year follow-up after autologous stem cell transplantation of a patient with immunoglobulin light-chain (AL) amyloidosis with deposits in the heart, liver and gastrointestinal tract.

  Mejhert M; Hast R; Sandstedt B; Janczewska I
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2011;108(30):12348-12353

  Genetic diversity and population structure of the endangered marsupial Sarcophilus harrisii (Tasmanian devil).

  Miller W; Hayes VM; Ratan A; Petersen DC; Wittekindt NE; Miller J; Walenz B; Knight J; Qi J; Zhao F; Wang Q; Bedoya-Reina OC; Katiyar N; Tomsho LP; Kasson LM; Hardie R-A; Woodbridge P; Tindall EA; Bertelsen MF; Dixon D; Pyecroft S; Helgen KM; Lesk AM; Pringle TH; Patterson N; Zhang Y; Kreiss A; Woods GM; Jones ME; Schuster SC
• Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2011;411(1):208-212

  Enhanced effects by 4-phenylbutyrate in combination with RTK inhibitors on proliferation in brain tumor cell models

  Marino A-M; Sofiadis A; Baryawno N; Johnsen JI; Larsson C; Vukojevic V; Ekstrom TJ
• Article: CARCINOGENESIS. 2011;32(7):1005-1012

  MYCN-regulated miRNA-92 inhibits secretion of the tumor suppressor DICKKOPF-3 (DKK3) in neuroblastoma

  Haug BH; Henriksen JR; Buechner J; Geerts D; Tomte E; Kogner P; Martinsson T; Flgstad T; Sveinbjornsson B; Einvik C
• Conference publication: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(18)

  Busulphan-melphalan as a myeloablative therapy (MAT) for high-risk neuroblastoma: Results from the HR-NBL1/SIOPEN trial

  Ladenstein RL; Poetschger U; Luksch R; Brock P; Castel V; Yaniv I; Papadakis V; Laureys G; Malis J; Balwierz W; Ruud E; Kogner P; Schroeder H; De Lacerda AF; Popovic MB; Bician P; Garami M; Trahair T; Pearson AD; Couanet DV
• Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(18_suppl):2

  Busulphan-melphalan as a myeloablative therapy (MAT) for high-risk neuroblastoma: Results from the HR-NBL1/SIOPEN trial.

  Ladenstein RL; Poetschger U; Luksch R; Brock P; Castel V; Yaniv I; Papadakis V; Laureys G; Malis J; Balwierz W; Ruud E; Kogner P; Schroeder H; Forjaz De Lacerda A; Beck Popovic M; Bician P; Garami M; Trahair T; Pearson AD; Valteau Couanet D
• Conference publication: FEBS JOURNAL. 2011;278:215

  Characterization of amplicon junction sequences in genomic regions surrounding the MYCN gene in neuroblastoma tumors; implications for clinical follow-up of high-risk patients

  Kryh H; Abrahamsson J; Jegeras E; Sjoberg R-M; Devenney I; Kogner P; Martinsson T
• Article: JOURNAL OF CYSTIC FIBROSIS. 2011;10:S172-S182

  The βENaC-overexpressing mouse as a model of cystic fibrosis lung disease

  Zhou Z; Duerr J; Johannesson B; Schubert SC; Treis D; Harm M; Graeber SY; Dalpke A; Schultz C; Mall MA
• Journal article: JOURNAL OF CLINICAL ONCOLOGY. 2011;29(15_suppl):2

  Busulphan-melphalan as a myeloablative therapy (MAT) for high-risk neuroblastoma: Results from the HR-NBL1/SIOPEN trial.

  Ladenstein RL; Poetschger U; Luksch R; Brock P; Castel V; Yaniv I; Papadakis V; Laureys G; Malis J; Balwierz W; Ruud E; Kogner P; Schroeder H; Forjaz De Lacerda A; Beck Popovic M; Bician P; Garami M; Trahair T; Pearson AD; Valteau Couanet D
• Conference publication: NEURO-ONCOLOGY. 2011;13:I9

  COMBINED EFFECTS OF 5-AZA-2′DEOXYCYTIDINE AND 4-PHENYLBUTYRATE ON MEDULLOBLASTOMA

  Marino AM; Johnsen J-I; Ekstrom TJ; Zaphiropoulos P; Ostman A
• Article: ACTA PAEDIATRICA. 2011;100(5):750-757

  Incidence and survival analyses in children with solid tumours diagnosed in Sweden between 1983 and 2007

  Ljungman G; Jakobson A; Behrendtz M; Ek T; Friberg L-G; Hjalmars U; Hjorth L; Lindh J; Pal N; Sandstedt B; Osterlundh G; Gustafsson G
• Article: INTERNATIONAL JOURNAL OF CANCER. 2011;128(9):2166-2173

  Birth characteristics and Wilms tumors in children in the Nordic countries: a register-based case-control study

  Schuz J; Schmidt LS; Kogner P; Lahteenmaki PM; Pal N; Stokland T; Schmiegelow K
• Article: PEDIATRIC BLOOD & CANCER. 2011;56(5):733-737

  Malignant Rhabdoid Tumours of the Kidney (MRTKs), Registered on Recent SIOP Protocols From 1993 to 2005: A Report of the SIOP Renal Tumour Study Group

  van den Heuvel-Eibrink MM; van Tinteren H; Rehorst H; Coulombe A; Patte C; de Camargo B; de Kraker J; Leuschner I; Lugtenberg R; Pritchard-Jones K; Sandstedt B; Spreafico F; Graf N; Vujanic GM
• Conference publication: CANCER RESEARCH. 2011;71:lb-209-lb-209

  Expression of O6-methylguanine DNA-methyltransferase is regulated by Wnt/β-catenin signalling in cancer cells: A new strategy for DNA alkylators in cancer therapy

  Milosevic J; Baryawno N; Dyberg C; Wickstrom M; Sveinbjornsson B; Northcott PA; Taylor MD; Kool M; Kogner P; Johnsen JI
• Article: CANCER CELL INTERNATIONAL. 2011;11:9

  A 6-gene signature identifies four molecular subgroups of neuroblastoma

  Abel F; Dalevi D; Nethander M; Jornsten R; De Preter K; Vermeulen J; Stallings R; Kogner P; Maris J; Nilsson S
• Conference publication: BONE MARROW TRANSPLANTATION. 2011;46:S17

  Early high-dose treatment: SCT results from the European High Risk Neuroblastoma Study

  Ladenstein R; Poetschger U; Luksch R; Brock P; Castel V; Yaniv I; Papadakis V; Laureys G; Malis J; Balwierz W; Ruud E; Kogner P; Schroeder H; Forjaz de Lacerda AM; Beck-Popovic M; Bician P; Garami M; Trahair T; Valteau-Couanet D
• Article: PEDIATRIC BLOOD & CANCER. 2011;56(4):584-589

  Differentiated Expression of Somatostatin Receptor Subtypes in Experimental Models and Clinical Neuroblastoma

  Georgantzi K; Tsolakis AV; Stridsberg M; Jakobson A; Christofferson R; Janson ET
• Article: INTERNATIONAL JOURNAL OF CANCER. 2011;128(7):1703-1711

  Omega-3 fatty acid supplementation delays the progression of neuroblastoma in vivo

  Gleissman H; Segerstrom L; Hamberg M; Ponthan F; Lindskog M; Johnsen JI; Kogner P
• Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2011;38(3):843-849

  Differential forms of p53 in medulloblastoma primary tumors, cell lines and xenografts

  Philipova T; Baryawno N; Hartmann W; Pietsch T; Drud H; Johnsen JI; Ekstrom TJ
• Article: BMC CANCER. 2011;11:66

  Identification of epigenetically regulated genes that predict patient outcome in neuroblastoma

  Caren H; Djos A; Nethander M; Sjoberg R-M; Kogner P; Enstrom C; Nilsson S; Martinsson T
• Article: PEDIATRIC BLOOD & CANCER. 2011;56(1):65-69

  Incidence of Childhood Central Nervous System Tumors in the Nordic Countries

  Schmidt LS; Schmiegelow K; Lahteenmaki P; Trager C; Stokland T; Grell K; Gustafson G; Sehested A; Raashou-Nielsen O; Johansen C; Schuz J
• Article: INTERNATIONAL BIODETERIORATION & BIODEGRADATION. 2011;65(1):147-152

  Horizontal arsC gene transfer among microorganisms isolated from arsenic polluted soil

  Villegas-Torres MF; Bedoya-Reina OC; Salazar C; Vives-Florez MJ; Dussan J
• Article: CANCER RESEARCH. 2011;71(1):98-105

  Appearance of the Novel Activating F1174S ALK Mutation in Neuroblastoma Correlates with Aggressive Tumor Progression and Unresponsiveness to Therapy

  Martinsson T; Eriksson T; Abrahamsson J; Caren H; Hansson M; Kogner P; Kamaraj S; Schonherr C; Weinmar J; Ruuth K; Palmer RH; Hallberg B
• Conference publication: PEDIATRIC BLOOD & CANCER. 2010;55(5):897

  DIFFERENCES IN BIOLOGICAL FEATURES AND SURVIVAL IMPROVEMENT BETWEEN GENETIC SUBSETS OF HIGH-RISK NEUROBLASTOMA INDICATE THE NEED OF ADAPTED TREATMENT

  Trager C; Vernby A; Caren H; Kryh H; Martinsson T; Hedborg F; Gustafsson G; Kogner P
• Conference publication: PEDIATRIC BLOOD & CANCER. 2010;55(5):896

  AGE-DEPENDENT GENOTYPES IN HIGH-RISK NEUROBLASTOMA: MYCN AMPLIFICATION IS A FAST TRACK TO AGGRESSIVE DISEASE WHEREAS SEGMENTAL DELETION OF 11Q IMPLIES A MORE COMPLEX, MULTI-STEP TUMOR EVOLUTION

  Hedborg F; Cetinkaya C; Martinsson T; Kogner P; Dumanski J; Trager C; de Stahl TD
• Article: AMERICAN JOURNAL OF PATHOLOGY. 2010;177(5):2609-2621

  Deletions of 16q in Wilms Tumors Localize to Blastemal-Anaplastic Cells and Are Associated with Reduced Expression of the IRXB Renal Tubulogenesis Gene Cluster

  Mengelbier LH; Karlsson J; Lindgren D; Ora I; Isaksson M; Frigyesi I; Frigyesi A; Bras J; Sandstedt B; Gisselsson D
• Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2010;37(5):1323-1330

  Suppression of RIZ in biologically unfavourable neuroblastomas

  Geli J; Kiss N; Kogner P; Larsson C
• Article: PLOS ONE. 2010;5(9):e12825

  Differentiation in Neuroblastoma: Diffusion-Limited Hypoxia Induces Neuro-Endocrine Secretory Protein 55 and Other Markers of a Chromaffin Phenotype

  Hedborg F; Fischer-Colbrie R; Ostlin N; Sandstedt B; Tran MGB; Maxwell PH
• Article: CLINICAL CANCER RESEARCH. 2010;16(17):4353-4362

  Meta-analysis of Neuroblastomas Reveals a Skewed ALK Mutation Spectrum in Tumors with MYCN Amplification

  De Brouwer S; De Preter K; Kumps C; Zabrocki P; Porcu M; Westerhout EM; Lakeman A; Vandesompele J; Hoebeeck J; Van Maerken T; De Paepe A; Laureys G; Schulte JH; Schramm A; Van den Broecke C; Vermeulen J; Van Roy N; Beiske K; Renard M; Noguera R; Delattre O; Janoueix-Lerosey I; Kogner P; Martinsson T; Nakagawara A; Ohira M; Caron H; Eggert A; Cools J; Versteeg R; Speleman F
• Article: PEDIATRIC BLOOD & CANCER. 2010;55(2):233-238

  Stromal and Epithelial Predominant Wilms Tumours Have an Excellent Outcome: The SIOP 93 01 Experience

  Verschuur AC; Vujanic GM; Van Tinteren H; Jones KP; de Kraker J; Sandstedt B
• Article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2010;59(8):1285-1294

  Therapeutic vaccination against a murine lymphoma by intratumoral injection of a cationic anticancer peptide

  Berge G; Eliassen LT; Camilio KA; Bartnes K; Sveinbjornsson B; Rekdal O
• Article: JOURNAL OF CLINICAL ONCOLOGY. 2010;28(21):3516-3524

  Randomized Trial of Prophylactic Granulocyte Colony-Stimulating Factor During Rapid COJEC Induction in Pediatric Patients With High-Risk Neuroblastoma: The European HR-NBL1/SIOPEN Study

  Ladenstein R; Valteau-Couanet D; Brock P; Yaniv I; Castel V; Laureys G; Malis J; Papadakis V; Lacerda A; Ruud E; Kogner P; Garami M; Balwierz W; Schroeder H; Beck-Popovic M; Schreier G; Machin D; Potschger U; Pearson A
• Article: CELL CYCLE. 2010;9(13):2548-2554

  Medulloblastoma A disease with disorganized developmental signaling cascades

  Baryawno N; Sveinbjornsson B; Kogner P; Johnsen JI
• Article: GENE. 2010;458(1-2):27-36

  Preliminary assessment of COSII gene diversity in lulo and a relative species: initial identification of genes potentially associated with domestication.

  Bedoya-Reina OC; Barrero LS
• Article: HEPATOLOGY. 2010;51(6):2172-2182

  Colon Carcinoma Cell Interaction with Liver Sinusoidal Endothelium Inhibits Organ-Specific Antitumor Immunity Through Interleukin-1-Induced Mannose Receptor in Mice

  Arteta B; Lasuen N; Lopategi A; Sveinbjornsson B; Smedsrod B; Vidal-Vanaclocha F
• Article: BREAST. 2010;19(3):219-225

  Feasibility study on the treatment of small breast carcinoma using percutaneous US-guided preferential radiofrequency ablation (PRFA)

  Wiksell H; Lofgren L; Schassburger K-U; Grundstrom H; Janicijevic M; Lagerstedt U; Leifland K; Nybom R; Rotstein S; Saracco A; Schultz I; Thorneman K; Wadstrom C; Westman L; Wigzell H; Wilczek B; Auer G; Sandstedt B
• Article: BRITISH JOURNAL OF CANCER. 2010;102(11):1670-1675

  Infectious exposure in the first years of life and risk of central nervous system tumours in children: analysis of birth order, childcare attendance and seasonality of birth

  Schmidt LS; Kamper-Jorgensen M; Schmiegelow K; Johansen C; Lahteenmaki P; Trager C; Stokland T; Grell K; Gustafson G; Kogner P; Sehested A; Schuz J
• Review: EXPERIMENTAL CELL RESEARCH. 2010;316(8):1365-1373

  Omega-3 fatty acids in cancer, the protectors of good and the killers of evil?

  Gleissman H; Johnsen JI; Kogner P
• Journal article: CANCER RESEARCH. 2010;70(8_Supplement):4354

  Abstract 4354: Celecoxib reduces MGMT expression and potentiates the effect of temozolomide in childhood medulloblastoma

  Baryawno N; Milosevic J; Wickström M; Sveinbjörnsson B; Eksborg S; Kogner P; Johnsen JI
• Article: CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION. 2010;19(4):1042-1052

  Fetal Growth, Preterm Birth, Neonatal Stress and Risk for CNS Tumors in Children: A Nordic Population- and Register-Based Case-Control Study

  Schmidt LS; Schuz J; Lahteenmaki P; Trager C; Stokland T; Gustafson G; Hjalgrim L; Sehested A; Johansen C; Schmiegelow K
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2010;107(9):4323-4328

  High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset

  Caren H; Kryh H; Nethander M; Sjoberg R-M; Trager C; Nilsson S; Abrahamsson J; Kogner P; Martinsson T
• Corrigendum: CANCER RESEARCH. 2010;70(5):2138-2139

  Small-Molecule Inhibitors of Phosphatidylinositol 3-Kinase/Akt Signaling Inhibit Wnt/β-Catenin Pathway Cross-Talk and Suppress Medulloblastoma Growth (vol 70, pg 266, 2010)

  Baryawno N; Sveinbjornsson B; Eksborg S; Chen C-S; Kogner P; Johnsen JI
• Article: FASEB JOURNAL. 2010;24(3):906-915

  Docosahexaenoic acid metabolome in neural tumors: identification of cytotoxic intermediates

  Gleissman H; Yang R; Martinod K; Lindskog M; Serhan CN; Johnsen JI; Kogner P
• Review: JOURNAL OF CLINICAL PATHOLOGY. 2010;63(2):102-109

  The pathology of Wilms' tumour (nephroblastoma): the International Society of Paediatric Oncology approach

  Vujanic GM; Sandstedt B
• Article: JOURNAL OF CELL SCIENCE. 2010;123(3):472-483

  Vang-like protein 2 and Rac1 interact to regulate adherens junctions

  Lindqvist M; Horn Z; Bryja V; Schulte G; Papachristou P; Ajima R; Dyberg C; Arenas E; Yamaguchi TP; Lagercrantz H; Ringstedt T
• Doctoral thesis: 2010

  Angiotensin II receptor blockers and acute pancreatitis

  Sjöberg Bexelius T
• Journal article: ECANCERMEDICALSCIENCE. 2010;4:156

  Might salicylate exert benefits against childhood cancer?

  Morgan G; Johnsen JI
• Review: MECHANISMS AND THERAPY OF LIVER CANCER. 2010;107:163-224

  MYC in Oncogenesis and as a Target for Cancer Therapies

  Albihn A; Johnsen JI; Henriksson MA
• Article: ARTHRITIS RESEARCH & THERAPY. 2010;12(6):R228

  Human articular chondrocytes express ChemR23 and chemerin; ChemR23 promotes inflammatory signalling upon binding the ligand chemerin^21-157

  Berg V; Sveinbjornsson B; Bendiksen S; Brox J; Meknas K; Figenschau Y
• Article: CANCER RESEARCH. 2010;70(1):266-276

  Small-Molecule Inhibitors of Phosphatidylinositol 3-Kinase/Akt Signaling Inhibit Wnt/β-Catenin Pathway Cross-Talk and Suppress Medulloblastoma Growth

  Baryawno N; Sveinbjornsson B; Eksborg S; Chen C-S; Kogner P; Johnsen JI
• Article: PLOS ONE. 2009;4(12):e8239

  DNA from KI, WU and Merkel Cell Polyomaviruses Is Not Detected in Childhood Central Nervous System Tumours or Neuroblastomas

  Giraud G; Ramqvist T; Pastrana DV; Pavot V; Lindau C; Kogner P; Orrego A; Buck CB; Allander T; Holm S; Gustavsson B; Dalianis T
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2009;106(44):18757-18762

  Microsomal prostaglandin E synthase 1 determines tumor growth in vivo of prostate and lung cancer cells

  Hanaka H; Pawelzik S-C; Johnsen JI; Rakonjac M; Terawaki K; Rasmuson A; Sveinbjornsson B; Schumacher MC; Hamberg M; Samuelsson B; Jakobsson P-J; Kogner P; Radmark O
• Conference publication: PEDIATRIC BLOOD & CANCER. 2009;53(5):807

  OMEGA-3 FATTY ACIDS IN CHILDHOOD CANCER: ELUCIDATION OF THE DOCOSAHEXAENOIC ACID METABOLIC PATHWAY IN NEUROBLASTOMA AND DEFINITION OF CYTOTOXIC INTERMEDIATES

  Kogner P; Gleissman H; Serhan CN; Hamberg M; Segerstrom L; Lindskog M; Johnsen JI
• Conference publication: PEDIATRIC BLOOD & CANCER. 2009;53(5):747

  NEUROBLASTOMA INCIDENCE WAS STABLE BUT DIFFERENT FOR BOYS AND GIRLS OVER 27 YEARS IN SWEDEN WHILE NEUROBLASTOMA PROGNOSIS IMPROVED, IN PARTICULAR FOR HIGH-RISK DISEASE

  Trager C; Kogner P; Vernby A; Caren H; Kryh H; Martinsson T; Gustafsson G; Kogner P
• Article: LAKARTIDNINGEN. 2009;106(44):2847-passim

  [New medical education programme at Karolinska Institute. The profession in focus and the research process as a pedagogical basis].

  Nilsson G; Josephson A; Kiessling A; Bexelius TS; Ponzer S
• Letter: PEDIATRIC BLOOD & CANCER. 2009;53(4):683-684

  Low Frequency of EWSR1 Rearrangements in Neoplasms Classified as High-Risk Wilms Tumors

  Frigyesi I; Moller E; Stewenius Y; Isaksson M; Bras J; Alumets J; Ora I; Sandstedt B; Gisselsson D
• Article: BMC MEDICAL GENOMICS. 2009;2:53

  Verification of genes differentially expressed in neuroblastoma tumours: a study of potential tumour suppressor genes

  Thorell K; Bergman A; Caren H; Nilsson S; Kogner P; Martinsson T; Abel F
• Article: ANTICANCER RESEARCH. 2009;29(8):3311-3319

  The Angiogenic Growth Factors HGF and VEGF in Serum and Plasma from Neuroblastoma Patients

  Skoldenberg EG; Larsson A; Jakobson A; Hedborg F; Kogner P; Christofferson RH; Azarbayjani F
• Doctoral thesis: 2009

  Lipid mediators in the prevention and therapy of neuroblastoma

  Gleissman H
• Doctoral thesis: 2009

  Neuroblastoma incidence, biology and outcome : with special emphasis on quantitative analysis of tyrosine hydroxylase mRNA in blood and bone marrow

  Träger C
• Conference publication: CANCER RESEARCH. 2009;69

  The cyclooxygenase-2 prostaglandin E2 pathway is expressed in childhood medulloblastoma providing novel therapeutic targets as indicated by promising response to Celecoxib-therapy in vitro, in vivo and pilot clinical experience

  Milosevic J; Baryawno N; Sveinbjornsson B; Eksborg S; Holm S; Johnsen J-I; Kogner P
• Conference publication: CANCER RESEARCH. 2009;69

  Omega-3 fatty acids in cancer: Elucidation of the docosahexaenoic acid metabolic pathway in neuroblastoma cells, and definition of cytotoxic intermediates

  Gleissman H; Serhan C; Hamberg M; Lindskog M; Kogner P; Johnsen J
• Conference publication: CANCER RESEARCH. 2009;69

  Novel tyrosine kinase inhibitors are effective in in vitro models of high risk neuroblastoma

  Palmberg E; Rickardson L; Johnsen JI; Kogner P; Lindskog M
• Conference publication: CANCER RESEARCH. 2009;69

  Analysis of copy neutral loss of heterozygosity (CN-LOH) and other allelic imbalances in neuroblastoma tumors using high density single nucleotide polymorphism arrays (SNP-arrays)

  Kryh H; Caren H; Sjoberg R-M; Abrahamsson J; Kogner P; Martinsson T
• Conference publication: CANCER RESEARCH. 2009;69

  Small molecule inhibitors of PI3K/Akt signaling inhibit WntA#946;-catenin pathway crosstalk and suppress medulloblastoma growth

  Ninib B; Sveinbjornsson B; Eksborg S; Chen C-S; Kogner P; Johnsen J-I
• Conference publication: CANCER RESEARCH. 2009;69

  Neuroblastoma cells produce PGE₂ and express all four PGE₂ receptors: Implications for tumorigenesis

  Rasmuson A; Johnsen JI; Koshnevis M; Simon-SantaMaria J; Elfman L; Fuskevag OM; Orrego A; Kogner P; Sveinbjornsson B
• Article: CANCER. 2009;115(9):1977-1983

  Central Pathology Review in Multicenter Trials and Studies Lessons From the Nephroblastoma Trials

  Vujanic GM; Sandstedt B; Kelsey A; Sebire NJ
• Review: APOPTOSIS. 2009;14(4):424-438

  Embryonal neural tumours and cell death

  Johnsen JI; Kogner P; Albihn A; Henriksson MA
• Article: INTERNATIONAL JOURNAL OF CANCER. 2009;124(5):1227-1234

  Metronomic scheduling of imatinib abrogates clonogenicity of neuroblastoma cells and enhances their susceptibility to selected chemotherapeutic drugs in vitro and in vivo

  Paimberg E; Johnsen JI; Paulsson J; Gleissman H; Wickstrom M; Edgren M; Ostman A; Kogner P; Lindskog M
• Article: PEDIATRIC AND DEVELOPMENTAL PATHOLOGY. 2009;12(2):111-115

  Nonviable Tumor Tissue Should Not Upstage Wilms' Tumor from Stage I to Stage II: A Report from the SIOP 93-01 Nephroblastoma Trial and Study

  Vujanic GM; Harms D; Bohoslavsky R; Leuschner I; de Kraker J; Sandstedt B
• Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2009;34(3):697-705

  The Phox2 pathway is differentially expressed in neuroblastoma tumors, but no mutations were found in the candidate tumor suppressor gene PHOX2A

  Wilzen A; Nilsson S; Sjoberg R-M; Kogner P; Martinsson T; Abel F
• Article: PANCREATOLOGY. 2009;9(6):786-792

  Use of Angiotensin II Receptor Blockers and the Risk of Acute Pancreatitis: A Nested Case-Control Study

  Bexelius TS; Garcia Rodriguez LA; Lindblad M
• Article: BREAST CANCER RESEARCH. 2009;11(1):r6

  Human antimicrobial protein hCAP18/LL-37 promotes a metastatic phenotype in breast cancer

  Weber G; Chamorro CI; Granath F; Liljegren A; Zreika S; Saidak Z; Sandstedt B; Rotstein S; Mentaverri R; Sanchez F; Pivarcsi A; Stahle M
• Article: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2008;178(12):1245-1256

  Preventive but Not Late Amiloride Therapy Reduces Morbidity and Mortality of Lung Disease in βENaC-overexpressing Mice

  Zhou Z; Treis D; Schubert SC; Harm M; Schatterny J; Hirtz S; Duerr J; Boucher RC; Mall MA
• Article: INTERNATIONAL JOURNAL OF CANCER. 2008;123(12):2849-2855

  mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis

  Trager C; Vernby A; Kullman A; Ora I; Kogner P; Kagedal B
• Article: BIOCHEMICAL JOURNAL. 2008;416(2):153-159

  High incidence of DNA mutations and gene amplifications of the ALK gene in advanced sporadic neuroblastoma tumours

  Caren H; Abel F; Kogner P; Martinsson T
• Article: JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY. 2008;30(11):807-814

  The Influence of Pediatric Cancer Diagnosis and Illness Complication Factors on Parental Distress

  Hoven E; Anclair M; Samuelsson U; Kogner P; Boman KK
• Article: FASEB JOURNAL. 2008;22(10):3525-3536

  Expression of enzymes and receptors of the leukotriene pathway in human neuroblastoma promotes tumor survival and provides a target for therapy

  Sveinbjornsson B; Rasmuson A; Baryawno N; Wan M; Pettersen I; Ponthan F; Orrego A; Haeggstrom JZ; Johnsen JI; Kogner P
• Article: NEURO-ONCOLOGY. 2008;10(5):661-674

  Tumor-growth-promoting cyclooxygenase-2 prostaglandin E₂ pathway provides medulloblastoma therapeutic targets

  Baryawno N; Sveinbjornsson B; Eksborg S; Orrego A; Segerstrom L; Oqvist CO; Holm S; Gustavsson B; Kagedal B; Kogner P; Johnsen JI
• Article: GENES CHROMOSOMES & CANCER. 2008;47(10):845-852

  High-resolution molecular cytogenetic analysis of Wilms tumors highlights diagnostic difficulties among small round cell kidney tumors

  Stewenius Y; Jin Y; Ora I; Panagopoulos I; Moller E; Mertens F; Sandstedt B; Alumets J; Akerman M; Merks JHM; de Kraker J; Gisselsson D
• Article: BMC GENOMICS. 2008;9:353

  High-resolution array copy number analyses for detection of deletion, gain, amplification and copy-neutral LOH in primary neuroblastoma tumors:: Four cases of homozygous deletions of the CDKN2A gene

  Caren H; Erichsen J; Olsson L; Enerback C; Sjoberg R-M; Abrahamsson J; Kogner P; Martinsson T
• Article: INTERNATIONAL JOURNAL OF CANCER. 2008;123(2):389-394

  Assessment of NORE1A as a putative tumor suppressor in human neuroblastoma

  Geli J; Kogner P; Lanner F; Natalishvili N; Juhlin C; Kiss N; Clark GJ; Ekstrom TJ; Farnebo F; Larsson C
• Conference publication: NEURO-ONCOLOGY. 2008;10(3):515

  The cyclooxygenase-2 prostaglandin E2 pathway is expressed in childhood medulloblastoma providing novel therapeutic targets as indicated by promising response to NSAID-therapy in vitro, in vivo and pilot clinical experience

  Baryawno N; Sveinbjbornsson B; Eksborg S; Orrego A; Segerstrom L; Oqvist CO; Holm S; Gustavsson B; Kagedal B; Kogner P; Johnsen JI
• Conference publication: NEURO-ONCOLOGY. 2008;10(3):506

  A novel celecoxib derivate, OSU03012, suppresses medulloblastoma growth by inhibiting catenin function and MYC expression

  Baryawno N; Sveinbjornsson B; Eksborg S; Kogner P; Johnsen JI
• Article: ONCOGENE. 2008;27(20):2910-2922

  Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo

  Johnsen JI; Segerstrom L; Orrego A; Elfman L; Henriksson M; Kagedal B; Eksborg S; Sveinbjornsson B; Kogner P
• Article: CANCER IMMUNOLOGY IMMUNOTHERAPY. 2008;57(5):731-743

  Soluble factors released by activated cytotoxic T lymphocytes interfere with death receptor pathways in neuroblastoma

  De Geer A; Carlson L-M; Kogner P; Levitskaya J
• Article: AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE. 2008;177(7):730-742

  Development of chronic bronchitis and emphysema in β-epithelial Na⁺ channel-overexpressing mice

  Mall MA; Harkema JR; Trojanek JB; Treis D; Livraghi A; Schubert S; Zhou Z; Kreda SM; Tilley SL; Hudson EJ; O'Neal WK; Boucher RC
• Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2008;32(3):575-583

  Analysis of neuroblastoma tumour progression;: loss of PHOX2B on 4p13 and 17q gain are early events in neuroblastoma tumourigenesis

  Krona C; Caren H; Sjoberg R-M; Sandstedt B; Laureys G; Kogner P; Martinsson T
• Article: CELL RESEARCH. 2008;18(3):398-411

  Differentiation induced by physiological and pharmacological stimuli leads to increased antigenicity of human neuroblastoma cells

  Carlson L-M; Pahlman S; De Geer A; Kogner P; Levitskaya J
• Conference publication: ANTICANCER RESEARCH. 2008;28(5C):3187

  GROWTH OF HUMAN TUMOUR CELLS IN A CELLULAR MICROENVIRONMENT SUPPLIED BY HUMAN EMBRYONIC STEM CELL INDUCED TERATOMAS

  Cedervall J; Jamil S; Sveinbjornsson B; Lewensohn K-L; Eskandarpour M; Gulyas M; Ringborg U; Hansson J; Kogner P; Ahrulund-Richter L
• Article: BRITISH JOURNAL OF CANCER. 2007;97(10):1416-1424

  Genetic and epigenetic changes in the common Ip36 deletion in neuroblastoma tumours

  Caren H; Fransson S; Ejeskar K; Kogner P; Martinsson T
• Article: CLINICAL CANCER RESEARCH. 2007;13(22 Pt 1):6593-6602

  Defective chromosome segregation and telomere dysfunction in aggressive Wilms' tumors.

  Stewénius Y; Jin Y; Øra I; de Kraker J; Bras J; Frigyesi A; Alumets J; Sandstedt B; Meeker AK; Gisselsson D
• Conference publication: PEDIATRIC BLOOD & CANCER. 2007;49(4):542

  Distress symptoms in parents of patients after complicated cancer and acute lymphoblastic leukemia

  Hoven E; Anclair M; Kogner P; Samuelsson U; Boman K
• Article: AMERICAN JOURNAL OF SURGICAL PATHOLOGY. 2007;31(10):1459-1468

  Anaplastic sarcoma of the kidney - A clinicopothologic study of 20 cases of a new entity with polyphenotypic features

  Vujanic GM; Kelsey A; Perlman EJ; Sandstedt B; Beckwith JB
• Article: CLINICAL GASTROENTEROLOGY AND HEPATOLOGY. 2007;5(10):1160-1166.e1

  Angiotensin-converting enzyme inhibitors and risk of esophageal and gastric cancer:: A nested case-control study

  Sjoberg T; Garcia Rodriguez LA; Lindblad M
• Article: MOLECULAR CANCER THERAPEUTICS. 2007;6(9):2409-2417

  The novel melphalan prodrug J1 inhibits neuroblastoma growth in vitro and in vivo

  Wickstrom M; Johnsen JI; Ponthan F; Segerstrom L; Sveinbjornsson B; Lindskog M; Lovborg H; Viktorsson K; Lewensohn R; Kogner P; Larsson R; Gullbo J
• Meeting abstract: CYTOKINE. 2007;39(1):33

  Expression of TWEAK and Fn-14 in neuroblastoma, and their implications in tumorigenesis

  Pettersen I; Bakkelund WH; Winberg J-O; Johnsen JI; Kogner P; Sveinbjornsson B
• Conference publication: FEBS JOURNAL. 2007;274:229

  Decrease of aerobic mitochondrial energy metabolism in neuroblastoma

  Feichtinger RG; Mayr JA; Jones N; Schilling FH; Kogner P; Sperl W; Kofler B
• Article: LAKARTIDNINGEN. 2007;104(20-21):1597-1598

  [Transformation of microscopic colitis to inflammatory bowel disease].

  Janczewska I; Stål P; Sandstedt B
• Conference publication: NEURO-ONCOLOGY. 2007;9(2):197

  Cyclooxygenase 2 is abundantly expressed in medulloblastoma tumors and cell lines:: Nonsteroidal anti-inflammatory drugs are potent inhibitors of medulloblastoma growth

  Baryawno N; Sveinbjornsson B; Holm S; Orrego A; Gustavsson B; Johnsen JI; Kogner P
• Article: ENDOCRINE-RELATED CANCER. 2007;14(1):125-134

  The Ras effectors NORE1A and RASSF1A are frequently inactivated in pheochromocytoma and abdominal paraganglioma

  Geli J; Kiss N; Lanner F; Foukakis T; Natalishvili N; Larsson O; Kogner P; Hoog A; Clark GJ; Ekstrom TJ; Backdahl M; Farnebo F; Larsson C
• Article: CLINICAL CANCER RESEARCH. 2007;13(3):1036-1044

  Celecoxib prevents neuroblastoma tumor development and potentiates the effect of chemotherapeutic drugs in vitro and in vivo

  Ponthan F; Wickstroem M; Gleissman H; Fuskevag OM; Segerstroem L; Sveinbjoernsson B; Redfern CPF; Eksborg S; Kogner P; Johnsen JI
• Article: CLINICAL NUCLEAR MEDICINE. 2007;32(1):24-28

  Different concentrations of I-123 MIBG and In-111 pentetreotide in the two main liver lobes in children -: Persisting regional functional differences after birth?

  Jacobsson H; Hellstroem PM; Kogner P; Larsson SA
• Article: CHILDS NERVOUS SYSTEM. 2006;22(11):1497-1501

  Intrathecal aspergillosis and fusiform arterial aneurysms in an immunocompromised child:: a clinico-pathological case report

  Laurencikas E; Sandstedt B; Soderman M
• Article: INTERNATIONAL JOURNAL OF CANCER. 2006;119(3):493-500

  The antimicrobial peptide, Lactoferricin B, is cytotoxic to neuroblastoma cells in vitro and inhibits xenograft growth in vivo

  Eliassen LT; Berge G; Leknessund A; Wikman M; Lindin I; Lokke C; Ponthan F; Johnsen JI; Sveinbjornsson B; Kogner P; Flægstad T; Rekdal O
• Article: INTERNATIONAL JOURNAL OF CANCER. 2006;118(10):2584-2593

  Neuroblastoma cell death in response to docosahexaenoic acid: Sensitization to chemotherapy and arsenic-induced oxidative stress

  Lindskog M; Gleissman H; Ponthan F; Castro J; Kogner P; Johnsen JI
• Article: LAKARTIDNINGEN. 2006;103(18):1440-1443

  [Wilms tumor in children--considerably improved survival].

  Wåhlin N; Christofferson R; Pal N; Kullendorff C-M
• Conference publication: CANCER RESEARCH. 2006;66(8)

  COX inhibitors as a potential adjuvant therapy in childhood medulloblastoma

  Baryawno N; Sveinbjornsson B; Holm S; Orrego A; Gustavsson B; Kogner P; Johnsen JI
• Conference publication: CANCER RESEARCH. 2006;66(8)

  Omega-3 docosahexaenoic acid inhibits neuroblastoma cell growth in vivo

  Gleissman H; Lindskog M; Ponthan F; Elfman L; Johnsen JI; Kogner P
• Conference publication: CANCER RESEARCH. 2006;66(8)

  Neuroblastoma cells express all four PGE₂ receptor subtypes and specific receptor antagonists may inhibit tumor growth

  Rasmuson A; Johnsen JI; Orrego A; Kogner P; Sveinbjornsson B
• Conference publication: PROSTAGLANDINS & OTHER LIPID MEDIATORS. 2006;79(1-2):185

  Expression of 5-lipoxygenase in human neuroblastoma and effects of its inhibitors on neuroblastoma cell proliferation and apoptosis

  Sveinbjörnsson B; Johnsen JI; Rasmuson A; Pettersen I; Orrego A; Phontan F; Elfnan L; Kogner P
• Article: JOURNAL OF MOLECULAR NEUROSCIENCE. 2006;29(2):145-152

  Gangliocytes in neuroblastic tumors express alarin, a novel peptide derived by differential splicing of the galanin-like peptide gene

  Santic R; Fenninger K; Graf K; Schneider R; Hauser-Kronberger C; Schilling FH; Kogner P; Ratschek M; Jones N; Sperl W; Kofler B
• Article: EXPERIMENTAL PHYSIOLOGY. 2006;91(1):191-199

  Dynamic expression of the angiotensin II type 2 receptor and duodenal mucosal alkaline secretion in the Sprague-Dawley rat.

  Ewert S; Sjoberg T; Johansson B; Duvetorp A; Holm M; Fandriks L
• Review: CANCER LETTERS. 2005;228(1-2):247-255

  Proton magnetic resonance spectroscopy in neuroblastoma: Current status, prospects and limitations

  Lindskog M; Spenger C; Klason T; Jarvet J; Gräslund A; Johnsen JI; Ponthan F; Douglas L; Nordell B; Kogner P
• Review: CANCER LETTERS. 2005;228(1-2):195-201

  NSAIDs in neuroblastoma therapy

  Johnsen JI; Lindskog M; Ponthan F; Pettersen I; Elfman L; Orrego A; Sveinbjörnsson B; Kogner P
• Article: ACTA PAEDIATRICA. 2005;94(8):1073-1084

  Long-term follow-up of Langerhans cell histiocytosis: 39 years' experience at a single centre

  Bernstrand C; Sandstedt B; Åhström L; Henter JI
• Article: BIOMEDICAL ENGINEERING ONLINE. 2005;4:41

  Influence of electrical and thermal properties on RF ablation of breast cancer: is the tumour preferentially heated?

  Ekstrand V; Wiksell H; Schultz I; Sandstedt B; Rotstein S; Eriksson A
• Published conference paper: NEUROPEPTIDES. 2005;39(3):353-359

  Galanin and galanin receptors in human cancers

  Berger A; Santic R; Hauser-Kronberger C; Schilling FH; Kogner P; Ratschek M; Gamper A; Jones N; Sperl W; Kofler B
• Article: INTERNATIONAL JOURNAL OF CANCER. 2005;114(5):713-719

  Antimicrobial protein hCAP18/LL-37 is highly expressed in breast cancer and is a putative growth factor for epithelial cells

  Heilborn JD; Nilsson MF; Jimenez CIC; Sandstedt B; Borregaard N; Tham E; Sorensen OE; Weber G; Ståhle M
• Article: EUROPEAN JOURNAL OF CANCER. 2005;41(4):635-646

  Imbalance of the mitochondrial pro- and anti-apoptotic mediators in neuroblastoma tumours with unfavourable biology

  Abel F; Sjöberg RM; Nilsson S; Kogner P; Martinsson T
• Article: PEDIATRIC BLOOD & CANCER. 2004;43(7):737-741

  Intracranial relapse in Wilms tumor patients

  van den Heuvel-Eibrink MM; Graf N; Pein F; Sandstedt B; van Tinteren H; van der Vaart KE; de Kraker J
• Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2004;39(12):1306-1309

  Primary AL-amyloidosis, ulcerative colitis and collagenous colitis in a 57-year-old woman: A case study

  Janczewska I; Mejhert M; Hast R; Runarsson G; Sandstedt B
• Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2004;25(6):1849-1857

  Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-γ and TRAIL

  Johnsen JI; Pettersen I; Ponthan F; Sveinbjornsson B; Flægstad T; Kogner P
• Article: BRITISH JOURNAL OF CANCER. 2004;91(10):1835-1841

  Investigation of the role of SDHB inactivation in sporadic phaeochromocytoma and neuroblastoma

  Astuti D; Morris M; Krona C; Abel F; Gentle D; Martinsson T; Kogner P; Neumann HPH; Voutilainen R; Eng C; Rustin P; Latif F; Maher ER
• Article: CANCER RESEARCH. 2004;64(20):7210-7215

  Cyclooxygenase-2 is expressed in neuroblastoma, and nonsteroidal anti-inflammatory drugs induce apoptosis and inhibit tumor growth in vivo

  Johnsen JI; Lindskog M; Ponthan F; Pettersen I; Elfman L; Orrego A; Sveinbjörnsson B; Kogner P
• Article: JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE. 2004;96(19):1457-1466

  Predicting resistance or response to chemotherapy by proton magnetic resonance spectroscopy in neuroblastoma

  Lindskog M; Spenger C; Jarvet J; Gräslund A; Kogner P
• Article: LANCET. 2004;364(9441):1229-1235

  Reduction of postoperative chemotherapy in children with stage I intermediate-risk and anaplastic Wilms' tumour (SIOP 93-01 trial): a randomised controlled trial

  de Kraker J; Graf N; van Tinteren H; Pein F; Sandstedt B; Godzinski J; Tournade MF
• Article: JOURNAL OF PEDIATRICS. 2004;145(3):373-379

  Serious illness in childhood: The different threats of cancer and diabetes from a parent perspective

  Boman KK; Viksten J; Kogner P; Samuelsson U
• Article: PIGMENT CELL & MELANOMA RESEARCH. 2004;17(4):346-351

  Pterin-dependent tyrosine hydroxylase mRNA is not expressed in human melanocytes or melanoma cells

  Kågedal B; Kullman A; Lenner L; Träger C; Kogner P; Farnebäck M
• Article: BRITISH JOURNAL OF CANCER. 2004;90(2):515-521

  SLIT2 promoter methylation analysis in neuroblastoma, Wilms tumour and renal cell carcinoma

  Astuti D; da Silva NF; Dallol A; Gentle D; Martinsson T; Kogner P; Grundy R; Kishida T; Yao M; Latif F; Maher ER
• Published conference paper: SPECTROSCOPY. 2004;18(2):123-132

  Monitoring intracellular metabolites in neuroblastoma with 1H NMR spectroscopy: effects of growth factor withdrawal and modulation of lipid metabolism

  Lindskog M; Jarvet J; Graslund A; Kogner P
• Conference publication: INTERNATIONAL JOURNAL OF PSYCHOLOGY. 2004;39(5-6):398

  Time-profiles of parental distress symptoms in pediatric diabetes and childhood cancer: Guides for psychosocial care management and long-term follow-up

  Boman KK; Viksten J; Kogner P; Samuelsson U
• Article: CANCER RESEARCH. 2003;63(22):8006-8013

  Retinoids act as multistep modulators of the major histocompatibility class I presentation pathway and sensitize neuroblastomas to cytotoxic lymphocytes

  Vertuani S; De Geer A; Levitsky V; Kogner P; Kiessling R; Levitskaya J
• Conference publication: AMERICAN JOURNAL OF HUMAN GENETICS. 2003;73(5):335

  SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumours and renal cell carcinoma.

  Astuti D; da Silva NF; Dallol A; Gentle D; Martinsson T; Kogner P; Grundy R; Kishida T; Yao M; Latif F; Maher ER
• Conference publication: JOURNAL OF MEDICAL GENETICS. 2003;40:S66

  SIN promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma

  Astuti D; da Silva NF; Dallol A; Gentle D; Martinsson T; Kogner P; Grundy R; Kishida T; Yao M; Latif F; Maher ER
• Journal article: EUROPEAN JOURNAL OF CANCER, SUPPLEMENT. 2003;1(5):s195

  651 Blood and bone marrow transcripts of tyrosine hydroxylase, dopa decarboxylase, and GD2 synthase in neuroblastoma

  Kullman A; Träger C; Kogner P; Kágedal B
• Article: ONCOLOGY REPORTS. 2003;10(5):1587-1592

  Evaluation of anti-tumour effects of oral fenretinide (4-HPR) in rats with human neuroblastoma xenografts

  Ponthan F; Lindskog M; Karnehed N; Castro J; Kogner P
• Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2003;82(8):716-721

  Hyrtl's anastomosis is normally developed in placentas from small for gestational age infants

  Ullberg U; Lingman G; Ekman-Ordeberg G; Sandstedt B
• Article: JOURNAL OF CLINICAL ONCOLOGY. 2003;21(11):2077-2084

  Quality assessment of genetic markers used for therapy stratification

  Ambros IM; Benard J; Boavida M; Bown N; Caron H; Combaret V; Couturier J; Darnfors C; Delattre O; Freeman-Edward J; Gambini C; Gross N; Hattinger CM; Luegmayr A; Lunec J; Martinsson T; Mazzocco K; Navarro S; Noguera R; O'Neill S; Pötschger U; Rumpler S; Speleman F; Tonini GP; Valent A; Van Roy N; Amann G; De Bernardi B; Kogner P; Ladenstein R; Mickon J; Pearson ADJ; Ambros PF
• Article: JOURNAL OF MEDICAL VIROLOGY. 2003;70(1):14-19

  Identification of a unique BK virus variant in the CNS of a patient with AIDS

  Jorgensen GEK; Hammarin AL; Bratt G; Grandien M; Flægstad T; Johnsen JI
• Article: INTERNATIONAL JOURNAL OF CANCER. 2003;104(4):418-424

  The synthetic retinoid Ro 13-6307 induces neuroblastoma differentiation in vitro and inhibits neuroblastoma tumour growth in vivo

  Ponthan F; Johnsen JI; Klevenvall L; Castro J; Kogner P
• Article: ONCOGENE. 2003;22(15):2343-2351

  Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p;: mutation and stage-specific expression in UBE4B/UFD2

  Krona C; Ejeskär K; Abel F; Kogner P; Bjelke J; Björk E; Sjöberg RM; Martinsson T
• Article: FASEB JOURNAL. 2003;17(6):598-609

  Evidence for hypoxia-induced neuronal-to-chromaffin metaplasia in neuroblastoma

  Hedborg F; Ullerås E; Grimelius L; Wassberg E; Maxwell PH; Hero B; Berthold F; Schilling F; Harms D; Sandstedt B; Franklin G
• Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 2003;22(3):579-588

  Apoptosis and tumor remission in liver tumor xenografts by 4-phenylbutyrate

  Svechnikova I; Gray SG; Kundrotiene J; Ponthan F; Kogner P; Ekström TJ
• Article: BRITISH JOURNAL OF CANCER. 2003;88(3):478-485

  Noninvasive estimation of tumour viability in a xenograft model of human neuroblastoma with proton magnetic resonance spectroscopy (¹H MRS)

  Lindskog M; Kogner P; Ponthan F; Schweinhardt P; Sandstedt B; Heiden T; Helms G; Spenger C
• Article: CLINICAL CHEMISTRY. 2003;49(1):104-112

  Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastorna cells in blood and bone marrow

  Träger C; Kogner P; Lindskog M; Ponthan F; Kullman A; Kågedal B
• Article: EXPERIMENTAL DERMATOLOGY. 2002;11(6):584-591

  Neutrophil gelatinase-associated lipocalin is a marker for dysregulated keratinocyte differentiation in human skin

  Mallbris L; O'Brien KP; Hulthén A; Sandstedt B; Cowland JB; Borregaard N; Ståhle-Bäckdahl M
• Article: IMMUNOLOGY. 2002;107(1):145-151

  Expression and regulation of the pattern recognition receptors Toll-like receptor-2 and Toll-like receptor-4 in the human placenta

  Holmlund U; Cebers G; Dahlfors AR; Sandstedt B; Bremme K; Ekström ES; Scheynius A
• Article: PEDIATRIC BLOOD & CANCER. 2002;38(4):240-246

  Pharmacokinetics of acyclovir in immunocompromized children with leukopenia and mucositis after chemotherapy:: Can intravenous acyclovir be substituted by oral valacyclovir?

  Eksborg S; Pal N; Kalin M; Palm C; Söderhäll S
• Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2002;127(2):274-282

  IgE is expressed on, but not produced by, fetal cells in the human placenta irrespective of maternal atopy

  Ekström ES; Nilsson C; Holmlund U; Van der Ploeg I; Sandstedt B; Lilja G; Scheynius A
• Article: NEUROENDOCRINOLOGY. 2002;75(2):130-138

  Elevated expression of galanin receptors in childhood neuroblastic tumors

  Berger A; Tuechler C; Almer D; Kogner P; Ratschek M; Kerbl R; Lismaa TP; Jones N; Sperl W; Kofler B
• Article: PEDIATRIC BLOOD & CANCER. 2002;38(2):79-82

  Revised International Society of Paediatric Oncology (SIOP) working classification of renal tumors of childhood

  Vujanic GM; Sandstedt B; Harms D; Kelsey A; Leuschner I; de Kraker J
• Article: JOURNAL OF PEDIATRIC SURGERY. 2002;37(1):50-56

  Diagnosing childhood tumors:: A review of 147 cutting needle biopsies in 110 children

  Sköldenberg EG; Jakobson A; Elvin A; Sandstedt B; Olsen L; Christofferson RH
• Published conference paper: PEDIATRIC BLOOD & CANCER. 2002;38(1):33-40

  Fine needle aspiration cytology in the diagnosis and management of children and adolescents with Ewing sarcoma and peripheral primitive neuroectodermal tumor

  Fröstad B; Tani E; Brosjö O; Skoog L; Kogner P
• Article: BRITISH JOURNAL OF CANCER. 2001;85(12):2004-2009

  Bioavailability and dose-dependent anti-tumour effects of 9-cis retinoic acid on human neuroblastoma xenografts in rat

  Ponthan F; Kogner P; Bjellerup P; Klevenvall L; Hassan M
• Article: ONCOGENE. 2001;20(51):7573-7577

  RASSF1A promoter region CpG island hypermethylation in phaeochromocytomas and neuroblastoma tumours

  Astuti D; Agathanggelou A; Honorio S; Dallol A; Martinsson T; Kogner P; Cummins C; Neumann HPH; Voutilainen R; Dahia P; Eng C; Maher ER; Latif F
• Article: ANTICANCER RESEARCH. 2001;21(6A):3733-3738

  Interferon-γ modulates TRAIL-mediated apoptosis in human colon carcinoma cells

  Langaas V; Shahzidi S; Johnsen JI; Smedsrod B; Sveinbjornsson B
• Article: EXPERIMENTAL CELL RESEARCH. 2001;270(1):88-95

  Methylation changes in the human IGF2 P3 promoter parallel IGF2 expression in the primary tumor, established cell line, and xenograft of a human hepatoblastoma

  Eriksson T; Frisk T; Gray SG; von Schweinitz D; Pietsch T; Larsson C; Sandstedt B; Ekström TJ
• Article: ORAL SURGERY ORAL MEDICINE ORAL PATHOLOGY ORAL RADIOLOGY. 2001;92(4):420-423

  Severe oral mucositis after therapeutic administration of [¹³¹I]MIBG in a child with neuroblastoma

  Dahllöf G; Borgström P; Lundell G; Jacobsson H; Kogner P
• Article: BRITISH JOURNAL OF CANCER. 2001;84(11):1505-1511

  p53 mutations in urinary bladder cancer

  Berggren P; Steineck G; Adolfsson J; Hansson J; Jansson O; Larsson P; Sandstedt B; Wijkström H; Hemminki K
• Published conference paper: JOURNAL OF UROLOGY. 2001;165(6):2274-2279

  Angiogenesis and angiogenic growth factors in Wilms tumor

  Sköldenberg EG; Christiansson J; Sandstedt B; Larsson A; Läckgren G; Christofferson R
• Article: PLACENTA. 2001;22(4):372-379

  Presence of CD30⁺ and CD30L⁺ cells in human placenta and soluble CD30 levels in cord blood are independent of maternal atopy

  Ekström ES; Bengtsson Å; Svensson A; Nilsson C; Östlund E; Sandstedt B; Bremme K; Lilja G; Scheynius A
• Article: PEDIATRIC BLOOD & CANCER. 2001;36(4):459-468

  Pulmonary abnormalities at long-term follow-up of patients with Langerhans cell histiocytosis

  Bernstrand C; Cederlund K; Sandstedt B; Åhström L; Lundell M; Dahlquist G; Henter JI
• Article: ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA. 2001;80(1):1-6

  Hyrtl's anastomosis, the only connection between the two umbilical arteries. A study in full term placentas from AGA infants with normal umbilical artery blood flow

  Ullberg U; Sandstedt B; Lingman G
• Published conference paper: PEDIATRIC BLOOD & CANCER. 2001;36(1):61-66

  Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours

  Ejeskär K; Sjöberg RM; Abel F; Kogner P; Ambros PF; Martinsson T
• Published conference paper: PEDIATRIC BLOOD & CANCER. 2001;36(1):56-60

  Absence of somatostatin receptor expression in vivo is correlated to di- or tetraploid 1p36-deleted neuroblastomas

  Schilling FH; Ambros PF; Bihl H; Martinsson T; Ambros IM; Borgström P; Jacobsson H; Falkmer UG; Treuner J; Kogner P
• Published conference paper: PEDIATRIC BLOOD & CANCER. 2001;36(1):149-153

  Evidence of chromaffin oxygen sensing in neuroblastoma

  Hedborg F; Franklin G; Norrman J; Grimelius L; Wassberg E; Hero B; Schilling F; Berthold F; Harms D; Sandstedt B
• Published conference paper: PEDIATRIC BLOOD & CANCER. 2001;36(1):127-131

  The vitamin A analogues:: 13-cis retinoic acid, 9-cis retinoic acid, and Ro 13-6307 inhibit neuroblastoma tumour growth in vivo

  Ponthan F; Borgström P; Hassan M; Wassberg E; Redfern CPF; Kogner P
• Conference publication: CANCER GENE THERAPY. 2000;7(12):S5

  The human polyomavirus BK (BKV) and neuroblastoma;: Mechanisms of action and possible strategy for treatment

  Johnsen JE; Jorgensen GE; Pontan F; Traavik T; Kogner P; Flægstad T
• Article: INTERNATIONAL JOURNAL OF CANCER. 2000;88(5):685-691

  p53-mediated negative regulation of stathmin/Op18 expression is associated with G₂/M cell-cycle arrest

  Johnsen JI; Aurelio ON; Kwaja Z; Jörgensen GE; Pellegata NS; Plattner R; Stanbridge EJ; Cajot JF
• Published conference paper: PEDIATRIC BLOOD & CANCER. 2000;35(6):688-691

  Combined ¹¹¹In-pentetreotide scintigraphy and ¹²³I-mIBG scintigraphy in neuroblastoma provides prognostic information

  Schilling FH; Bihl H; Jacobsson H; Ambros PF; Martinsson T; Borgström P; Schwarz K; Ambros IM; Treuner J; Kogner P
• Published conference paper: PEDIATRIC BLOOD & CANCER. 2000;35(6):593-596

  Human polyomavirus BK (BKV) and neuroblastoma:: Mechanisms of oncogenic action and possible strategy for novel treatment

  Jorgensen GEK; Johnsen JI; Ponthan F; Kogner P; Flægstad T; Traavik T
• Article: JOURNAL OF INTERNAL MEDICINE. 2000;248(4):299-308

  Associations of leptin, insulin resistance and thyroid function with long-term weight loss in dieting obese men

  Näslund E; Andersson I; Degerblad M; Kogner P; Kral JG; Rössner S; Hellström PM
• Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 2000;6(2):161-169

  Expression of genes involved with cell cycle control, cell growth and chromatin modification are altered in hepatoblastomas

  Gray SG; Hartmann W; Eriksson T; Ekström C; Holm S; Kytölä S; von Schweinitz D; Pietsch T; Larsson C; Kogner P; Sandstedt B; Ekström TJ
• Article: BRITISH JOURNAL OF CANCER. 2000;83(2):171-176

  Limited neuropeptide Y precursor processing in unfavourable metastatic neuroblastoma tumours

  Bjellerup P; Theodorsson E; Jörnvall H; Kogner P
• Journal article: NUCLEAR MEDICINE COMMUNICATIONS. 2000;21(6):588

  Biodistribution of liposomal 131I-VIP in rat using gamma camera

  Hassan M; Refai E; Kogner P; Jonsson C; Andersson M; Jacobsson H; Larsson S
• Article: BRITISH JOURNAL OF CANCER. 2000;82(9):1561-1567

  Altered expression of members of the IGF-axis in hepatoblastomas

  Gray SG; Eriksson T; Ekström C; Holm S; von Schweinitz D; Kogner P; Sandstedt B; Pietsch T; Ekström TJ
• Article: PEDIATRIC BLOOD & CANCER. 2000;34(3):183-190

  Complete necrosis induced by preoperative chemotherapy in Wilms tumor as an indicator of low risk: Report of the International Society of Paediatric Oncology (SIOP) Nephroblastoma Trial and Study 9

  Boccon-Gibod L; Rey A; Sandstedt B; Delemarre J; Harms D; Vujanic G; De Kraker J; Weirich A; Tournade MF
• Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 2000;35(2):184-189

  Local short-chain fatty acids supplementation without beneficial effect on inflammation in excluded rectum

  Schauber J; Bark T; Jaramillo E; Katouli M; Sandstedt B; Svenberg T
• Article: CLINICAL CANCER RESEARCH. 2000;6(2):610-615

  Bladder cancer:: Allelic deletions at and around the retinoblastoma tumor suppressor gene in relation to stage and grade

  Wada T; Louhelainen J; Hemminki K; Adolfsson J; Wijkström H; Norming U; Borgström E; Hansson J; Sandstedt B; Steineck G
• Article: CYTOGENETIC AND GENOME RESEARCH. 2000;89(1-2):62-66

  Fine mapping of the human preprocortistatin gene (CORT) to neuroblastoma consensus deletion region 1p36.3→p36.2, but absence of mutations in primary tumors

  Ejeskär K; Abel F; Sjöberg RM; Bäckström J; Kogner P; Martinsson T
• Article: EUROPEAN RADIOLOGY. 2000;10(6):1026-1028

  Uptake of ¹¹¹In-pentetreotide and ^99mTc-labeled autologous granulocytes in Kimura's disease

  von Sivers K; Kettis AA; Svedhem V; Sandstedt B; Garmelius B; Jacobsson H
• Article: BRITISH JOURNAL OF CANCER. 1999;81(8):1402-1409

  Gain of chromosome arm 17q is associated with unfavourable prognosis in neuroblastoma, but does not involve mutations in the somatostatin receptor 2 (SSTR2) gene at 17q24

  Abel F; Ejeskär K; Kogner P; Martinsson T
• Conference publication: BRAIN RESEARCH. 1999;848(1-2):A31

  Galanin binding as a marker of clinical outcome in childhood neuroblastic tumors

  Berger A; Tuechler C; Almer D; Kogner P; Ambros IM; Ambros PF; Iismaa TP; Jones N; Sperl W; Kofler B
• Article: NUCLEAR MEDICINE AND BIOLOGY. 1999;26(8):931-936

  Biodistribution of liposomal ¹³¹I-VIP in rat using gamma camera

  Refai E; Jonsson C; Andersson M; Jacobsson H; Larsson S; Kogner P; Hassan M
• Conference publication: AMERICAN JOURNAL OF HUMAN GENETICS. 1999;65(4):A117

  Fine mapping of a neuroblastoma tumor suppressor candidate gene region in 1p36.2-3, and mutation analysis of the cortistatin gene localized to the region.

  Abel F; Ejeskar K; Sjoberg RM; Kogner P; Martinsson T
• Article: NATURE CELL BIOLOGY. 1999;1(5):312-319

  Mammalian Suppressor-of-Fused modulates nuclear-cytoplasmic shuttling of GLI-1

  Kogerman P; Grimm T; Kogerman L; Krause D; Undén AB; Sandstedt B; Toftgård R; Zaphiropoulos PG
• Published conference paper: PEDIATRIC RESEARCH. 1999;46(3):328-332

  The somatostatin analogue octreotide inhibits neuroblastoma growth in vivo

  Borgström P; Hassan M; Wassberg E; Refai E; Jonsson C; Larsson SA; Jacobsson H; Kogner P
• Article: LIFE SCIENCES. 1999;65(2):165-174

  In vivo evaluation of the biodistribution of ¹¹C-labeled PD153035 in rats without and with neuroblastoma implants

  Fredriksson A; Johnström P; Thorell JO; von Heijne G; Hassan M; Eksborg S; Kogner P; Borgström P; Ingvar M; Stone-Elander S
• Article: PEDIATRIC BLOOD & CANCER. 1999;32(6):433-435

  Position paper - Nephroblastoma with fibroadenomatous structures revisited

  Vujanic GM; Sandstedt B; Harms D; Delemarre JFM
• Article: INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE. 1999;3(6):585-589

  Variable expression and absence of mutations in p73 in primary neuroblastoma tumors argues against a role in neuroblastoma development

  Ejeskär K; Sjöberg RM; Kogner P; Martinsson T
• Article: INFECTION AND IMMUNITY. 1999;67(5):2561-2566

  The human cationic antimicrobial protein (hCAP18), a peptide antibiotic, is widely expressed in human squamous epithelia and colocalizes with interleukin-6

  Nilsson MF; Sandstedt B; Sorensen O; Weber G; Borregaard N; Ståhle-Bäckdahl M
• Article: PEDIATRIC BLOOD & CANCER. 1999;32(5):317-323

  New definitions of focal and diffuse anaplasia in Wilms tumor: The International Society of Paediatric Oncology (SIOP) experience

  Vujanic GM; Harms D; Sandstedt B; Weirich A; de Kraker J; Delemarre JFM
• Published conference paper: CANCER. 1999;87(2):60-68

  The use of fine-needle aspiration cytology in the molecular characterization of neuroblastoma in children

  Fröstad B; Martinsson T; Tani E; Falkmer U; Darnfors C; Skoog L; Kogner P
• Article: PEDIATRIC BLOOD & CANCER. 1999;32(4):283-288

  Pretreatment, ultrasound-guided cutting needle biopsies in childhood renal tumors

  Sköldenberg EG; Jakobson Å; Elvin A; Sandstedt B; Läckgren G; Christofferson RH
• Article: BRITISH JOURNAL OF ANAESTHESIA. 1999;82(3):391-394

  Neuropeptide Y response to tracheal intubation in anaesthetized children:: effects of clonidine vs midazolam as premedication

  Bergendahl HTG; Eksborg S; Kogner P; Lönnqvist PA
• Article: CANCER RESEARCH. 1999;59(5):1160-1163

  A possible contributory role of BK virus infection in neuroblastoma development

  Flægstad T; Andresen PA; Johnsen JI; Asomani SK; Jorgensen GE; Vignarajan S; Kjuul A; Kogner P; Traavik T
• Article: ACTA PAEDIATRICA. 1999;88(2):166-168

  Helicobacter pylori gastritis in children:: efficacy of 2 weeks of treatment with clarithromycin, amoxicillin and omeprazole

  Tirén U; Sandstedt B; Finkel Y
• Book chapter: MOLECULAR BIOLOGY OF HEMATOPOIESIS 6. 1999;p. 119-122

  Molecular Biology of Childhood Solid Tumors

  Dominici C; Kogner P
• Article: LABORATORY INVESTIGATION. 1999;79(1):67-79

  The basic helix-loop-helix transcription factor dHAND, a marker gene for the developing human sympathetic nervous system, is expressed in both high- and low-stage neuroblastomas

  Gestblom C; Grynfeld A; Ora I; Örtoft E; Larsson C; Axelson H; Sandstedt B; Cserjesi P; Olson EN; Påhlman S
• Published conference paper: PEDIATRIC BLOOD & CANCER. 1998;31(5):421-425

  Screening for neuroblastoma: Ethical and psychological aspects

  Philip T; Ladenstein R; Kogner P; Perrier L; Bergeron C
• Published conference paper: PEDIATRIC BLOOD & CANCER. 1998;31(5):408-418

  What can we expect from neuroblastoma screening? Clinicians point of view

  Ladenstein R; Matthay K; Berthold F; Kogner P; Pearson ADJ; Frappaz D; DeBernardi B; Yamamoto K; Hartmann O
• Article: NEUROSCIENCE LETTERS. 1998;253(1):17-20

  Levels and molecular forms of chromogranins in human childhood neuroblastomas and ganglioneuromas

  Eder U; Fischer-Colbrie R; Kogner P; Leitner B; Bjellerup P; Winkler H
• Article: BRITISH JOURNAL OF CANCER. 1998;77(11):1787-1791

  Loss of heterozygosity of 3p markers in neuroblastoma tumours implicate a tumour-suppressor locus distal to the FHIT gene

  Ejeskär K; Aburatani H; Abrahamsson J; Kogner P; Martinsson T
• Published conference paper: EUROPEAN JOURNAL OF CANCER. 1998;34(4):529-536

  The clinical use of fine needle aspiration cytology for diagnosis and management of children with neuroblastic tumours

  Fröstad B; Tani E; Kogner P; Maeda S; Björk O; Skoog L
• Article: PEDIATRIC RESEARCH. 1998;43(3):386-392

  Pediatric rhabdomyosarcomas express the intermediate filament nestin

  Kobayashi M; Sjöberg G; Söderhäll S; Lendahl U; Sandstedt B; Sejersen T
• Article: CANCER RESEARCH. 1998;58(3):448-452

  A lack of neuroblastoma in Down syndrome:: A study from 11 European countries

  Satgé D; Sasco AJ; Carlsen NLT; Stiller CA; Rubie H; Hero B; de Bernardi B; de Kraker J; Coze C; Kogner P; Langmark F; Hakvoort-Cammel FGAJ; Beck D; von der Weid N; Parkes S; Hartmann O; Lippens RJJ; Kamps WA; Sommelet D
• Article: INTERNATIONAL JOURNAL OF CANCER. 1998;75(2):176-180

  Promoter-specific methylation and expression alterations of igf2 and h19 are involved in human hepatoblastoma

  Li XR; Kogner P; Sandstedt B; Haas OA; Ekström TJ
• Article: LABORATORY INVESTIGATION. 1998;78(1):29-45

  Developmental gene expression of sympathetic nervous system tumors reflects their histogenesis

  Hoehner JC; Hedborg F; Eriksson L; Sandstedt B; Grimelius L; Olsen L; Pahlman S
• Article: JOURNAL OF INFECTIOUS DISEASES. 1998;177(1):247-252

  Virulence and colonization-associated properties of Helicobacter pylori isolated from children and adolescents

  Çelik J; Su B; Tirén U; Finkel Y; Thoresson AC; Engstrand L; Sandstedt B; Bernander S; Normark S
• Article: ARCHIVES OF ORAL BIOLOGY. 1997;42(12):869-876

  Effects of capsaicin in temporomandibular joint arthritis in rats

  Carleson J; Kogner P; Bileviciute I; Theodorsson E; Appelgren A; Appelgren B; Kopp S; Yousef N; Lundeberg T
• Article: CANCER RESEARCH. 1997;57(21):4677-4681

  Trichoepitheliomas contain somatic mutations in the overexpressed PTCH gene: Support for a gatekeeper mechanism in skin tumorigenesis

  Vorechovsky I; Unden AB; Sandstedt B; Toftgard R; StahleBackdahl M
• Article: VIRUS RESEARCH. 1997;52(1):61-71

  The human polyomavirus BK T antigen induces gene expression in human cytomegalovirus

  Kristoffersen AK; Johnsen JI; Seternes OM; Rollag H; Degré M; Traavik T
• Article: CANCER RESEARCH. 1997;57(20):4469-4473

  Inactivation of H19, an imprinted and putative tumor repressor gene, is a preneoplastic event during Wilms' tumorigenesis

  Cui HM; Hedborg F; He LM; Sandstedt B; PfeiferOhlsson S; Ohlsson R
• Published conference paper: EUROPEAN JOURNAL OF CANCER. 1997;33(12):2113-2116

  The International Neuroblastoma Risk Groups (INRG): a preliminary report

  Castleberry RP; Pritchard J; Ambros P; Berthold F; Brodeur GM; Castel V; Cohn SL; De Bernardi B; Dicks-Mireaux C; Frappaz D; Haase GM; Haber M; Jones DR; Joshi VV; Kaneko M; Kemshead JT; Kogner P; Lee REJ; Matthay KK; Michon JM; Monclair R; Roald BR; Seeger RC; Shaw PJ; Shimada H; Shuster JJ
• Published conference paper: EUROPEAN JOURNAL OF CANCER. 1997;33(12):2084-2089

  Somatostatin in neuroblastoma and ganglioneuroma

  Kogner P; Borgström P; Bjellerup P; Schilling FH; Refai E; Jonsson C; Dominici C; Wassberg E; Bihl H; Jacobsson H; Theodorsson E; Hassan M
• Published conference paper: EUROPEAN JOURNAL OF CANCER. 1997;33(12):2058-2063

  Coexpression of mRNA for the full-length neurotrophin receptor trk-C and trk-A in favourable neuroblastoma

  Svensson T; Rydén M; Schilling FH; Dominici C; Sehgal R; Ibáñez CF; Kogner P
• Published conference paper: EUROPEAN JOURNAL OF CANCER. 1997;33(12):2037-2042

  Analysis of candidate gene co-amplification with MYCN in neuroblastoma

  George RE; Kenyon R; McGuckin AG; Kohl N; Kogner P; Christiansen H; Pearson ADJ; Lunec J
• Published conference paper: EUROPEAN JOURNAL OF CANCER. 1997;33(12):1997-2001

  Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours

  Martinsson T; Sjöberg RM; Hallstensson K; Nordling M; Hedborg F; Kogner P
• Article: CANCER GENETICS. 1997;95(2):183-189

  Homozygous deletion of the neurofibromatosis-1 gene in the tumor of a patient with neuroblastoma

  Martinsson T; Sjoberg RM; Hedborg F; Kogner P
• Article: LABORATORY INVESTIGATION. 1997;76(5):717-728

  Collagenase-3 (MMP-13) is expressed during human fetal ossification and re-expressed in postnatal bone remodeling and in rheumatoid arthritis

  StahleBackdahl M; Sandstedt B; Bruce K; Lindahl A; Jimenez MG; Vega JA; LopezOtin C
• Article: AMERICAN JOURNAL OF PATHOLOGY. 1997;150(1):107-117

  In vivo spontaneous neuronal to neuroendocrine lineage conversion in a subset of neuroblastomas

  Gestblom C; Hoehner JC; Hedborg F; Sandstedt B; Pahlman S
• Article: LABORATORY INVESTIGATION. 1996;75(5):659-675

  A developmental model of neuroblastoma: Differentiating stroma-poor tumors' progress along an extra-adrenal chromaffin lineage

  Hoehner JC; Gestblom C; Hedborg F; Sandstedt B; Olsen L; Pahlman S
• Published conference paper: VETERINARY IMMUNOLOGY AND IMMUNOPATHOLOGY. 1996;54(1-4):127-131

  PR-39, a proline-rich peptide antibiotic from pig, and FALL-39, a tentative human counterpart

  Agerberth B; Gunne H; Odeberg J; Kogner P; Boman HG; Gudmundsson GH
• Article: AMERICAN JOURNAL OF MEDICAL GENETICS PART A. 1996;65(1):60-67

  Monosomy 1p36.31-33->pter due to a paternal reciprocal translocation: Prognostic significance of FISH analysis

  Blennow E; Bui TH; Wallin A; Kogner P
• Article: BRITISH JOURNAL OF CANCER. 1996;74(5):773-779

  Expression of mRNA for the neurotrophin receptor trkC in neuroblastomas with favourable tumour stage and good prognosis

  Ryden M; Sehgal R; Dominici C; Schilling FH; Ibanez CF; Kogner P
• Article: JOURNAL OF INVESTIGATIVE DERMATOLOGY. 1996;107(2):147-153

  Stromelyin-3 mRNA associated with myofibroblasts is overexpressed in aggressive basal cell carcinoma and in dermatofibroma but not in dermatofibrosarcoma

  Unden AB; Sandstedt B; Bruce K; Hedblad MA; StahleBackdahl M
• Article: INTERNATIONAL JOURNAL OF ONCOLOGY. 1996;8(6):1137-1142

  Analysis of location and integrity of the human PITSLRE (p58(cdc2L1)) genes in neuroblastoma cell genomes: Evidence against involvement in tumorigenesis

  Sjoberg RM; Hallstensson K; Nordling M; Kogner P; Gardellin P; Lubyova B; Onyango P; Weith A; Martinsson T
• Article: EUROPEAN JOURNAL OF PEDIATRICS. 1996;155(6):464-467

  Proctocolitis in exclusively breast-fed infants

  AnvedenHertzberg L; Finkel Y; Sandstedt B; Karpe B
• Article: NUCLEIC ACIDS RESEARCH. 1996;24(11):2158-2165

  Isolation and characterization of the QM promoter

  Farmer AA; Johnsen JI; Loftus TM; Smith KP; Stanbridge EJ
• Article: HISTOPATHOLOGY. 1996;28(4):333-340

  Rhabdoid tumour of the kidney: A clinicopathological study of 22 patients from the International Society of Paediatric Oncology (SIOP) nephroblastoma file

  Vujanic GM; Sandstedt B; Harms D; BocconGibod L; Delemarre JFM
• Article: JOURNAL OF ENDOCRINOLOGY. 1996;149(1):117-124

  Expression levels of the insulin-like growth factor-II gene (IGF2) in the human liver: Developmental relationships of the four promoters

  Li X; Cui H; Sandstedt B; Nordlinder H; Larsson E; Ekstrom TJ
• Conference publication: CYTOGENETIC AND GENOME RESEARCH. 1996;72(2-3):149

  Analysis of 1p-deletions in neuroblastoma tumors; Delimitation of the critical region with genetically mapped short tandem repeat polymorphisms

  Martinsson T; Sjoberg RM; Hallstensson K; Hedborg F; Kogner P
• Conference publication: CYTOGENETIC AND GENOME RESEARCH. 1996;72(2-3):149-150

  PITSLRE (p58cdc2L1) genes in neuroblastoma cell genomes: Evidence against involvement in tumorigenesis

  Martinsson T; Sjlberg R; Hallstensson K; Nordling M; Kogner P; Gardellin P; Lubyova B; Onyango P; Weith A
• Article: CANCER RESEARCH. 1995;55(23):5681-5686

  DELETION OF CHROMOSOME 1P LOCI AND MICROSATELLITE INSTABILITY IN NEUROBLASTOMAS ANALYZED WITH SHORT-TANDEM REPEAT POLYMORPHISMS

  MARTINSSON T; SJOBERG RM; HEDBORG F; KOGNER P
• Article: INTERNATIONAL JOURNAL OF CANCER. 1995;63(4):516-522

  CONSTITUTIONAL AND SOMATIC MUTATIONS IN THE WT1 GENE IN WILMS-TUMOR PATIENTS

  NORDENSKJOLD A; FRIEDMAN E; SANDSTEDT B; SODERHALL S; ANVRET M
• Article: LAKARTIDNINGEN. 1995;92(42):3903-3904

  [Young children may suffer from bacterial gastritis].

  Landehag J; Finkel Y; Granström M; Sandstedt B; Nordström B
• Article: LAKARTIDNINGEN. 1995;92(42):3885-3889

  [Inflammatory bowel disease or infectious colitis? Clinical picture, microbiology and histology offer guidelines].

  Schumacher G; Ljungh A; Sandstedt B
• Article: ONCOGENE. 1995;11(2):221-229

  EXPRESSION, PROMOTER USAGE AND PARENTAL IMPRINTING STATUS OF INSULIN-LIKE GROWTH-FACTOR-II (IGF2) IN HUMAN HEPATOBLASTOMA - UNCOUPLING OF IGF2 AND H19 IMPRINTING

  LI XR; ADAM G; CUI HM; SANDSTEDT B; OHLSSON R; EKSTROM TJ
• Other: ACTA ANAESTHESIOLOGICA SCANDINAVICA. 1995;39(5):705-708

  ADENOSINE FOR PEROPERATIVE BLOOD-PRESSURE CONTROL IN AN INFANT WITH NEUROBLASTOMA

  SELLDEN H; KOGNER P; SOLLEVI A
• Article: JOURNAL OF GENERAL VIROLOGY. 1995;76:1571-1581

  SUBPOPULATIONS OF NONCODING CONTROL REGION VARIANTS WITHIN A CELL CULTURE-PASSAGED STOCK OF BK VIRUS - SEQUENCE COMPARISONS AND BIOLOGICAL CHARACTERISTICS

  JOHNSEN JI; SETERNES OM; JOHANSEN T; MOENS U; MANTYJARVI R; TRAAVIK T
• Article: AMERICAN JOURNAL OF PATHOLOGY. 1995;147(1):102-113

  ASSOCIATION OF NEUROTROPHIN RECEPTOR EXPRESSION AND DIFFERENTIATION IN HUMAN NEUROBLASTOMA

  HOEHNER JC; OLSEN L; SANDSTEDT B; KAPLAN DR; PAHLMAN S
• Other: AMERICAN JOURNAL OF PATHOLOGY. 1995;146(5):1073-1078

  DECREASED EXPRESSION OF RAS GTPASE-ACTIVATING PROTEIN IN HUMAN TROPHOBLASTIC TUMORS

  STAHLEBACKDHAL M; INOUE M; ZEDENIUS J; SANDSTEDT B; DEMARCO L; FLAM F; SILFVERSWARD C; ANDRADE J; FRIEDMAN E
• Article: PEDIATRIC PATHOLOGY AND LABORATORY MEDICINE. 1995;15(3):469-475

  Nephrogenic rest associated with a mesoblastic nephroma--what does it tell us?

  Vujanić GM; Sandstedt B; Dijoud F; Harms D; Delemarre JF
• Article: AMERICAN JOURNAL OF PATHOLOGY. 1995;146(4):833-847

  IGF2 EXPRESSION IS A MARKER FOR PARAGANGLIONIC SIF CELL-DIFFERENTIATION IN NEUROBLASTOMA

  HEDBORG F; OHLSSON R; SANDSTEDT B; GRIMELIUS T; HOEHNER JC; PAHLMAN S
• Article: SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 1995;30(2):157-163

  Circulating granulocyte antibodies in first attacks of colitis.

  Schumacher G; Kollberg B; Sandstedt B; Ljungh A; Nässberger L
• Conference publication: JOURNAL OF CELLULAR BIOCHEMISTRY. 1995;:265

  FALL-39, A PUTATIVE NOVEL HUMAN PEPTIDE ANTIBIOTIC, CYSTEIN-FREE AND EXPRESSED IN BONE-MARROW AND TESTIS

  AGERBERTH B; GUNNE H; ODEBERG J; KOGNER P; BOMAN HG; GUDMUNDSSON GH
• Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 1995;92(1):195-199

  FALL-39, A PUTATIVE HUMAN PEPTIDE ANTIBIOTIC, IS CYSTEINE-FREE AND EXPRESSED IN BONE-MARROW AND TESTIS

  AGERBERTH B; GUNNE H; ODEBERG J; KOGNER P; BOMAN HG; GUDMUNDSSON GH
• Article: EUROPEAN JOURNAL OF CANCER. 1995;31A(4):557-560

  PANCREASTATIN IMMUNOREACTIVITY IN FAVORABLE CHILDHOOD NEUROBLASTOMA AND GANGLIONEUROMA

  KOGNER P; BJELLERUP P; SVENSSON T; THEODORSSON E
• Article: EUROPEAN JOURNAL OF CANCER. 1995;31A(4):481-485

  SOMATOSTATIN AND VASOACTIVE-INTESTINAL-PEPTIDE (VIP) IN NEUROBLASTOMA AND GANGLIONEUROMA - CHROMATOGRAPHIC CHARACTERIZATION AND RELEASE DURING SURGERY

  BJELLERUP P; THEODORSSON E; KOGNER P
• Article: EUROPEAN JOURNAL OF CANCER. 1995;31A(4):435-443

  BIOCHEMICAL-EVIDENCE FOR A MATURE PHENOTYPE IN MORPHOLOGICALLY POORLY DIFFERENTIATED NEUROBLASTOMAS WITH A FAVORABLE OUTCOME

  HEDBORG F; BJELFMAN C; SPAREN P; SANDSTEDT B; PAHLMAN S
• Review: VIRUS GENES. 1995;10(3):261-275

  NONCODING CONTROL REGION OF NATURALLY-OCCURRING BK VIRUS VARIANTS - SEQUENCE COMPARISON AND FUNCTIONAL-ANALYSIS

  MOENS U; JOHANSEN T; JOHNSEN JI; SETERNES OM; TRAAVIK T
• Review: NEUROSCIENCE FOR ADDICTION MEDICINE: FROM PREVENTION TO REHABILITATION - CONSTRUCTS AND DRUGS. 1995;104:325-338

  Neuropeptides in neuroblastomas and ganglioneuromas

  Kogner P
• Journal article: JOURNAL OF IMMUNOLOGICAL METHODS. 1994;173(2):149-156

  A 2-FUSION PARTNER SYSTEM FOR RAISING ANTIBODIES AGAINST SMALL IMMUNOGENS EXPRESSED IN BACTERIA

  HEY AW; JOHNSEN JI; JOHANSEN B; TRAAVIK T
• Journal article: ACTA PAEDIATRICA. 1994;83(4):423-427

  PLASMA NEUROPEPTIDE-Y IN HEALTHY-CHILDREN - INFLUENCE OF AGE, ANESTHESIA AND THE ESTABLISHMENT OF AN AGE-ADJUSTED REFERENCE INTERVAL

  KOGNER P; BJORK O; THEODORSSON E
• Book chapter: ACUTE LEUKEMIAS IV. 1994;p. 102-105

  Elevated Plasma Neuropeptide Y as a Marker of B Cell Precursor Leukemia in Children

  Kogner P; Ericsson A; Barbany G; Persson H; Theodorsson E; Björk O
• Journal article: PROGRESS IN CLINICAL AND BIOLOGICAL RESEARCH. 1994;385:147-153

  Expression of nerve growth factor receptor mRNAs and clinical response to retinoic acid in neuroblastoma.

  Kogner P; Barbany G; Persson H; Söderhäll S; Ahström L; Björk O
• Journal article: PROGRESS IN CLINICAL AND BIOLOGICAL RESEARCH. 1994;385:137-145

  Trk mRNA and low affinity nerve growth factor receptor mRNA expression and triploid DNA content in favorable neuroblastoma tumors.

  Kogner P; Barbany G; Björk O; Castello MA; Donfrancesco A; Falkmer UG; Hedborg F; Kouvidou H; Persson H; Raschella G
• Journal article: CANCER RESEARCH. 1993;53(9):2044-2050

  COEXPRESSION OF MESSENGER-RNA FOR TRK PROTOONCOGENE AND LOW-AFFINITY NERVE GROWTH-FACTOR RECEPTOR IN NEUROBLASTOMA WITH FAVORABLE PROGNOSIS

  KOGNER P; BARBANY G; DOMINICI C; CASTELLO MA; RASCHELLA G; PERSSON H
• Journal article: PEDIATRIC BLOOD & CANCER. 1993;21(5):317-322

  NEUROPEPTIDE-Y IN NEUROBLASTOMA - INCREASED CONCENTRATION IN METASTASIS, RELEASE DURING SURGERY, AND CHARACTERIZATION OF PLASMA AND TUMOR EXTRACTS

  KOGNER P; BJORK O; THEODORSSON E
• Journal article: BLOOD. 1992;80(5):1324-1329

  NEUROPEPTIDE-Y (NPY) SYNTHESIS IN LYMPHOBLASTS AND INCREASED PLASMA NPY IN PEDIATRIC B-CELL PRECURSOR LEUKEMIA

  KOGNER P; ERICSSON A; BARBANY G; PERSSON H; THEODORSSON E; BJORK O
• Journal article: NEUROPEPTIDES. 1992;22(1):36-37

  Vasoactive intestinal peptide (VIP) in ganglioneuromas and neuroblastomas with favourable outcome indicating tumor differentiating activity of VIP in vivo

  Kogner P; Rutgers M; Theodorsson E
• Journal article: NEUROPEPTIDES. 1992;22(1):64-65

  Tachykinin immunoreactivity in neuroblastoma tissue represents neurokinin A (NKA) but not neurokinin B (NKB)

  Svensson T; Kogner P; Theodorsson E
• Journal article: NEUROPEPTIDES. 1992;22(1):66

  Plasma neuropeptide Y (NPY) in neuroblastoma: Prognostic significance and chromatographic characterization

  Theodorsson E; Kogner P; Björk O
• Journal article: NEUROPEPTIDES. 1992;22(1):36

  Neuropeptide Y (NPY) synthesis in malignant B-cell precursors and clinical significance of elevated plasma NPY

  Kogner P; Björk O; Ericsson A; Barbany G; Persson H; Theodorsson E
• Journal article: PEDIATRIC BLOOD & CANCER. 1992;20(4):292-300

  N-MYC GENE AMPLIFICATION IN NEUROBLASTOMA - A CLINICAL APPROACH USING ULTRASOUND GUIDED CUTTING NEEDLE BIOPSIES COLLECTED AT DIAGNOSIS

  HEDBORG F; LINDGREN PG; JOHANSSON I; KOGNER P; SAMUELSSON BO; BEKASSY AN; OLSEN L; KREUGER A; PAHLMAN S
• Journal article: PROGRESS IN CLINICAL AND BIOLOGICAL RESEARCH. 1991;366:351-357

  CHARACTERIZATION OF NEUROPEPTIDE-Y IN PEDIATRIC NEURAL CREST TUMORS - RELATION TO TUMOR MALIGNANCY AND GENETIC FINDINGS

  KOGNER P; BJORK O; HEDBORG F; NORDENSKJOLD A; NORDENSKJOLD M; SODERHALL S; THEODORSSON E
• Journal article: PROGRESS IN CLINICAL AND BIOLOGICAL RESEARCH. 1991;366:367-373

  PLASMA NEUROPEPTIDE-Y (NPY) - A NOVEL MARKER OF NEUROBLASTOMA

  KOGNER P; THEODORSSON E; BJORK O
• Journal article: ANNALS OF THE NEW YORK ACADEMY OF SCIENCES-SERIES. 1990;611:495-496

  NEUROPEPTIDE-Y IN PEDIATRIC NEURAL CREST TUMORS - CORRELATION WITH MALIGNANCY, METASTASES, AND CLINICAL OUTCOME

  KOGNER P; THEODORSSON E; BJORK O
• Journal article: ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 1990;611(1):495-496

  Neuropeptide Y in Pediatric Neural Crest Tumors

  KOGNER P; THEODORSSON E; BJÖRK O
• Conference publication: CENTRAL AND PERIPHERAL SIGNIFICANCE OF NEUROPEPTIDE Y AND ITS RELATED PEPTIDES. 1990;611:495-496

  NEUROPEPTIDE-Y IN PEDIATRIC NEURAL CREST TUMORS - CORRELATION WITH MALIGNANCY, METASTASES, AND CLINICAL OUTCOME

  KOGNER P; THEODORSSON E; BJORK O
• Journal article: PEDIATRIC PATHOLOGY. 1990;10(1-2):207-216

  Neuropeptide Y as a marker in pediatric neuroblastoma.

  Kogner P; Björk O; Theodorsson E
• Conference publication: PEDIATRIC RESEARCH. 1989;25(4):A319

  OBSTRUCTIVE SLEEP-APNEA IN ARNOLD-CHIARI MALFORMATION TREATED WITH ACETAZOLAMIDE

  MILERAD J; LAGERCRANTZ H; KOGNER P
• Show more

Staff and contact

Group leader

• 

  John Inge Johnsen

  Principal Researcher | Docent

  E-mail john.inge.johnsen@ki.se
• 

  Per Kogner

  Professor, Senior

  E-mail per.kogner@ki.se

All members of the group

• 

  Oscar Bedoya Reina

  Affiliated to Research

  E-mail oscar.bedoya.reina@ki.se
• 

  Tomas Bexelius

  Affiliated to Research

  E-mail tomas.bexelius@ki.se
• Cecilia Dyberg

  Assistant Professor

  E-mail cecilia.dyberg@ki.se
• 

  Kleopatra Georgantzi

  Affiliated to Research

  Telephone +46852486049

  E-mail kleopatra.georgantzi@ki.se
• Gustav Hedberg

  Clinical Assistant

  E-mail gustav.hedberg@ki.se
• 

  Kristina Susana Ihrmark Lundberg

  Phd Student

  E-mail kristina.ihrmark.lundberg@ki.se
• Thale Kristin Olsen

  Affiliated to Research

  E-mail thale.kristin.olsen@ki.se
• Niklas Pal

  Affiliated to Research

  E-mail niklas.pal@ki.se
• 

  Panagiotis Alkinoos Polychronopoulos

  Phd Student

  E-mail alkinoos.polychronopoulos@ki.se
• Diana Treis

  Affiliated to Research

  E-mail diana.treis@ki.se
• 

  Catarina Träger

  Affiliated to Research

  E-mail catarina.trager@ki.se
• Dimitrios Tsagkogiannis

  Affiliated to Research

  E-mail dimitrios.tsagkogiannis@ki.se
• 

  Ioanna Tsea

  Postdoctoral Studies

  E-mail ioanna.tsea@ki.se